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ABSTRACT 
This dissertation focuses on the design and tailoring of dirhodium complexes and the 
investigation of their structural, spectroscopic and theoretical properties. The variation of 
the ligands occupying the equatorial (eq) positions results in appreciable changes in the 
structure and the electronic properties, which renders them suitable for different 
applications.  
     The coordination of methyl isocyanide ligands to dirhodium centers bridged by 
electron-rich formamidinate or orthometalated phosphine ligands led to a family of 
unprecedented dirhodium complexes of general formula cis-[Rh2(μ-L)2(CNCH3)6]
2+
 (L = 
bridging ligand). These complexes exhibit unusually long Rh-Rh bond distances and 
short Rh-C (CH3NC) contacts and exhibit the unexpected bonding situation in which the 
Rh2(π*) levels lie lower in energy than the Rh2(σ) orbitals. 
     Reactions between cis-[Rh2(Form)2(CH3CN)6]
2+
 (Form = formamidinate) and the 
electron accepting chelating diimine ligands dpq = dipyrido[3,2-f:2',3'-h]-quinoxaline, 
dppz = dipyrido[3,2-a:2’,3’-c]phenazine and dppn =  benzo[i]dipyrido[3,2-a:2’,3’-
h]quinoxaline produce complexes of the general type cis-[Rh2(Form)2(N-N)2]
2+
 with 
intriguing photophysical properties. The lowest energy absorption in their electronic 
absorption spectra is a Ligand-to-Ligand Charger-Transfer (LL’CT) transition which 
leads to interesting excited state reactivity patterns, most notably water reduction to 
produce hydrogen. 
     Three 6-R-hydroxyl-pyridine ligand with different substituents (R= -CH3, -F, -Cl) 
was selected as a bridging ligand for the series of partial paddlewheel complexes cis-
iii 
 
[Rh2(μ-L)2(CH3CN)6]
2+
. The goal was to probe the effect of the bridging ligand 
substituents on the lability of the eq CH3CN ligands. It was shown the substitution rate 
of the eq CH3CN ligands is intimately correlated to the electronic characteristics of the 
bridging ligands with decreased lability occurring in the order of  –F < –Cl < –CH3, in 
accord with the stronger trans effect exerted by the more electron donating ligands. 
     Additional efforts to tune the electronic properties of dirhodium complexes with 
chelating diimine ligands include the search for new bridging ligands, e.g. [Ph2P(C6H4)]
-
. 
Density Functional Theory (DFT) and Time Dependent (TD) DFT calculations on the 
synthesized cis-[Rh2[Ph2P(C6H4)]2(N-N)2]
2+
 (N-N = dpq, dppz, and dppn) complexes 
indicate that they exhibit very different electronic structures as compared to the 
dirhodium complexes with formamidinate bridging ligands. 
     Finally, additional studies were directed at the synthesis of ligands with hydrophilic 
functional groups to improve the water solubility of the complexes in order to enhance 
their activity as photodynamic anticancer therapy agents and water reduction 
photocatalysts. 
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CHAPTER I  
INTRODUCTION 
Dirhodium complexes play important roles in various areas of chemical research due to 
the ease with which their properties can be tuned through rational ligand design. They 
have been widely used in many different applications such as carbene transfer reaction 
catalysts,
 1 , 2
 anticancer 
3 - 7
and photodynamic therapy agents,
8 - 10
 building blocks for 
supramolecular arrays,
11 , 12
 photocatalysts for H2O reduction,
13 -
 
17
chromogenic or 
fluorescence-based sensors for small gaseous molecules such as NO 
18
 and CO 
19,20
 as 
well as many others.
21
 The most common dirhodium complexes in the literature are 
those bridged by four carboxylate ligands in the equatorial (eq) positions with two labile 
ligands occupying the axial (ax) positions as shown in Figure 1.1. Other important 
bridging ligands include formamidinates, triazenides and acetamides as well as 
orthometalated phosphines.
21
 One fundamental aspect of the investigation of these 
dirhodium complexes is the effect of the co-ligands on their electronic structures. 
Without the perturbation of the ligand field, the d
7
-d
7
 dirhodium(II,II) center core 
generally adopts the electronic structure σ2π4δ2δ*2π*4σ0, which results in a bond order of 
1 (Figure 1.2).
21 
Upon coordination of bridging ligands, such as the carboxylate groups, 
the interactions between the Rh2(δ*) orbitals with the pπ lone pairs on the O atoms 
results in a destabilization of the Rh2(δ*) orbital. Therefore, the electronic configuration 
pertaining to the dimetal centers changes to σ2π4δ2 π*4δ*2σ0. 22  In the electronic 
absorption spectra of Rh2(μ-OCCR)42L (L = CH3CN, CH3OH, pyridine, PPh3), the 
lowest energy absorption band originates from the Rh2(π*) to the Rh2(σ*) orbital 
  2 
 
transitions as predicted by many different levels of calculations: this transition is 
responsible for the wide variety of colors observed for dirhodium paddlewheel 
complexes. The ax ligands, which are usually kinetically labile, only affect the σ type 
orbitals.
21
 On the other hand, the eq ligands, which are generally more stable as 
compared to the ax ligands, influence both the π and δ types of orbitals. Generally, the 
eq ligands are more influential in determining the chemical properties of the complexes. 
For example, dirhodium complexes with chiral carboxylate groups in the eq positions are 
demonstrated to be effective for catalyzing the formation of chiral organic molecules.
1,2
 
Another good example is that the replacement of the four eq carboxylate groups with 
more electron-rich formamidinate groups, e.g. Rh2(DTolF)4, Rh2(F-form)4, renders them 
excellent reducing agents in their excited states and thus useful for the decomposition of 
harmful organic pollutants in the environment.
23
  
 
 
 
 
 
Figure 1.1 Structural representation of dirhodium tetracarboxylate complexes. 
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Figure 1.2 Depictions of the d orbital overlap for metal-metal bonded units. 
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     In the Dunbar research group, we have long been interested in the design and 
synthesis of partial paddlewheel dirhodium complexes featuring two cis-oriented 
bridging groups in the eq positions with the remaining sites being occupied by either 
monodentate or diimine ligands as shown in Figure 1.3. The exploration of their 
applications as photodynamic therapy (PDT) agents for cancer treatment and 
photocatalysts for H2O reduction are important aspects of our research in this area.   
 
 
 
 
Figure 1.3 Structural representation of two types of partial paddlewheel complexes. 
 
 
 
Photodynamic therapy 
Photodynamic therapy is a rapidly evolving approach for the treatment of cancer and 
pre-cancerous conditions.
24
 Typically, the administration of photosensitizers (PS) is 
followed by selectively irradiating the affected area with low intensity light (preferably ~ 
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600-850 nm). Reactive oxygen species (ROS) such as singlet oxygen, 
1
O2, are generated 
through an energy transfer process (Figure 1.4).
25-27 
Subsequently, these cytotoxic ROS 
oxidize various biomolecules including proteins, nucleic acids and lipids.
28
 These 
reactions eventually lead to cell death in the tumors while only inducing a low level of 
systematic cytotoxicity towards normal tissues.
29-33 
 
 
 
 
Figure 1.4 Relaxation pathways for the excited photosensitizer, with the display of the 
1
O2 generation through an energy transfer process. 
 
 
 
     Successful candidates as photosensitizers in PDT treatment should conform to the 
following criteria: Firstly, it is preferable for them to be activated by red or near infrared 
light, for the purpose of deeper tissue penetration as well as producing less damage to 
the surrounding normal tissues. Secondly, they should be soluble in aqueous solution for 
easy administration. Thirdly, they should be chemically stable and have very low 
systemic cytotoxicity in the dark. 
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     Most 
1
O2 sensitizing agents are organic molecules such as those depicted in Figure 
1.5,
34
 but some transition metal complexes are also very efficient photosensitizers for the 
generation of 
1
O2 especially Ru(II)
35,36
, Os(II)
37
, Ir(III)
38,39
, Re(I) 
40,41
compounds. In 
particular, various Ru(II) diimine complexes exhibit very strong absorptions in the 
visible region and can generate 
1
O2 in aerated solutions through a long-lived metal-to-
ligand charge-transfer (MLCT) process with relatively high quantum yields upon light 
irradiation.
42
 In addition to the sensitization of 
1
O2, the quenching of the excited states of 
transition metal complexes can be triggered by an electron transfer process (redox event). 
During this period, the in situ generated products are shown to capable of binding to or 
oxidizing biomolecules
43
 which provides an advantage for transition metal complexes as 
effective PDT agents against hypoxic tumors, since their anticancer activity is 
independent of O2. 
     Initially, the Turro group explored the photochemistry of Rh2(μ-O2CCH3)4•2L (L: 
alcohol, PPh3, pyridine, THF, H2O).
44  
These complexes exhibit long-lived excited states 
(τ = 3.5-5.0 µs) that can be accessed by visible light irradiation (500-700 nm). Moreover, 
the bis-aqua species Rh2(μ-O2CCH3)4•2H2O is able to bind to and photocleave DNA (Kb 
= 4.6x10
2 
M
-1
) in the presence of electron acceptors such as 3-cyano-1-methylpyridinium 
tetrafluoroborate in its excited state due to the generation of the mixed valence cation 
[Rh2(µ-O2CCH3)4]
+
. 
     Follow-up studies by us involved the incorporation of electron accepting diimine 
ligands directly into the scaffold of the dirhodium core; these include dpq (dipyrido[3,2- 
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Figure 1.5 Chemical structures of commonly used organic photosensitizers for the 
generation of 
1
O2. 
 
 
 
f:2',3'-h]-quinoxaline), dppz (dipyrido[3,2-a:2’,3’-c]phenazine) and dppn 
((benzo[i]dipyrido[3,2-a:2’,3’-h] quinoxaline) ligands. For example, the compounds cis-
[Rh2(µ-O2CCH3)2(dppz)(η
1
-O2CCH3)(CH3OH)]
+
 and cis-[Rh2(µ-O2CCH3)2(dppz)2]
2+
 
cause direct pUC18 plasmid cleavage in vitro upon the irradiation with visible light (λirr > 
395 nm, 15 min), resulting in the formation of nicked circular DNA (Figure 1.6).
45-47 
One advantage afforded by the aforementioned complexes as compared to the commonly 
used organic photosensitizers is that the photocleavage of DNA occurs in the absence of 
O2. In addition, cell studies showed a 3.4-fold increase of the cytotoxicity for cis-[Rh2(µ-
O2CCH3)2(dppz)2]
2+
 towards human skin cells (Hs-27) upon irradiation (with 400-700 
nm light for 30 min). Moreover, the series of dirhodium-dppn complexes, e.g. cis-
[Rh2(µ-O2CCH3)2(dppz)(dppn)]
2+
 and cis-[Rh2(µ-O2CCH3)2(dppn)2]
2+
  were reported to 
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exhibit a 21- and 24- fold increase of cytotoxicity towards Hs-27 human skin fibroblasts 
upon irradiation with visible light (λirr > 375 nm, 30 min) respectively as compared to 
their activities in the dark.
48
 
 
 
 
 
Figure 1.6 Ethidium bromide stained agarose gels (2%) of 100 μM pUC18 plasmid in 
the presence of 20 μM cis-[Rh2(µ-O2CCH3)2(dppz)2]
2+
 in 5 mM Tris, 50 mM NaCl (pH 
= 7.5) buffer solution irradiated with λirr > 395 nm light: (a) lane 1, plasmid only, dark; 
lane 2, plasmid + SmaI; lane 3, plasmid + 1, dark; lane 4, plasmid + 1, irr 15 min; lane 5, 
plasmid + compound, dark; lane 6, plasmid + compound, irr for 15 min; (b) lane 1, 
plasmid only, dark; lane 2, plasmid only, irr for 20 min; lane 3, plasmid + compound, 
dark; lane 4, plasmid + compound, irr for 20 min, air; lane 5, plasmid + compound, irr 
for 20 min, 50% D2O; lane 6, plasmid + compound, irr for 20 min, under N2 ; lane 7, 
plasmid + compound, irr for 20 min, freeze-pump-thaw. 
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     Another important partial paddlewheel dirhodium (II,II) complex with excellent 
potential as a PDT agent is depicted in Figure 1.3a, namely cis-[Rh2(µ-
O2CCH3)2(CH3CN)6][BF4]2.
8
 Irradiation of this compound with visible light (400-700 
nm) for 30 minutes induced cell damage towards the Hs-27 human skin cells with LC50 
values decreasing from 410 ± 9 to 12 ± 2µM. The 34-fold increase of toxicity upon 
irradiation is attributed to the generation of the photoactive species cis-[Rh2(µ-
O2CCH3)2(CH3CN)2(H2O)4]
2+
, which binds to double-stranded  DNA (ds-DNA) as 
evidenced by the gel mobility studies shown in Figure 1.7. The generation of this active 
species occurs via a one-photon process, leading to the initial photosubstitution of one eq 
CH3CN ligand, followed by the loss of a second eq CH3CN ligand bound to the same 
metal center in a dark reaction.
9
 Time-dependent Density Functional Theory (TD-DFT) 
calculations for three different isomers of cis-[Rh2(µ-O2CCH3)2(CH3CN)2(H2O)4]
2+
 were 
performed, indicating the charge-transfer process in the excited states involving placing 
electron density onto the σ* molecular orbital between Rh and the eq CH3CN ligands. 
This explains the facile dissociation of two eq CH3CN ligands upon irradiation. The 
quantum yield for this exchange process is also dependent on the power of the light used 
during the photolysis experiment, which is characteristic of the excited states of 
transition metal complexes. Of even greater interest, the increase of cytotoxicity is also 
independent of O2.  
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Figure 1.7 Imaged ethidium bromide stained agarose gel of 50 μM linearized pUC18 
plasmid (10 mM phosphate, pH = 7.5) in the presence of various concentrations of cis-
[Rh2(µ-O2CCH3)2(CH3CN)6][BF4]2 (a) irradiated (λ > 455 nm) and (b) incubated in the 
dark at 25 °C for 20 min; lanes 1 and 8: DNA molecular weight standard (1kb, Sigma); 
lanes 2 and 7: linearized plasmid alone; lanes 3-6: [DNA bp]/[complex] ) 100, 20, 10, 5. 
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Photocatalysis for H2O reduction 
The environmental issues and impending energy crisis arising from the rapid 
consumption of traditional fossil fuels has led to an upsurgence in research aimed at 
developing clean and renewable energy resources.
49
 Utilization of abundant sunlight is 
an attractive alternative solution to these problems but one major challenge lies in its 
storage for further use.
50-51
 One simple and effective way is to convert it into chemical 
bonds, such as the photocatalytic reduction of H2O to produce H2 as a clean fuel. Nature 
provides elegant catalytic systems for this purpose in the form of hydrogenases whose 
active sites are composed of dinuclear thiolate bridged nickel and/or iron complexes 
with ancillary CO and CN
-
 ligands.
52
 Their instability under ambient conditions
53, 54
 
requires further development using more stable coordination complexes.   
     The photocatalytic systems for H2O reduction studied to date are typically composed 
of multiple parts: a photosensitizer to harvest photons, a sacrificial electron donor to 
provide the electron source, the photocatalyst, and a redox-active electron mediator 
couple to effect electron transfer between the photosensitizer and the photocatalyst under 
most conditions.
55
 The commonly used photosensitizers include complexes of Ru(II),
56
 
Pt(II),
57, 58
 Re(I),
59,60
 Ir(III)
61
 as well as some newly reported Cu(I) complexes.
62
 The 
catalysts used with these sensitizers are generally based on Co(II),
63
 Ni(II),
64
 Mo(III),
65
 
and Fe(II).
66
  These systems, however, require further improvement since the additional 
charge-transfer step between the photosensitizer and the catalysts reduces the efficiency 
of the H
+
 reduction process. 
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     Two different strategies have been developed to address this issue. The first one is the 
incorporation of the photosensitizer directly into the water reduction catalyst. One 
typical example in this category is the tethering of a Ir(III) photosensitizer to the 
cobaloxime catalyst (Figure 1.8), leading to a turnover number (TON) of 210 after 15 h 
irradiation (TOF = 42 h
–1
) for the catalytic system (600 equivalents of Et3N as sacrificial 
electron donor and 600 equivalents of Et3NH
+
 as the proton source).
67
 This result 
represents a better performance as compared to a TON of 160 under the same conditions 
for the multicomponent system. 
     Another strategy is to design transition metal complexes that can act as both a 
photosensitizer and a H
+
 reduction catalyst, such as LRh(0)2(dfpma)3L or the mixed-
valence compound LRh(0)Rh(II)(dfpma)3X2 (Figure 1.9a) (dfpma = MeN(PF2)2, L = CO, 
PR3, CNR, X = Cl, Br) studied by Nocera and coworkers.
68-70
 Important progress has 
been made by the same group of researchers, including the design of complexes with 
more oxidizing dimetal centers, such as the homobimetallic bioctahedral d
7–d7 complex 
Pt2(III,III)(tfepma)2Cl6 (tfepma = MeN[P(OCH2CF3)2]2) (Figure 1.9b) which 
photoeliminates Cl2 in the excited state. The quantum yield for the bis-platinum complex 
reaches 38% as compared to a quantum yield of < 1% for the aforementioned dirhodium 
complexes.
71
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Figure 1.8 Chemical structure of the assembly of an Ir(III) photosensitizer with the 
Co(II) catalyst. 
 
 
 
 
Figure 1.9 Structures of Rh and Pt catalysts for H2 generation. 
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CHAPTER II  
COMPREHENSIVE INVESTIGATION OF A FAMILY OF UNUSUAL PARTIAL 
PADDLEWHEEL DIRHODIUM ISOCYANIDE COMPLEXES
*
 
Introduction 
Dirhodium complexes are important members of the large family of metal-metal bonded 
compounds. One central issue for research pertaining to dirhodium complexes is the 
modification of the equatorial ligands to tune properties. For example, cis-
[Rh2(DTolF)2(O2CCF3)2]•2H2O ([DTolF]
-
 = p-ditolylformamidinate) exhibits 
comparable anticancer activity to the widely used chemotherapy drug cisplatin but with 
reduced toxicities,
72
 and dirhodium complexes with orthometalated phosphines and other 
N,O-donor type bridging groups are excellent catalysts for enantioselective C-H 
insertion reactions of α-diazo compounds via metallocarbene intermediates.1,2,73  In a 
similar vein, the progressive replacement of the acetate groups by the more electron-rich 
acetamidate ligands in the series of Rh2(O2CCH3)4-n(HNCOCH3)n (n = 1-4) increases the 
electron density on the dirhodium core and thus raises the energy of the HOMO orbital 
rendering the substituted derivatives better electron donors than Rh2(O2CCH3)4.
74,75
 In 
fact, Rh2(HNCOCH3)4, Rh2(DPhF)4
76
 (DPhF: N,N'-diphenylformamidinate) and 
Rh2(DTolF)4 form stable complexes with CO at room temperature,
77
 as compared to 
Rh2(O2CCH3)4(CO)2 which can be isolated only at low temperatures.
22
 Of special 
interest in this vein is that a dirhodium compound with two orthometalated phosphine 
                                                          
*Reprinted with permission from “Unprecedented partial paddlewheel dirhodium methyl isocyanide compounds with unusual 
structural and electronic properties: a comprehensive experimental and theoretical study” by Zhanyong Li, Helen T. 
Chifotides, and Kim R. Dunbar, 2013. Chem. Sci., 4, 4470-4485, Copyright [2013] by The Royal Society of Chemistry 
(RSC). http://pubs.rsc.org/en/content/articlelanding/2013/sc/c3sc51641e#!divCitation 
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groups has been recently applied as a sensitive and selective chromogenic CO 
sensor.
19,20 
These phosphine ligands render the dirhodium unit more electron-rich, 
leading to enhanced π-backbonding to the CO ligand.78-80  
     Of specific relevance to the present study is the use of isocyanide ligands in transition 
metal chemistry.
81
 Reports of Rh2(II,II) metal-metal bonded isocyanide complexes are 
quite scarce,
82,83
 however, due to the ease of reduction to Rh(I) species, and, in the case 
of other metal-metal bonded dimetallic cores such as Cr2(II,II), Mo2(II,II), W2(II,II) and 
Re2(III,III), cleavage of the dimetal unit has been found to be facile.
84-88
  Pioneering 
studies by Gray et al. in the late 1970s led to an exciting discovery involving dirhodium 
isocyanide compounds, viz., oxidative addition of halogens to the Rh(I) isocyanide 
precursors Rh2[CN(CH2)3NC]4
2+ 89
 and [Rh2(TMB)4]
2+
, upon irradiation at 550 nm in 
strongly acidic HCl solutions, to form H2 and the dirhodium(II,II) containing salts 
[Rh2[CN(CH2)3NC]4Cl2]Cl2 
90
and [Rh2(TMB)4Cl2][PF6]2 (TMB = 2,5-di-isocyano-2,5-
dimethylhexane)
91
, respectively. More recently, Nocera and coworkers have made 
important progress in developing dirhodium-based photocatalysts bearing isocyanide 
ligands.
15-17
 From the mechanistic studies, they found that L-Rh(0)-Rh(II)-X2 or L-
Rh(0)-Rh(0)-L complexes (L = CO, PR3, CNR; X= Br, Cl) lead to Rh(II)-Rh(II) species, 
which are responsible for the photocatalytic production of H2 or the reduction of O2 in 
HX solutions.  
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     The promising chemistry that has been reported over the years with a handful of 
Rh2(II,II) isocyanide complexes with halogens in the axial positions notwithstanding,
92-
100
 this chemistry, especially with monodentate isocyanide ligands, remains relatively 
unexplored due to the challenge of preventing reduction to Rh(I) mononuclear products. 
In this chapter several members of an entirely new type of metal-metal bonded complex 
(5-8) are described which feature two cis strong σ-donating bridging groups p-
ditolylformamidinate (a), p-difluorophenylformamidinate (b), p-ditolyltriazenide (c) or 
orthometalated phosphine (d) and methyl isocyanide ligands in the axial and the other 
four equatorial positions (Scheme 2.1). The isocyanide series of dirhodium complexes 5-
8 (Scheme 2.1, L = CH3NC) and the corresponding acetonitrile analogs 1-4 (Scheme 2.1, 
L = CH3CN), which are synthetic precursors for the methyl isocyanide derivatives, were 
fully characterized by X-ray crystallography,
 1
H, 
31
P NMR, electronic and infrared 
spectroscopies as well as electrochemical studies. Noteworthy structural and 
spectroscopic features of 5-8 were probed in a comprehensive fashion as compared to 1-
4. In particular, compound 8 (Scheme 2.1, L = CH3NC) exhibits nearly the same ax and 
eq Rh-C (CH3NC) distances, which, to our knowledge, is unprecedented for dirhodium 
compounds. The experimental data for 1-8 were corroborated by DFT and TD-DFT 
calculations, which also unearthed notable findings that are detailed herein.  
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Scheme 2.1 Structural representation of partial paddlewheel dirhodium (II,II) 
compounds with the bridging groups (a) p-ditolylformamidinate (1, 5), (b) p-
difluorophenylformamidinate (2, 6), (c) p-ditolyltriazenide (3, 7) and (d) orthometalated 
phosphine (4, 8). 
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Experimental section 
Starting materials  
The precursor [RhCl(COD)]2 (COD: cycloocta-1,5-diene) was purchased from Pressure 
Chemicals whereas [FeCp2][BF4] and [RhCl(CO)2]2 were purchased from Sigma-
Aldrich; all reagents were used as received. Methyl isocyanide
101
, [Rh(F-form)(COD)]2,
102
 and [Rh(NNN)(CO)2]2 and NNNH (ditolyltriazene)
103
 were 
prepared by slightly modified published procedures. The compounds cis-
[Rh2(DTolF)2(CH3CN)6][BF4]2 
104
(1) and cis-[Rh2[Ph2P(C6H4)]2(CH3CN)6][BF4]2
105
 (4) 
were synthesized according to published methods. The acetonitrile solvent was pre-dried 
over 3 Å molecular sieves and distilled under N2 whereas dichloromethane was pre-dried 
over 4 Å molecular sieves and distilled over P2O5 under N2. All manipulations were 
conducted using standard Schlenk-line techniques unless otherwise stated. The work-up 
and isolation of the products, however, were conducted in air. 
Preparation of cis-[Rh2(F-form)2(CH3CN)6][BF4]2 (2). A quantity of [Rh(F-
form)(COD)]2 (120 mg, 0.14 mmol) was added to 30 mL of CH2Cl2:CH3CN (1:1 v/v) 
and the red/orange solution was stirred until the solid was fully dissolved. Subsequently 
AgBF4 (106 mg, 0.55 mmol) was added to the solution which led to a gradual color 
change to green. The reaction solution was stirred in the dark at room temperature for 24 
h and then filtered through Celite

 to remove finely divided silver particles. The filtrate 
was evaporated to dryness and redissolved in 10 mL of CH3CN (red solution). The 
addition of diethyl ether (40 mL) induced precipitation of the desired product. Yield: 
75% (112 mg, 0.10 mmol). Anal. Calcd for C38H36N10B2F12Rh2•3CH2Cl2: C, 36.64; N, 
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10.43; H, 3.15 %. Found: C, 36.67; N, 10.33; H, 3.11%. 
1
H NMR (CD3CN-d3), δ (ppm): 
2.53 (s, eq CH3CN), 7.05 (m, p-difluorophenyl), 7.49 (t, NCHN, 
3
JRh-H = 4 Hz).  
Preparation of cis-[Rh2(NNN)2(CH3CN)6][BF4]2 (3). Samples of [RhCl(CO)2]2 (50 mg, 
0.13 mmol) and 58 mg (0.26 mmol) of NNNH were added to dry CH2Cl2 (25 mL). After 
dissolution of the two reactants, NEt3 (45 μL, 0.32 mmol) was added to the solution 
which was accompanied by an instantaneous color change from yellow to red. The 
reaction solution was stirred under N2 for 20 minutes and evaporated to dryness. The 
product [Rh(NNN)(CO)2]2 was extracted with hexanes (3 x 10 mL). The three extracts 
of hexanes were combined, reduced to dryness and re-dissolved in dry CH3CN (30 mL). 
To this solution was added [FeCp2][BF4] (70 mg, 0.26 mmol) and the mixture was 
refluxed for 48 h. The solution was filtered and concentrated to 5 mL and diethyl ether 
was added to precipitate the product. Yield: 81 mg, 60%. X-ray quality crystals were 
obtained by slow diffusion of diethyl ether into an acetonitrile solution of the product. 
Anal. Calcd for C40H46N12B2F8Rh2•5CH2Cl2•H2O: C, 35.60; N, 11.08; H, 3.85%. Found: 
C, 35.71; N, 11.07; H, 3.91 %.  
1
H NMR in (CD3CN-d3), δ (ppm): 2.31 (s, CH3, tolyl), 
2.52 (s, eq CH3CN), 7.11 (m, tolyl-triazenide).  
Preparation of cis-[Rh2(DTolF)2(CNCH3)6][BF4]2 (5). Methyl isocyanide (39 μL, 0.75 
mmol) was added to a reddish/brown slurry of cis-[Rh2(DTolF)2(CH3CN)6][BF4]2 (80 
mg, 0.075 mmol) in CH3CN (10 mL) which led to a color change to yellow. The solution 
was stirred under N2 for 8 h, concentrated to 5 mL and then treated with an excess of 
diethyl ether to induce precipitation of the product. The filtered solid was washed with 
diethyl ether (3 x 5 mL) and dried overnight under vacuum. Yield 83% (66 mg, 0.062 
20 
 
mmol). X-ray quality crystals were obtained by slow diffusion of diethyl ether into a 
solution of the product in acetonitrile. Anal. Calcd for 
C42H48N10B2F8Rh2•CH3CN•CH2Cl2: C, 45.07; N, 12.86; H, 4.46 %. Found: C, 45.11; N, 
12.75; H, 4.26 %. 
1
H NMR (CD3CN-d3) δ (ppm): 2.28 (s, tolyl CH3), 2.60 (s, ax 
CH3NC), 3.67 (s, eq CH3NC), 7.02 (m, tolyl), 7.86 (t, 
3
JRh-H = 3 Hz, NCHN). ESI-MS: 
m/z: 408.02 for [Rh2(DTolF)2(CNCH3)3]
2+
.  
Preparation of cis-[Rh2(F-form)2(CNCH3)6][BF4]2 (6). Methyl isocyanide (48 μL, 0.92 
mmol) was added to a reddish/brown slurry of cis-[Rh2(F-form)2(CH3CN)6][BF4]2 (100 
mg, 0.092 mmol) in CH3CN (10 mL) which led to the instantaneous formation of a 
yellow solution which was stirred under N2 for 12 h to complete the reaction and then 
concentrated to 5 mL. An excess volume of diethyl ether was added to the solution to 
induce precipitation of 6. The resulting solid was washed with diethyl ether (3 x 5 mL) 
and dried overnight under vacuum to afford the product. Yield 81% (81 mg, 0.074 
mmol). X-ray quality crystals were obtained by slow diffusion of diethyl ether into a 
solution of the product in acetonitrile. Anal. Calcd for C38H36N10B2F12Rh2•2H2O: C, 
40.56; N, 12.46; H, 3.59 %. Found: C, 40.60; N, 12.06; H, 3.19 %. 
1
H NMR (CD3CN-d3) 
δ (ppm): 2.74 (s, ax CH3NC), 3.68 (s, eq CH3NC), 7.04 (m, p-difluorophenyl), 7.84 (t, 
3
JRh-H = 3 Hz, NCHN). ESI-MS: 436.54 for [Rh2(F-form)2(CNCH3)4]
2+
.  
Preparation of cis-[Rh2(NNN)2(CNCH3)6][BF4]2 (7). The addition of methyl 
isocyanide (38 μL, 0.73 mmol) to a reddish/brown slurry of cis-
[Rh2(NNN)2(CH3CN)6][BF4]2 (78 mg, 0.073 mmol) in CH3CN (10 mL) led to an 
immediate color change to yellow. The solution was stirred under N2 for 12 h and 
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concentrated to 5 mL. Excess diethyl ether was added to the solution to induce 
precipitation of the product which was collected, washed with diethyl ether (3 x 5 mL) 
and dried overnight under vacuum to afford 7. Yield 85% (66 mg, 0.061 mmol). X-ray 
quality crystals were obtained by slow diffusion of diethyl ether into a solution of the 
product in acetonitrile. Anal. Calcd for C46H55B2F8N15Rh2•6CH2Cl2: C, 36.56; N 12.31; 
H, 3.96 %. Found: C, 36.34; N, 12.44; H, 4.13 %. 
1
H NMR (CD3CN-d3) δ (ppm): 2.31 
(s, tolyl CH3), 2.73 (s, ax CH3NC), 3.66 (s, eq CH3NC), 7.10 (m, tolyl-triazenide). ESI-
MS: [Rh2(NNN)2(CNCH3)3]
2+
, 408.02.  
Preparation of cis-[Rh2[Ph2P(C6H4)]2(CNCH3)6][BF4]2 (8). Methyl isocyanide (45 μL, 
0.86 mmol) was added to a solution of cis-[Rh2[Ph2P(C6H4)]2(CH3CN)6][BF4]2 (85 mg, 
0.074 mmol) in CH3CN (5 mL) which led to a color change from reddish-yellow to light 
yellow. The reaction mixture was stirred for 30 min under N2 and treated with diethyl 
ether which led to precipitation of the desired product Yield 88 % (75 mg, 0.65 mmol). 
X-ray quality crystals were obtained by slow diffusion of diethyl ether into an 
acetonitrile solution of the product in the dark. C48H46N6B2F8P2Rh2•2H2O: C, 48.64; N 
7.10; H, 4.26 %. Found: C, 48.78; N, 7.22; H, 4.07 %. 
1
H NMR (CD3CN-d3) δ (ppm): 
2.50 (s, ax CH3NC), 3.27 (s, eq CH3NC, trans to C), 3.48 (s, eq CH3NC, trans to P), 
6.70-7.70 ppm (m, Ph2P(C6H4)). 
31
P NMR (CD3CN-d3) δ (ppm): 20.94  
(
1
JRh-P=101.5 Hz). ESI-MS: {[Rh2[Ph2P(C6H4)]2(CNCH3)6][BF4]}
+
 1061.16; 
{[Rh2[Ph2P(C6H4)]2(CNCH3)5][BF4]}
+
 1020.13; {[Rh2[Ph2P(C6H4)]2(CNCH3)5][BF4]}
+
 
979.11.  
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Instrumentation 
The 
1
H NMR spectra were collected on a 300 MHz Varian spectrometer and the 
chemical shifts were referenced relative to the residual proton impurities of the 
deuterated solvent (CD3CN, d3). Electronic absorption spectra were obtained on a 
Shimadzu UV-1601PC spectrophotometer. Infrared spectra were recorded as Nujol 
mulls between KBr plates with a Nicolet Nexus 470 FT-IR spectrometer. Elemental 
analyses were performed by Atlantic Microlab, Inc. Electrospray mass spectral data were 
obtained in the Laboratory for Biological Mass Spectrometry at Texas A&M University 
using a PE Sciex (Concord, Ontario, Canada) API Qstar Pulsar with an Ionwerks time-
to-digital converter, TDCx4, for data recording. Electrochemical data were collected 
using a CH Instruments analyzer in dry CH3CN. The working electrode was a BAS Pt 
disk electrode, the reference electrode was Ag/AgCl, and the counter electrode was a Pt 
wire. X-ray data sets for 2, 3, 5-8 were collected on a Bruker CCD APEX diffractometer 
with graphite monochromated Mo Kα radiation (λ = 0.71073 Å). 
Methods 
Cyclic voltammetric measurements were performed at 298 K in CH3CN with 0.1 M 
tetra-n-butylammonium hexafluorophosphate ([n-Bu4N][PF6]) as the supporting 
electrolyte. The E1/2 values were referenced to the Ag/AgCl electrode without correction 
for the junction potentials [E1/2 = (Ep,a + Ep,c)/2]. The FeCp2/[FeCp2]
+
 couple is located at 
E1/2 = + 0.45 V in CH3CN at the same conditions used for the compounds.  
     The molecular and electronic structure calculations were performed by Density 
Functional Theory (DFT) methods using the Gaussian09 (G09) program package.
106
 The 
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MPW1PW91 correlation and exchange functionals
107-109
were used with the Stuttgart 
RSC 1997 Electron Core Potential (ECP)
110
 basis set for the Rh atoms and the 6-31G (d’) 
basis set for the C, N, F, H atoms.
111,112
 Geometric parameters were taken from the 
crystal structures without the [BF4]
-
 anions, and were used as the starting point for the 
simulations, followed by frequency calculations to evaluate the full optimization. Time-
Dependent Density Functional Theory (TD-DFT)
113-119 
calculations were conducted in 
the gas phase as well as using the polarized continuum model (PCM) with CH3CN as the 
solvent,
120,121
 based on the optimized singlet ground state geometry. The first twenty 
lowest singlet-to-singlet excitations were included for both the gas phase and solvation 
models in the singlet state calculations. The molecular orbitals were plotted with the 
graphic software ‘agui’ 122  with an iso-value = 0.04. Detailed analysis of the 
compositions of the orbitals was obtained through the Chemissian program 
http://www.chemissian.com.  
     A hemisphere of crystallographic data was collected by a combination of four sets of 
exposure. Each set had a different φ angle for the crystals, and each exposure covered 
0.3 in . The exposure time for 5-8 was 10 s whereas for 2, 3, it was 20 s. Crystal decay 
was monitored by analyzing duplicate reflections and was found to be less than 1%, 
therefore no decay correction was applied. The frames were integrated with the Bruker 
AXS SAINT Software package,
123
 and the data were corrected for absorption using the 
SADABS program in the same software package.
124
 The structures were solved by direct 
methods and refined by using X-SEED,
125-127
 a graphical interface to the SHELX97 suite 
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of programs.
128
 In the final cycles of the refinement, all atoms except for hydrogen were 
refined anisotropically.  
Results 
Synthesis  
Compounds 1-3 were prepared by oxidation of Rh(I) starting materials; 1 and 2 were 
synthesized by similar procedures whereas [Rh(F-form)(COD)]2, which is a precursor to 
2, was synthesized according to a method similar to [Rh(DTolF)(COD)]2. Subsequently, 
[Rh(F-form)(COD)]2 was reacted with an excess of AgBF4 to afford 2 (Eq. 2.1): 
     The compound [Rh(NNN)(CO)2]2, which is a precursor to 3, was prepared by a 
slightly modified published procedure. As shown in Eq. 2.2, a slight excess of 
[FeCp2][BF4] was used to oxidize Rh(I) to Rh(II) to afford 3 and ferrocene, which was 
removed by excess amount of diethyl ether.  
 
     The corresponding methyl isocyanide analogs 5-8 were prepared by substitution of 
the monodentate acetonitrile ligands with methyl isocyanide in 1-4. An excess of 
CH3NC was used during the syntheses of the methyl isocyanide analogs 5-8. The general 
synthetic route for 5-7 is depicted in Eq. 2.3:  
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     A characteristic color change occurs from reddish/brown to light yellow upon 
addition of methyl isocyanide to solutions of 1-3 to afford 5-7, respectively. Unlike 
compounds 5-7, prolonged stirring of 8 in CH3CN leads to product decomposition as 
evidenced by 
1
H-NMR spectroscopy (vide infra) therefore 8 was prepared by stirring 4 
under N2 for 30 min only, in the presence of CH3NC. 
X-ray crystallographic studies 
The crystal parameters and information pertaining to the data collection and refinement 
for 2, 3 and 5-8 are summarized in Table 2.1. 
cis-[Rh2(F-form)2(CH3CN)6)][BF4]2•Et2O (2•Et2O), (2). A thermal ellipsoid plot of the 
cationic unit in 2 is shown in Figure 2.1. The dirhodium unit is bridged by two [F-form]
-
 
ligands in a cis arrangement with six CH3CN ligands occupying the remaining Rh(II) 
coordination sites. The Rh-Rh bond distance is 2.571(1) Å which is comparable to 1 and 
the compounds cis-[Rh2(DTolF)2(bpy)(CH3CN)3][BF4]2 and cis-
[Rh2(DTolF)2(bpy)2(CH3CN)][BF4]2.
129
 The Rh-N [F-form]
-
 and Rh-N (eq CH3CN) 
distances are in the ranges 2.024(4)-2.052(5) and 2.032(5)-2.043(5) Å, respectively. The 
previous distances are similar to 1 but longer than the corresponding distances in cis-
[Rh2(O2CCH3)2(CH3CN)6][BF4]2.
130
 As in the case of 1 and cis-
[Ir2(DTolF)2(CH3CN)6][BF4]2,
131
 a splaying of the four eq CH3CN ligands occurs. The 
[F-form]
-
 groups are twisted by 18.0(2)° from the eclipsed conformation and the eq 
CH3CN groups are twisted by 22.8(2)° due to the steric constraints imposed by the 
bridging ligands. 
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Table 2.1 Crystal and structural refinement data for 2•Et2O, 3, 5-8. 
 2•Et2O 3 5 
Formula  C42H46N10F12B2ORh2 C40H46N12B2F8Rh
2 
C42H48N10B2F
8Rh2 
Formula weight  1162.31 1074.30 1072.33 
Temperature/ K 110(2) 110(2) 110(2) 
Crystal system  Monoclinic Orthorhombic Orthorhombic 
Space group  P21/c Pbca Pbca 
a, b, c/ Å 11.042(2),  
32.589(7), 
14.243(3) 
14.135(3), 
21.331(4), 
31.170(6) 
14.338(3), 
21.619(4), 
31.136(6) 
, , / º 90, 100.66(3), 90 90, 90, 90 90, 90, 90 
V/ Å3 5036.5(17) 9399(3) 9651(3) 
Crystal description, 
color 
red plate red block yellow plate 
Crystal size/ mm
3
 0.04 x 0.08 x 0.10 0.08 x 0.10 x 0.13 0.02 x 0.06 x 
0.25 
Z 4 8 8 
Dcalc./g/cm
3
 1.5314 1.5183 1.4758 
2θ  range for data 
collection/º 
53.62 41.63 57.24 
Diffraction limits (h, 
k, l) 
-13 ≤ h ≤ 13 
-41 ≤ k ≤ 41 
-17 ≤ l ≤ 17 
-14 ≤ h ≤ 14 
-21 ≤ k ≤ 21 
-31 ≤ l ≤ 31 
-18 ≤ h ≤ 19 
-29 ≤ k ≤ 28 
-41 ≤ l ≤ 39 
Reflections measured 54314 57506 105468 
Independent 
reflections 
R(int) = 0.0635 R(int) = 0.0248 R(int) = 
0.0301 
Completeness to  
max/% 
99.3 99.9 95.4 
Data/restraints/param
eters 
10690/0/630 4201 /12/588 11808/0/587 
R1,
a
 wR2
b
 [I >2(I)] R = 0.0587, 
wR = 0.1314 
R = 0.059, 
wR = 0.1570 
R = 0.0262, 
wR = 0.0590 
R1,
a
 wR2
b
 (all data) R = 0.0852,  
wR = 0.1435 
R =  0.0677,  
wR = 0.1719 
R = 0.0374,  
wR = 0.0660  
Goodness-of-fit 
parameter (all 
data)
c
(F
2
) 
1.052 1.193 1.059 
Largest diff. peak and 
hole/ e.Å
-3
 
0.91/-0.93 0.88/-0.65 0.83/-0.62 
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Table 2.1 Continued 
 6•Et2O 7 8 
Formula  C42H46N10F12B2
ORh2 
C40H46N12B2F8Rh2 C96H92N12P4B4F16
Rh4 
Formula weight  1162.31 1074.30 2296.60 
Temperature/ K 110(2) 110(2) 110(2) 
Crystal system  Monoclinic Orthorhombic Monoclinic 
Space group  P21/c Pbca P21/c 
a, b, c/ Å 11.110(2), 
31.777(6), 
14.195(3) 
14.126(3), 
21.399(4), 
31.434(6) 
22.272(4), 
22.161(4), 
22.409(4) 
, , / º 90, 101.13(3), 90 90, 90, 90 90, 119.43(3), 90 
V/ Å3 4917.3(17) 9502(3) 9633(3) 
Crystal description, 
color 
Yellow block Yellow plate Yellow block 
Crystal size/ mm
3
 0.05 x 0.10 x 
0.11 
0.13 x 0.10 x 0.03 0.16 x 0.12 x 0.11 
Z 4 8 4 
Dcalc./ g/cm
3
 1.5698 1.5017 1.5833 
2θ  range for data 
collection/º 
50.02 49.46 54.64 
Diffraction limits (h, 
k, l) 
-13 ≤ h ≤ 13 
-37 ≤ k ≤ 37 
-16 ≤ l ≤ 16 
-16 ≤ h ≤ 16 
-25 ≤ k ≤ 25 
-36 ≤ l ≤ 36 
-28 ≤ h ≤ 28 
-28 ≤ k ≤ 28 
-28 ≤ l ≤ 28 
Reflections measured 44350 83459 107654 
Independent 
reflections 
R(int) = 0.0359 R(int) = 0.0885 R(int) = 0.0443 
Completeness to  
max/% 
100 100 99.5 
Data/restraints/param
eters 
8664/ 0/630 8110/0/587 21603/0/1256 
R1,
a
 wR2
b
  [I >2(I)] R = 0.0374, 
wR = 0.0914 
R = 0.0443,  
wR = 0.1010 
R = 0.0328,  
wR = 0.0899 
R1,
a
 wR2
b
 (all data) R = 0.0480, 
wR = 0.0981 
R = 0.0680,  
wR = 0.1133 
R = 0.0459,  
wR = 0.0978 
Goodness-of-fit 
parameter (all data)
c
 
1.038 1.019 1.060 
Largest diff. peak 
and hole/ e.Å
-3
 
1.08/-0.66 1.08/-1.09 0.62/-0.78 
aR = ∑Fo-Fc/∑Fo. 
b
wR = {∑[w(Fo
2
 - Fc
2
)
2]/∑w(Fo
2
)
2
]}
1/2
.
 c
Goodness-of-
fit = {∑[w(Fo
2
- Fc
2
)
2
]/(n-p)}
1/2
, where n is the number of reflections and p is the 
total number of parameters refined. 
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Figure 2.1 Thermal ellipsoid plot for the cationic unit in 2 at the 50% probability level. 
 
 
 
cis-[Rh2(NNN)2(CH3CN)6][BF4]2, (3). The cationic unit in 3 is shown in Figure 2.2. 
The Rh-Rh bond distance is 2.5135(9) Å, which is slightly shorter than the Rh-Rh 
distance in cis-[Rh2(NNN)2(CH3CN)3(bpy)][PF6]2 (2.534(2) Å).
132
 The Rh-N (eq 
CH3CN) bond distances are in the range 1.996(7)-2.024(6) Å and are comparable to the 
corresponding distances in 1, 2 and cis-[Rh2(NNN)2(CH3CN)3(bpy)][PF6]2. The Rh-N 
([NNN]
-
) bond distances are in the range 2.011(6)-2.024(6) Å,  and are slightly shorter 
than the corresponding ones in 1, 2 and Rh-N (N trans to eq bpy in [NNN]
-
) and 
comparable to the Rh-N ([NNN]
-
, trans to eq CH3CN) in cis-
[Rh2(NNN)2(CH3CN)3(bpy)][PF6]2. The eq CH3CN groups and the bridging ligands 
([NNN]
-
) are twisted by ~23.0° and ~20.3°, respectively, from the eclipsed configuration. 
cis-[Rh2(DTolF)2(CNCH3)6][BF4]2, (5). Compound 5 crystallizes in the space group 
Pbca. The cationic unit is shown in Figure 2.3. The coordination sphere of the Rh(II)  
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Figure 2.2 Thermal ellipsoid plot for the cationic unit in 3 at the 50% probability level. 
 
 
 
 
 
Figure 2.3 Thermal ellipsoid plot for the cationic unit in 5 at the 50% probability level. 
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atoms is similar to those in 1-3, but with all the CH3CN ligands being substituted by 
CH3NC. The Rh-Rh distance is 2.6262(4) Å, i.e., slightly longer than the corresponding 
distances in 1-3 and much shorter than in [Rh2(p-CNC6H4CH3)8I2][PF6]2
95 
and 
[Rh2[CN(CH2)3NC]4Cl2]C12•8H2O
89
, for which the Rh-Rh distances are 2.785(2) and 
2.837(1) Å, respectively. The bond distances Rh-C (ax CH3NC) in 5 (2.099(2) and 
2.080(2) Å) are longer than the corresponding distance in Rh2(DPhF)4(CNC6H5)
82 
(1.991(4) Å) and shorter than in Rh2(O2CCH3)4•2CNC6H4R {R = (CH3)2N, H, CF3} 
wherein the Rh-C (ax) distances are 2.148(4), 2.133(3), 2.122(3) Å,
133
 respectively. The 
Rh-C (eq CH3NC) distances are in the range 1.935(2)-1.949(2) Å, and are comparable to 
the corresponding distances in [{Rh2(μ-pz)2(I)(CN
t
Bu)4}2(η-I)][CF3SO3] {Rh-C (eq 
CN
t
Bu) ~ 1.896(11)-1.958(12) Å}.
97 
The Rh-N ([DTolF]
-
) bond distances range from 
2.078(2) to 2.094(2) Å, and are thus longer than the corresponding ones in 1. The 
dihedral angles C31-Rh1-Rh2-C33 and C35-Rh1-Rh2-C37 are 20.99(8)° and 20.48(8)°, 
respectively. Additionally, the angles N1-Rh1-Rh2-N2 and N3-Rh1-Rh2-N4 are 
17.79(6)° and 17.97(6)°, respectively, following a similar trend as observed for 1-3. 
cis-[Rh2(F-form)2(CNCH3)6][BF4]2, (6). Compound 6 crystallizes in the same space 
group as 2, namely P21/c. The structure of the cationic unit in 6 is similar to 2 (Figure 
2.4). The Rh-Rh bond distance is 2.6105(9) Å, which is ~ 0.04 Å longer than the 
corresponding distance in 2. The Rh-C (ax) bond distances are 2.074(4), 2.133(4) Å, and 
the Rh-C(eq) bond distances are in the range 1.937(5)-1.953(4) Å, which is similar to the 
range in 5. The Rh-N ([F-form]
-
) bond distances range from 2.079(3) to 2.098(3) Å and 
are longer than the corresponding distances in 2. The CH3NC groups and the bridging 
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[F-form]
-
 ligands are twisted from the eclipsed geometry by 21.6(2)°, 23.5(2)° and 
18.1(1)°, 17.2(1)°, respectively. 
cis-[Rh2(NNN)2(CNCH3)6][BF4]2, (7). As in the case of 3, complex 7 crystallizes in the 
space group Pbca. The thermal ellipsoid plot of the cationic unit is shown in Figure 2.5. 
The Rh-Rh bond distance is 2.5852(6) Å which is ~ 0.07 Å longer than that in 3, 
following a similar trend as observed for 1 vs. 5 and 2 vs. 6. The Rh-C (The Rh-C (ax 
CH3NC 2.089(4) and 2.093(4) Å), and Rh-C (eq CH3NC 1.940(5)-1.950(5) Å) are in a 
similar range as the corresponding distances in 5 and 6. The Rh-N [NNN]
-
 bond 
distances range from 2.070(3) to 2.089(3) Å, which is ~0.06 Å longer than the 
corresponding Rh-N distances in 3. The four eq CH3NC ligands are twisted by 21.8(2)° 
and 21.0(2)° and the two [NNN]
-
 ligands by 18.9(1)° and 19.8(1)° from the eclipsed 
conformation. 
 
 
 
 
 
Figure 2.4 Thermal ellipsoid plot for the cationic unit in 6 at the 50% probability level. 
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Figure 2.5 Thermal ellipsoid plot for the cationic unit in 7 at the 50% probability level. 
 
 
 
cis-[Rh2[Ph2P(C6H4)]2(CNCH3)6][BF4]2, (8). Compound 8 crystallizes in the 
centrosymmetric monoclinic space group P21/c with two independent dimetal complexes 
in one asymmetric unit and two isomers 8-R and 8-S, as was found for compound 4. The 
cationic units of the two isomers 8-R and 8-S are shown in Figure 2.6. As is the case of 4, 
both the R and S isomers in 8 exhibit similar structural parameters. The Rh-Rh bond 
distances in 8-S and 8-R are 2.7682(6) and 2.766(1) Å, respectively, i.e., longer than the 
corresponding distances in 4 (2.655(1) and 2.656(1) Å) and 5-7. 
     It is important to note that, to our initial surprise, 8 exhibits very similar distances for 
the ax and eq Rh-C bonds (with CNCH3) which is unprecedented for dirhodium 
compounds. The Rh-C (ax CH3NC) bond lengths are 2.023(4), 2.037(4) Å for 8-S and 
2.033(3), 2.040(2) Å for 8-R, i.e., by ~ 0.07 Å shorter than the corresponding distances 
in 5-7. For both isomers of 8, the Rh-C (eq CH3NC) distances are in the range 2.00-2.02 
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Å. The Rh-P bond lengths for both isomers of 8 are ~ 2.30 Å, i.e., by ~ 0.10 Å longer 
than the corresponding distances in cis-[Rh2[Ph2P(C6H4)]2(O2CCH3)2]•2CH3CO2H and 
cis-[Rh2(O2CCH3)2[Ph2P(C6H4)]2]•2C5H5N 
134
, and by ~ 0.05 Å longer than those in 
4.
105
 The Rh-C (bridging phosphine) bond lengths in 8 are ~ 2.07 Å, i.e., by 0.07 Å 
longer than the corresponding distances in the orthometalated compounds cis-
[Rh2[Ph2P(C6H4)]2(O2CCH3)2]•2CH3CO2H, cis-[Rh2(O2CCH3)2[Ph2P(C6H4)]2]•2C5H5N 
and 4. The CH3NC groups in 8-S are considerably twisted from an eclipsed 
conformation by -35.9(1)° and -29.4(1)°, which are similar to the analogous ones for 
CH3CN in 4. The corresponding dihedral angles for the CH3NC groups in 8-R are 
30.7(1)° and 31.8(1)°. Considerably smaller distortions are found for the bridging 
phosphine groups, with dihedral angles -21.29(8)° and  
-20.47(8)° in 8-S. Likewise, for 8-R, they are 21.08(8)° and 21.19(8)°. These distortions 
are similar to those encountered in 4, but larger than the angles in  
cis-[Rh2[Ph2P(C6H4)]2(O2CCH3)2]•2CH3CO2H, wherein the acetate bridging groups are 
twisted by ~12.22°  from the eclipsed conformation. 
     The detailed bond distances, and dihedral angles for complexes 2, 3 and 5-8 are all 
complied in Table 2.2 
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Figure 2.6 Thermal ellipsoid plot for the cationic unit of 8-R, 8-S at the 50% probability 
level.  
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Table 2.2 Important bond distances and dihedral angles in compounds 2-3, 5-8. 
 
2  3 
Bond distances Å Bond distances Å 
Rh1-Rh2  2.571(1) Rh2-Rh1  2.5135(9) 
Rh1-N9  2.251(4) Rh2-N12  2.202(7) 
Rh1-N1  2.038(5)  Rh2-N3  2.017(6) 
Rh1-N3  2.052(5) Rh2-N6  2.011(6) 
Rh1-N5  2.032(5) Rh2-N10  1.996(7) 
Rh1-N6  2.040(5) Rh2-N9  2.024(6) 
Rh2-N2  2.046(5) Rh1-N4  2.023(6) 
Rh2-N4  2.024(4) Rh1-N11  2.225(7) 
Rh2-N8  2.034(5) Rh1-N1  2.024(6) 
Rh2-N7  2.043(5) Rh1-N7  2.007(8) 
Rh2-N10  2.195(4) Rh1-N8  2.004(6) 
Dihedral angles ° Dihedral angles ° 
N5-Rh1-Rh2-N7  22.8(2) N3-Rh2-Rh1-N1  20.2(2) 
N1-Rh1-Rh2-N2  18.0(2) N6-Rh2-Rh1-N4  20.6(2) 
N6-Rh1-Rh2-N8  22.8(2) N10-Rh2-Rh1-N8  23.0(3) 
N3-Rh1-Rh2-N4  18.0(2) N9-Rh2-Rh1-N7  22.7(3) 
5  6  
Bond distances Å Bond distances Å 
Rh1-Rh2  2.6262(4) Rh1-Rh2  2.6105(9) 
Rh1-N1  2.093(2) Rh1-N2  2.081(3) 
Rh2-N2  2.078(2) Rh2-N1  2.097(3) 
Rh1-N3  2.094(2) Rh1-N4  2.094(3) 
Rh2-N4  2.081(2) Rh2-N3  2.080(3) 
Rh1-C39  2.099(2) Rh1-C29  1.947(3) 
Rh2-C41  2.080(2) Rh2-C27  1.951(4) 
Rh1-C31  1.935(2) Rh1-C33  1.954(4) 
Rh2-C33  1.948(2) Rh2-C31  1.937(4) 
Rh1-C35  1.949(2) Rh1-C37  2.074(4) 
Rh2-C37  1.939(2) Rh2-C35  2.134(4) 
Dihedral angles ° Dihedral angles ° 
C31-Rh1-Rh2-C33  20.99(8) C33-Rh1-Rh2-C31  21.6(2)   
C35-Rh1-Rh2-C37  20.48(8) C29-Rh1-Rh2-C27  23.5(2) 
N1-Rh1-Rh2-N2  17.79(6) N2-Rh1-Rh2-N1  18.1(1) 
N3-Rh1-Rh2-N4  17.97(6) N4-Rh1-Rh2-N3  17.2(1) 
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Table 2.2 Continued 
7  8-S  
Bond distances Å Bond distances Å 
Rh1-Rh2  2.5860(6) Rh1-Rh2  2.7682(6) 
Rh1-N3  2.068(4) Rh1-P1  2.2929(9) 
Rh1-N6  2.077(4) Rh1-C45  2.023(4) 
Rh1-C37  2.097(5) Rh1-C37  2.007(2) 
Rh1-C35  1.949(5) Rh1-C41  2.000(3) 
Rh1-C29  1.939(5) Rh1-C1  2.078(2) 
Rh2-N4  2.088(4) Rh2-P2  2.3077(9) 
Rh2-N1  2.091(4) Rh2-C43  2.009(2) 
Rh2-C39  2.094(5) Rh2-C19  2.090(3) 
Rh2-C31  1.949(5) Rh2-C47  2.037(4) 
Rh2-C33  1.946(5) Rh2-C39  2.026(3) 
Dihedral angles ° Dihedral angles ° 
N3-Rh1-Rh2-N1  18.9(2) C41-Rh1-Rh2-C43  -29.4(1) 
N6-Rh1-Rh2-N4  19.8(2) C37-Rh1-Rh2-C39  -35.9(1) 
C35-Rh1-Rh2-C33  21.7(2) P1-Rh1-Rh2-C19  -21.29(8) 
C29-Rh1-Rh2-C31  21.1(2) C1-Rh1-Rh2-P2 -20.47(8) 
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NMR spectroscopic studies 
In the 
1
H NMR spectrum of 2, the characteristic triplet resonance, attributed to the 
bridging head H atoms on the [F-form]
-
 ligands, appears at 7.49 ppm (Figure 2.7a), with 
the coupling constant to the Rh(II) centers being 3 Hz, similar to that in 1. The multiplet 
at 7.05 ppm results from the protons on the phenyl ring of the [F-form]
-
 ligands. The 
resonance at δ = 2.53 ppm corresponds to the protons of the eq CH3CN ligands but the 
ratio of the integration between this resonance and the one at δ = 7.49 ppm (bridging 
head H) is less than 6 after the dissolution of 2 in CD3CN for only 10 min, indicating the 
fast exchange of eq CH3CN ligands with the CD3CN solvent molecules (Figure 2.7a). 
The spectrum obtained after dissolving 2 in CD3CN for 6 hours shows the total 
disappearance of this resonance, confirming the fast exchange process of the eq CH3CN 
ligands. For compound 3, the multiplet at δ = 7.11 ppm corresponds to the H nucleus on 
the phenyl ring of the bridging [NNN]
-
 ligands. The resonances at δ = 2.52 ppm and δ = 
2.31 ppm is attributed to the eq CH3CN ligands and –CH3 groups on the [NNN]
-
 ligands 
respectively. The ratio of the integration of those two resonances is less than 1 after 10 
min dissolution, indicating the lability of the eq CH3CN ligands in the CD3CN solution, 
same as 2. This is also confirmed by the disappearance of the resonance at δ = 2.52 ppm 
after 24 h dissolution in the dark. 
     For compounds 5 and 6, the triplet of the bridge-head H nuclei appear at δ = 7.87 and 
δ = 7.84 ppm respectively, downfield shifted compared to those of 1 and 2 with the same 
coupling constant to the two Rh(II) centers. The singlets at 3.67, 2.61 ppm in 5, 3.68,  
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Figure 2.7 (a) 
1
H NMR spectra change of compound 2 after dissolving in CD3CN for 6 
h (b) 
1
H NMR spectrum of compound 5 after dissolution in CD3CN for 1 week. 
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2.74 ppm in 6, 3.66, 2.73 ppm in 7 correspond to the eq CH3NC and ax CH3NC ligands 
with integration ratios of 2:1. No exchange of the CH3NC ligands with CD3CN in 5-7 
(Figure 2.7b for 5) for one week indicates the stronger interaction of those CH3NC with 
the dimetal core in those compounds. 
     The X-ray crystallographic data for the orthometalated compounds 4 and 8 revealed 
racemic mixtures of the R and S isomers; the Rh centers are supported by two cis 
[Ph2P(C6H4)]
-
 groups in a head-to-tail orientation. As evidenced by the 
1
H-NMR spectra, 
both isomers exhibit the same chemical shifts due to fast rotation of the molecules in 
solution. The presence of only one resonance for CH3CN in the 
1
H NMR spectrum of 4, 
within 10 min of dissolution, indicates fast exchange of the eq CH3CN ligands with the 
CD3CN solvent due to the strong σ-donating ability of the bridging phosphine ligands. In 
contrast, due to the decreased lability of CH3NC, as compared to CH3CN, and the 
asymmetry of the bridging ligands, the 
1
H NMR spectrum of 8 displays three CH3NC 
resonances at δ 3.48, 3.27 and 2.50 ppm, in a 1:1:1 ratio (Figure 2.8a), which correspond 
to eq CH3NC trans to the P and C atoms as well as the ax CH3NC groups, respectively. 
A monitoring of 8 with 
1
H NMR spectroscopy in CD3CN, however, revealed slow 
decomposition as indicated by the disappearance of the three aforementioned CH3NC 
resonances at the same rate and the concomitant appearance of a new resonance at δ 3.38 
ppm in the 
1
H NMR spectra (Figure 2.8a). The 
31
P{
1
H} NMR spectrum of 8 exhibits a 
doublet at δ ~ 21 ppm (1JRh-P = 101.5 Hz) with the characteristic 
102
Rh-
31
P coupling;
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the doublet decreases in intensity and after 12 h, new resonances appear in the spectrum, 
and increase in intensity with time (Figure 2.8b; spectra at 12 h and 4 days). The  
40 
 
 
 
Figure 2.8 (a)
1
H NMR and (b) 
31
P NMR spectra of compound 8 after dissolution in 
CD3CN. 
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instability of 8 in solution as a function of time, indicated by the NMR data, is also 
corroborated by the fragmentation pattern of 8 in the MS studies. On the contrary, the 
ESI-MS data for 2-7 show the main peaks corresponding to the parent species with a 2
+ 
charge and the appropriate isotopic distributions. Sequential loss of the monodentate 
ligands, either CH3CN or CH3NC, is observed in the ESI-MS of 2-7. 
     In the ESI-MS spectra of 2-3, 5-7, all the main peaks are correspondent to the 2
+
 
charge with the appropriate isotope distributions, assigned to be the cationic part of the 
compounds respectively. Moreover, sequential loss of the monodentate ligands, either 
CH3CN or CH3NC, are observed in the ESI-MS spectra of those compounds. In the ESI 
spectrum of 8 in CH3CN, different small fragments of the molecule are observed, with 
the assignments as follows: [Rh2{Ph2P(C6H4)}2]
2+
, 366.00; [Rh2{Ph2P 
(C6H4)}2(CNCH3)]
2+
, 384.51; [Rh2{Ph2P(C6H4)}2(CNCH3)2]
2+
, 405.00; 
[Rh2{Ph2P(C6H4)}2(CNCH3)3]
2+
, 425.51; [Rh2{Ph2P(C6H4)}2(CNCH3)4]
2+
, 446.03; 
[Rh2{Ph2 P(C6H4)}2(CNCH3)5]
2+
, 466.56; [Rh{Ph2P(C6H4)}2]+H
+
, 625.07; 
[Rh{Ph2P(C6H4)}2(CNCH3)]+H
+
, 666.09; [Rh{Ph2P(C6H4)}2(CNCH3)2]+H
+
, 707.13;  
[Rh2{PPh2P(C6H4)}2(CNCH3)3](BF4)
+
, 938.08; [Rh2{Ph2P(C6H4)}2(CNCH3)4](BF4)
+
, 
979.11; [Rh2{Ph2P(C6H4)}2(CNCH3)5](BF4)
+
, 1020.13; 
[Rh2{Ph2P(C6H4)}2(CNCH3)6](BF4)
+
, 1061.16. These data reveal the instability of the 
compound, in accord with the NMR studies. The identity of the decomposition product 
has not been determined as of yet, but it is postulated to be the product caused by the 
cleavage of the Rh-Rh bond. 
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Electronic absorption spectral studies 
The electronic absorption data for 1-8 measured in CH3CN are summarized in Table 2.3 
and selected spectra in the range 200-600 nm are depicted in Figure 2.9. 
     Given that compounds 1, 2 and 5, 6 are structurally analogous, it is not surprising that 
similar electronic absorption features are observed in each case. Compounds 1-2 (Figure 
2.9a) and 5-6 exhibit characteristic intense bands at λ ~ 260 nm, which are ascribed to 
metal-centered transitions involving contributions from the orbitals of both the bridging 
and monodentate ligands. In 1-3 (Figure 2.9a, c), there is a shoulder of moderate 
intensity at λ ~ 320 nm (ɛ ~ 8.0 x 103 M-1 cm-1) in addition to the intense absorption at λ 
= 258 nm (Figure 2.9a, c). It is notable that two weak but obvious shoulders appear at λ 
= 420 and 515 nm (ɛ ~103 and 500 M-1cm-1, respectively); these maxima display 
significant hypsochromic shifts as compared to the lowest energy bands of the series 
Rh2(R-DPhF)4 (R = OCH3, Cl), which occur at λ > 800 nm and are attributed to the 
Rh2(π*)Rh2(σ*) transitions.
136 , 137
 The aforementioned band shifts indicates the 
differences in the electronic structures of the partial paddlewheel Rh2(II,II) compounds 
1-3 after substituting two cis-formamidinate bridging ligands with four monodentate 
CH3CN groups. Furthermore, the substitution of CH3CN with CH3NC in the series 5-7 
results in a shift of the lowest energy bands to higher energies (λ ~ 420 nm) with no 
apparent absorptions at λ > 500 nm (Figure 2.9b, c). The electronic absorption spectrum 
of 3 is similar to those of 1 and 2, presumably due to the similarity of the interactions 
between Rh2(II,II) with the [NNN]
-
 and [DTolF]
-
 bridging ligands. The intense 
absorption maximum at λ = 250 nm is of the same character as that in 1 and 2 at ~260  
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Table 2.3 Electronic absorption data for compounds 1-8 in CH3CN. 
Compound λmax (ɛ x 10
3
) (nm, M
-1
cm
-1
) 
1 258 (55), ~321 (8.8), ~425 (1.05), ~521 (0.45) 
2 254 (47.5), ~312 (7.4), ~416 (0.85), ~510 (0.4) 
3 244 (19.28), 285 (13.9), ~ 463 (0.8), ~ 534 (0.2) 
4 206 (67), ~ 246 (23), 286 (19.3),  ~ 355 (1.5), 478 (0.57) 
5 267 (46.6), ~313 (10.9), ~345 (5), ~392 (1.2), ~425 (0.76) 
6 259 (40.9), ~ 318 (11), ~ 340 (4.4), ~ 388  (1.9),  ~ 420 (0.8) 
7 232 (18.3), 284 (11), 389 (1.4), ~450 (0.3) 
8 204 (120), 273 (14), ~290 (11), 362 (10) 
 
 
 
 
 
 
 
Figure 2.9 Overlay of the electronic spectra for (a) 1 and 2, (b) 1 and 5, (c) 3 and 7, and 
(d) 4 and 8. 
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nm, whereas the transition at λ = 285 nm is tentatively assigned to the intramolecular 
1ππ* transition of the [NNN]- ligands in 3 because it is also present, albeit slightly 
shifted, in the electronic spectrum of the free ligand as well as 7. A distinct feature in the 
electronic spectrum of 4 is the weak but apparent absorption at λ = 478 nm (ɛ ~ 570 M-
1
cm
-1
) as opposed to 8, which exhibits a moderately strong absorption at λ = 362 nm (ɛ ~ 
9700 M
-1
cm
-1
) (Figure 2.9d). This difference in the spectra of 4 and 8 reflects the drastic 
changes in their electronic configurations upon substitution of CH3CN for CH3NC 
ligands. 
Computational studies  
DFT calculations were performed on the cationic units of 1-8 in an attempt to gain 
further insight into their structural, electrochemical and electronic absorption properties. 
The structural parameters of the optimized metal complexes closely resemble those 
experimentally found by X-ray crystallography. In 1-3, the Rh-Rh bond distances in the 
cationic units are ~ 0.09 Å shorter than the distances in 5-7. Moreover, a significant 
decrease of the Rh-L bond distances (L monodentate ligand, L: CH3CN in 1-3, L: 
CH3NC in 5-7) was also successfully predicted by the calculations for the pairs 1/5, 2/6, 
3/7. The Rh-Rh bond distance in the optimized cationic unit of 4 is comparable to the 
crystal structure, whereas in 8, it is ~ 0.05 Å longer than the experimentally value. In 4, 
slightly longer Rh-N bond distances (eq CH3CN, trans to C) than the Rh-N bond 
distances (eq CH3CN trans to P) were also successfully predicted, indicating the stronger 
trans influence imposed by the Rh-C bond. For 8, the Rh-C (ax CNCH3) and Rh-C (eq 
CNCH3) bond distances are very similar, in agreement with the X-ray diffraction data. 
45 
 
The calculated dihedral angles ω in 1-8, defined by the eq ligands and the two Rh centers, 
are slightly higher than those in the crystal structures but within a similar range. In 
general, the good agreement of the bond distances and angles with the X-ray data 
indicates that the level of theory and the basis sets that were used are reliable.  
     DFT calculations for CH3CN and CH3NC were also conducted to illustrate the 
different electronic properties of the ligands. From the MO diagrams depicted in Figure 
2.10, the HOMO of CH3NC between the C and N atoms has σ* character with the 
electron density mainly localized on the terminal C atom, whereas the HOMO of 
CH3CN is mainly the π bonding orbital between the C and N atoms. Moreover, the 
HOMO of CH3NC lies higher than that of CH3CN (the HOMO and HOMO-1 for 
CH3CN are degenerate). These features explain the better σ-donating ability of CH3NC 
as compared to CH3CN. The LUMO+1 and LUMO+2 levels for both ligands are sets of 
degenerate π* orbitals, lying at ~ 0.12 eV and ~ 0.56 eV for CH3NC and CH3CN, 
respectively, in accord with the improved π-accepting ability of CH3NC. The 
aforementioned factors also affect the Rh-Rh bond lengths of compounds 5-8 in an 
interdependent fashion (vide infra). 
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Figure 2.10 MO diagrams for the ligands CH3CN and CH3NC with graphical 
representations of the HOMO, LUMO+1, LUMO+2 (iso-value 0.04); the HOMO and 
HOMO-1 for CH3CN are degenerate. 
 
 
 
Bonding in the dirhodium unit 
It is widely accepted that without perturbation from the ligand field, the electronic 
configuration of the Rh2(II,II)
 dimetallic core is σ2π4δ2δ*2π*4σ*0, resulting in a bond 
order of one.
21
 Upon coordination of the four [DTolF]
-
 ligands, however, the dirhodium 
unit adopts the electronic configuration σ2π4δ2π*4δ*2π*0 as the Rh2(δ*) orbital is 
destabilized due to the antibonding interaction with the pπ lone pairs of the bridging 
[DTolF]
-
 groups.
136 
It is notable that in the two sets of dirhodium compounds 1, 2 and 5, 
6 with monodentate acetonitrile and methyl isocyanide ligands, respectively, however, 
unusual configurations of the molecular orbitals arise; these differences entail lowering 
of the Rh2(δ*) below the Rh2(δ) and considerable elevation of the Rh2(σ) orbitals (for 
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example, Rh2(δ) lies ~ 0.98 and 1.02 eV higher in energy as compared to Rh2(δ
*
) in 1 
and 2, respectively; Table 2.4, Figure 2.11 for 1 and 5; Table 2.5, Figure 2.12 for 2 and 
6). The substitution of two cis-[DTolF]
-
 by four eq CH3CN in Rh2(DTolF)4 and the 
presence of two ax CH3CN ligands lead to stabilization of the Rh2(δ*) as compared to 
Rh2(δ) in 1. This is attributed to the combined effects of two factors: the presence of 
only two bridging ligands in 1 induces a staggered configuration with ω ~ 20º and a 
subsequent reduced overlap between the two dxy orbitals of the two Rh(II) centers, which 
are responsible for the formation of the Rh2(δ) and Rh2(δ*) bonds. Furthermore, there 
are interactions of the Rh2(δ*) with the low lying π* orbitals of the eq monodentate 
CH3CN ligands as well as the pπ lone pairs of the formamidinate groups which further 
stabilize the Rh2(δ*) (Figure 2.13) and slightly destabilize the pπ lone pair, thus 
rendering it the HOMO in 1 (it has 27% Rh2(δ*) and 71% [DTolF]
-
 contributions; Table 
2.4). 
     In contrast to 1 and 2, the Rh2(δ*) orbital in 3 is slightly higher in energy as 
compared to Rh2(δ) (Table 2.6), which is not surprising as the graphic representation of 
its Rh2(δ*) indicates negligible participation of the low-lying π* orbitals of the CH3CN 
ligands. For similar reasons (Figure 2.13), the Rh2(δ*) orbitals are lower in energy as 
compared to Rh2(δ) in 5-7. Both orbitals Rh2(π) and Rh2(π*), however, are stabilized as 
compared to their anologs 1-3, since their interactions with the low lying empty π* 
orbitals of the CH3NC ligands are stronger due to the better π-accepting ability of 
CH3NC. 
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Table 2.4 Bond character of orbitals, energy levels (eV) and orbital compositions (%) 
for the dirhodium units of 1 and 5. 
1 5 
 Energy 
(eV) 
Orbital 
Composition 
Energy 
(eV) 
Orbital 
Composition 
δ*  -8.85 43 (DTolF)    
42  Rh    
15 (eq CH3CN) 
-9.05 51  Rh    
24 (eq CH3NC)    
22 (DTolF) 
π -8.49 72  Rh    
18 (DTolF)    
5 (eq CH3CN) 
-8.88 58  Rh    
19 (DTolF)    
12 (eq CH3NC)    
11 (ax CH3NC) 
π -8.30 80  Rh    
9 (eq CH3CN)    
8 (DTolF) 
-8.73 63  Rh    
19 (eq CH3NC)    
12 (DTolF)    
7 (ax CH3NC) 
δ -7.83 79  Rh    
13 (DTolF)    
8 (eq CH3CN) 
-8.46 71 Rh   
16 (eq CH3NC)    
12 (DTolF) 
π* -7.28 78  Rh   
11 (DTolF)    
9 (ax CH3CN) 
-8.10 81  Rh    
9 (eq CH3NC)   
7 (ax CH3NC) 
π* -7.25 88  Rh    
5 (DTolF) 
-8.08 83  Rh  
8 (eq CH3NC)    
6 (ax CH3NC) 
σ -7.21 78  Rh   
13 (ax CH3CN) 
-6.76 51  Rh    
26 (ax CH3NC)    
14 (DTolF)    
9 (eq CH3NC) 
HOMO
a
 -5.75 71 (DTolF)    
27  Rh 
-5.97 80  (DTolF)    
15  Rh 
σ* -2.11 66  Rh   
12 (DTolF) 
16 (ax CH3CN)     
 6 (eq CH3CN) 
-1.84 63  Rh   
13 (DTolF) 
14 (ax CH3NC)    
10 (eq CH3NC) 
a
Not a dirhodium-based orbital. 
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Table 2.5 Bond character of orbitals, energy levels (eV) and orbital compositions (%) 
for the dirhodium units of 2 and 6.  
 
  2 6 
 Energy 
(eV) 
Orbital 
Composition 
Energy 
(eV) 
Orbital 
Composition 
δ*  -8.90 46 (Rh)    
37 (F-form)    
17 (eq CH3CN) 
-9.15 50 (Rh)    
26 (eq CH3NC)    
21 (F-form) 
π -8.58 71 (Rh)    
18 (F-form)    
6 (eq CH3CN)    
5 (ax CH3CN) 
-8.98 62 (Rh)    
15 (F-form)    
12 (eq CH3NC)    
11 (ax CH3NC) 
π -8.33 79 (Rh)    
10 (eq CH3CN)   
7 (F-form)  
-8.81 64 (Rh)    
19 (eq CH3NC)    
10 (F-form)   
7 (ax CH3NC) 
δ -7.88 77 (Rh)    
14 (F-form)    
10 (eq CH3CN) 
-8.54 72 (Rh)   
17 (eq CH3NC)    
11 (F-form) 
π* -7.39 67 (Rh)    
18 (F-form)    
12 (ax CH3CN) 
-8.17 80 (Rh)    
9 (eq CH3NC)    
6 (ax CH3NC) 
π* -7.30 87 (Rh) 
  
-8.15 84 (Rh)    
8 (eq CH3NC)    
6 (ax CH3NC) 
σ -7.23 72 (Rh)    
15 (F-form)    
9 (ax CH3CN) 
-6.85 52 (Rh)    
26 (ax CH3NC)    
13 (F-form)    
9 (eq CH3NC) 
HOMO
a
 -5.91 69 (F-form)    
29 (Rh) 
-6.11 80 (F-form)    
15 (Rh) 
σ* -2.16 66 (Rh)    
15 (ax CH3CN)   
12 (F-form)    
7 (eq CH3CN) 
-1.94 63 (Rh)    
14 (ax CH3NC)    
14 (F-form)    
9 (eq CH3NC) 
a
Not a dirhodium-based orbital. 
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Table 2.6 Bond character of orbitals, energy levels (eV) and orbital compositions (%) 
for the dirhodium units of 3 and 7. 
 
 3 7 
 Energy 
(eV) 
Orbital 
Composition 
Energy 
(eV) 
Orbital 
Composition 
δ* -7.68 51 (NNN)    
44 Rh 
-9.32 43 Rh    
28 (NNN)    
25 (eq CH3NC) 
π -8.63 74 Rh    
12 (NNN)    
11 (eq CH3CN) 
  
-9.19 63 Rh    
14 (NNN)    
12 (eq  CH3NC)    
11 (ax  CH3NC) 
π -8.52 49 Rh    
42 (NNN)    
8 (eq CH3CN) 
-9.03 63 Rh    
20 (eq  CH3NC)    
12 (NNN)    
5 (ax  CH3NC) 
δ -8.27 78 Rh    
13 (eq CH3CN)    
9 (NNN) 
-8.88 71 Rh    
22 (eq  CH3NC)    
6 (NNN) 
π* -7.54 86 Rh    
6 (NNN) 
 
-8.28 64 Rh    
21 (NNN)    
9 (eq  CH3NC)    
6 (ax  CH3NC) 
π* -7.54 86 Rh    
6 (NNN) 
-8.28 53 Rh    
32 (NNN)    
11 (eq  CH3NC) 
σ -7.42 45 (NNN)    
40 Rh    
13 (ax CH3CN) 
-6.92 46 Rh    
24 (ax  CH3NC)    
22 (NNN)    
7 (eq  CH3NC) 
σ* -2.32 66 Rh    
15 (ax CH3CN)    
12 (NNN)    
7 (eq CH3CN) 
-2.06 65 Rh    
16 (NNN)    
11 (ax  CH3NC)    
9 (eq  CH3NC) 
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Figure 2.11 MO diagrams involving the Rh2(II,II) units in 1 and 5 obtained by DFT 
calculations (iso-value=0.04). 
 
 
 
 
Figure 2.12 MO diagrams involving the Rh2(II,II) units in 2 and 6 obtained by DFT 
calculations (iso-value=0.04). 
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Figure 2.13 Representation of the orbital interactions between Rh2(δ*), pπ lone pairs on 
the bridging ligand and the low lying π*orbital on the CH3NC ligands. 
 
 
 
     Apart from the Rh2(δ*) orbital becoming stabilized due to its interactions with two 
staggered [DTolF]
-
 ligands in 1, the Rh2(σ) orbital increases in energy as compared to 
the Rh2(π*) orbital (Figure 2.11, Table 2.4) due to the interactions with the two ax 
CH3CN ligands present in 1 but not in Rh2(DTolF)4. Analogous observations were made 
for the orbital levels in 2 and 3 (Figure 2.12, Table 2.5 for 2, Table 2.6 for 3). 
Importantly, the increase in energy for the Rh2(σ) and Rh2(σ*) orbitals for the methyl 
isocyanide analogs 5-7 (Figures 2.11 and 2.12, Tables 2.4 and 2.5 for 5 and 6, Table 2.6 
for 7) is even more pronounced as compared to 1-3 due to the better σ-donating ability of 
CH3NC. Additionally in 5-7, the Rh2(π), Rh2 (π*) and Rh2 (δ), Rh2(δ*) orbitals are 
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stabilized by 0.2 to 0.8 eV as compared to 1-3, respectively. This is attributed to the 
increased π-accepting ability of CH3NC (vide supra) as the Rh2(π), Rh2(π*) orbitals have 
significant contributions from both the ax and eq CH3NC ligands and the Rh2(δ*) orbital 
has ~20% contribution from the eq CH3NC ligands (Table 2.4), e.g., the energy 
difference between the Rh2(π*) and Rh2(σ*) orbitals is ~ 1.32 and ~0.05 eV in 5 and 1, 
respectively (Figure 2.12 and Table 2.5 for compounds 2 and 6).  
     In 8, the MOs pertaining to Rh2(II,II), which are primarily metal-based orbitals 
(Table 2.7), are in the order of π4δ2δ*2π*4σ2σ*0 (Figure 2.14). The stabilization of the π 
symmetry orbitals is attributed to significant π-backbonding from the dirhodium unit to 
the CH3NC ligands, as in compounds 5-7. In the case of 8, however, the much stronger 
interactions of the dirhodium core with the ax CH3NC ligands lead to a significant 
increase in the energy of the Rh2(σ) orbital to the extent that it actually becomes the 
HOMO level. As indicated from the MO diagram for 8 (Figure 2.14), the energy 
difference between the Rh2(σ) and Rh2(π*) orbitals is 1.66 eV, i.e., ~ 0.32 eV higher 
than that for 5 (Table 2.4). In contrast to 5, the Rh2(δ) and Rh2(δ*) orbitals in 8 are very 
close in energy as larger distortions from the eclipsed configuration occur for the 
CH3NC (the groups are twisted by ω ~ 30°); this situation results in decreased orbital 
overlap which reduces the energy difference between the Rh2(δ) and Rh2(δ*) orbitals. 
The graphical representation also indicates that both Rh2(δ) and Rh2(δ*) orbitals have 
similar and strong interactions with the eq CH3NC ligands (Figure 2.14). 
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Table 2.7 Bond character of orbitals, energy levels (eV) and orbital compositions (%) 
for the dirhodium units of 8. 
 
 8 
  Energy (eV) Orbital Composition 
π HOMO-20 -8.59 68 Rh 
14 (eq CH3NC) 
12 [Ph2P(C6H4)] 
6 (ax CH3NC) 
π HOMO-19 -8.53 67 Rh 
13 (eq CH3NC) 
13 [Ph2P(C6H4)] 
8 (ax CH3NC) 
δ HOMO-18 -8.38 49 Rh 
28 [Ph2P(C6H4)] 
21 (eq CH3NC) 
δ* HOMO-17 -8.35 56 Rh 
22 [Ph2P(C6H4)] 
18 (eq CH3NC) 
π* HOMO-14 -7.89 55 Rh 
29 [Ph2P(C6H4)] 
10 (eq CH3NC) 
6 (ax CH3NC) 
π* HOMO-13 -7.81 79 Rh 
8 [Ph2P(C6H4)] 
7 (ax CH3NC) 
6 (eq CH3NC) 
σ HOMO -6.17 59 Rh 
18 (ax CH3NC) 
15 [Ph2P(C6H4)] 
9 (eq CH3NC) 
σ* LUMO -1.67 52 Rh 
26 [Ph2P(C6H4)] 
11 (eq CH3NC) 
11 (ax CH3NC) 
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Figure 2.14 Diagram of the MO levels for the dirhodium unit in 8 with visualization of 
the corresponding orbitals generated by agui (iso-value = 0.04). 
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TD-DFT calculations 
The calculated and experimental electronic absorption spectra for 1-4, 5-8 are overlaid in 
Figures 2.15 and 2.16. The similarities between the spectra confirm the reliability of the 
calculations. The compositions of selected frontier MOs of the calculated cationic units 
for 1-8 are listed in Table 2.8.  
     The orbital compositions for HOMO-2 to LUMO+2, which were found to be mainly 
involved in the electronic transitions derived from the TD-DFT/PCM calculations for 1-
8, are listed in Table 2.8 and the spatial plots for 1-4, 5-8 are displayed in Figures 2.17 
and 2.18. The unoccupied orbitals for compounds 1, 2, 5 and 6 exhibit similar character, 
namely the LUMOs Rh2(σ*) are primarily rhodium based orbitals (~ 65%) with ~ 15% 
contribution from the ax ligands (CH3CN for 1, 2 and CH3NC for 5, 6; Table 2.8). The 
other two low-lying orbitals, i.e., the LUMO+1 (σ*L-Rh-DTolF) and LUMO+2 (σ*L-Rh-DTolF), 
have 45% Rh, 35% bridging ligand ([DTolF]
-
 for 1, 5 and [F-form]
-
 for 2, 6) and 20% eq 
monodentate ligand (CH3CN in 1, 2 and CH3NC in 5, 6) contributions.  
     Variable contributions were obtained, however, for the occupied orbitals of 1, 2 and 5, 
6. For 1, the formamidinate orbitals mainly contribute to the HOMO-2 (π*phenyl), 
HOMO-1 (pπDTolF) and HOMO (π*Rh-DTolF) (Figure 2.17, Table 2.8). Similar orbital 
characters are encountered in 2. As discussed earlier, however, the HOMO-2 in 5 and 6 
have Rh2(σ) character, whereas the HOMO-1 (pπbridging) and HOMO (pπbridging) comprise 
a set of closely lying orbitals with pπ lone-pair character from the bridging 
formamidinate ligands and much smaller contributions from metal-based orbitals (ratio 
~5:1) (Figure 2.18, Table 2.8). For 3 and 7, which are supported by triazenide bridging 
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Figure 2.15 Overlay of the experimental and calculated electronic absorption spectra (in 
solvation model with CH3CN as solvent) for 1-4. 
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Figure 2.16 Overlay of the experimental and calculated electronic absorption spectra (in 
solvation model with CH3CN as solvent) for 5-8. 
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Figure 2.17 Visualization of the frontier molecular orbitals primarily involved in the 
electronic transitions for the DFT calculations of 1-4 (iso-value 0.04). 
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Figure 2.18 Visualization of the frontier molecular orbitals primarily involved in the 
electronic transitions for the TD-DFT calculations of 5-8 (iso-value 0.04). 
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Table 2.8 Composition (%) of selected frontier molecular orbitals, derived from TD-
DFT calculations for 1-8. 
 
 1 2 3 4 
HOMO-2 91 (DTolF) 
7   Rh 
80 (F-form) 
17  Rh 
92 (NNN) 
7   Rh 
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[Ph2P(C6H4)] 
40  Rh 
HOMO-1 93 (DTolF) 
5  Rh 
90 (F-form) 
8   Rh 
94 (NNN) 51 [Ph2P(C6H4)] 
46  Rh 
HOMO 71 (DTolF) 
27 Rh 
69 (F-form) 
29  Rh 
79 (NNN) 
20 (Rh) 
68  Rh 
20 [Ph2P(C6H4)] 
10 (ax CH3CN) 
LUMO 66  Rh 
16 (ax 
CH3CN) 
7 (eq 
CH3CN) 
66  Rh 
15 (ax CH3CN) 
12 (F-form) 
7 (eq CH3CN) 
66 Rh 
15 (ax 
CH3CN) 
12 (NNN) 
7 (eq 
CH3CN) 
55  Rh 
29 [Ph2P(C6H4)] 
11 (ax CH3CN) 
5 (eq CH3CN) 
LUMO+1 43  Rh 
35 (DTolF) 
21 (eq 
CH3CN) 
43 Rh 
37 (F-form) 
20 (eq CH3CN) 
44 (NNN) 
39 (Rh) 
16 (eq 
CH3CN) 
61 [Ph2P(C6H4)] 
33  Rh 
6 (eq CH3CN) 
LUMO+2 45  Rh 
33 (DTolF) 
22 (eq 
CH3CN) 
44  Rh 
35 (F-form) 
21 (eq CH3CN) 
60 (NNN) 
36  Rh 
63 [Ph2P(C6H4)] 
29  Rh 
7 (eq CH3CN) 
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Table 2.8 Continued 
 
 5 6 7 8 
HOMO-2 51 Rh  
26 (ax CH3NC)    
14 (DTolF)    
9 (eq CH3NC) 
52  Rh  
26 (ax CH3NC) 
13 (F-form) 
9 (eq CH3NC) 
46  Rh    
24 (ax CH3NC)    
22 (NNN)    
7 (eq CH3NC) 
76  [Ph2P(C6H4)] 
21  Rh 
HOMO-1 86 (DTolF)    
11  Rh 
86  (F-form) 
10  Rh 
90 (NNN)    
7  Rh 
86  [Ph2P(C6H4)] 
13   Rh 
HOMO 80  (DTolF)    
15  Rh 
80 (F-form) 
15  Rh 
86 (NNN)    
12  Rh 
59  Rh   
18 (ax CH3NC)    
15  [Ph2P(C6H4)] 
9  (eq CH3NC) 
LUMO 63  Rh 
14 (ax CH3NC) 
13 (DTolF)    
10 (eq CH3NC) 
63 Rh    
14 (ax CH3NC) 
14 (F-form) 
9 (eq CH3NC) 
65  Rh    
16 (NNN)    
11 (ax CH3NC)    
9  (eq CH3NC) 
52  Rh 
26 [Ph2P(C6H4)] 
11 (eq CH3NC)    
11  (ax CH3NC) 
LUMO+1 43  Rh    
34 (DTolF)    
21 (eq CH3NC) 
44  Rh 
34  (F-form) 
21 (eq CH3NC) 
47 (NNN)   
35  Rh    
16 (eq CH3NC) 
60  [Ph2P(C6H4)] 
35  Rh 
LUMO+2 41  Rh 
36 (DTolF)    
19 (eq CH3NC) 
41   Rh 
36 (F-form) 
19 (eq CH3NC) 
51 (NNN)    
38   Rh    
8 (eq CH3NC) 
49  [Ph2P(C6H4)]  
47  Rh 
 
 
 
 
groups, the electronic transitions mainly involve the orbitals from HOMO-2 to LUMO+2. 
These orbitals in 3 and 7 exhibit very similar characters to the corresponding orbitals in 
1 and 5, respectively.  
     For 4 and 8, the spatial plots of the LUMOs indicate that they are also of Rh2(σ*) 
character but with slightly lower Rh orbital contributions (50%) as compared to 1-3 and 
5-7. The two low-lying unoccupied orbitals LUMO+1 and LUMO+2 in 4 are composed 
of ~60/40% bridging ligand/metal characters. A similar composition is also found for the 
LUMO+1 in 8, whereas the LUMO+2 has ~50/50% bridging ligand/metal based 
characters. For the occupied orbitals, the HOMOs of both compounds are mainly metal-
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based, but their spatial plots reveal Rh2(π*) and Rh2(σ) characters in 4 and 8, 
respectively (Figures 2.17 and 2.18). The HOMO-1 (π*phenyl) and HOMO-2 (π*phenyl) in 
8 comprise a set of closely lying orbitals residing on the two bridging ligands; in contrast, 
both orbitals in 4 have ~40% metal character. Other orbitals with dirhodium character, 
which are involved in the excited states of 4, derived from TD-DFT calculations, include 
the HOMO-18 to HOMO-14 and HOMO-5 to HOMO-3 (vide infra). A notable point, 
however, is that most of these orbitals also have significant contributions from bridging 
ligands with several of them having equal or even higher bridging ligand components, 
thus no Rh2(σ, π, δ) character can be assigned to them. 
     The different substituents on the formamidinate ligands affect the energy differences 
between the orbitals of 1, 2 and 5, 6. As shown in the MO diagrams (Figure 2.19), the 
orbitals in 2 and 6 lie at lower energies than in 1 and 5, respectively, but the energy 
differences between the orbital sets are different for each compound. For example, the 
energies of the HOMO (-5.91 eV) and LUMO (-2.16 eV) for 2 are by ~ 0.16 and 0.05 eV 
lower than the corresponding orbital energies for 1 due to the electron withdrawing 
fluorine groups on the bridging formamidinate ligands in 2. Furthermore, the various 
contributions from the bridging ligands result in different degrees of stabilization for the 
different orbitals in 1 and 2. As shown in Table 2.8, the bridging ligands have major 
contributions to the HOMOs but with only minor participation in the LUMOs. Similar 
trends are also observed for 5 and 6. On the other hand, the HOMOs of 5 and 6 are 
stabilized as compared to their CH3CN congeners 1 and 2, due to their antibonding 
character in 1 and 2, as opposed to their non-bonding nature in 5 and 6. Furthermore, the 
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LUMOs Rh2(σ*) for 5, 6 become destabilized, as compared to 1 and 2, due to the better 
σ-donating ability of the ax CH3NC ligands, which essentially leads to larger HOMO-
LUMO energy gaps in 5 and 6 vs. 1 and 2, respectively (Figure 2.19). Similarly, in 7, the 
HOMO is stabilized by ~ 0.27 eV, whereas the LUMO is destabilized by ~ 0.26 eV, as 
compared to the corresponding orbitals in 3, for the same reason that accounts for the 
larger HOMO-LUMO energy gap in 5 as compared to 1. In compound 4, the HOMO and 
LUMO lie at -6.42 and -1.92 eV respectively, i.e., they are by ~ 0.25 eV lower than the 
corresponding orbitals in 8. The destabilization of the Rh2(σ) (HOMO) and Rh2(σ*)   
 
 
 
 
 
Figure 2.19 Energy levels of the MOs for 1-8 derived from TD-DFT calculations. 
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(LUMO) in 8 are attributed to the better σ-donating ability of the ax CH3NC. The 
destabilization of the HOMO Rh2(σ) thus results in a weaker Rh-Rh bond in 8. 
     The electronic transitions for 1 and 2 computed by TD-DFT calculations are 
summarized in Table 2.9. As the results of the TD-DFT calculation with the solvation 
model indicate, the lowest energy band in 1 involves a HOMOLUMO transition 
occurring at 538 nm ( = 0.0015), thus it is primarily a ligand-to-metal charge-transfer 
transition (LMCT) with minor Rh2(δ*)Rh2(σ*) character (Tables 2.4 and 2.8). The 
corresponding transition in 2 occurs at 525 nm ( = 0.0011) and exhibits a hypsochromic 
shift as compared to 1, which is attributed to the larger HOMO-LUMO energy gap in 2 
due to the reasons we noted in the aforementioned section. The next higher energy 
absorption bands in 1 and 2 are in the range 435-440 nm (Table 2.9), involving 
transitions from HOMO-5 and HOMO-6 to LUMO in 1 and HOMO-5, HOMO-4 to 
LUMO in 2. As indicated in Table 2.9, these occupied orbitals have significant Rh2(π*) 
contribution, thus attributing metal-centered character (MC) to these transitions. The 
excited states 4-7 in 1 and 2 involve transitions from HOMO, HOMO-1 to LUMO+1 and 
LUMO+2, and occur in the broad range 330-410 nm. The involvement of HOMO and 
HOMO-1 orbitals leads to a bathochromic shift in 1 as compared to 2 (Table 2.9). The 
next set of transitions in the range 300-320 nm originates primarily from HOMO-15, 
HOMO-14, HOMO-13 to LUMO in both 1 and 2. Since the three occupied orbitals 
mainly consist of Rh2(π) and Rh2(σ) related orbitals (vide supra), the transitions are 
considered MC with moderate oscillator factors due to being allowed by the Laporte 
rules.      
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Table 2.9 Excited states calculated by TD-DFT/PCM (CH3CN as the solvent) with 
major transitions* involved in the excitations, transition coefficients, vertical excitation 
energies (nm), and oscillator strengths () for 1 and 2. 
 
1 2 
excitations E/  
nm 
 excitations E/  
nm 
 
     H ->L             94.1% 538 0.0015 H ->L     93.6% 525 0.0011 
H-6 ->L          30.2% 
H-1 ->L          39.8% 
441 0.0099 H-1 ->L     22.3% 442 0.0019 
     H-5 ->L         88.3%  435 0.0001 H-5 ->L     64.2% 
H-4->L    20.51% 
436 0.0001 
     H-6 ->L         22.5% 
     H-1 ->L         37.0%  
424 
 
0.0201 H-1->L    21.84% 
H->L+1   44.81% 
419 0.0150 
     H-1 ->L         20.4% 
     H ->L+1         58.9% 
417 0.0001 H-1->L    50.20% 
H->L+1   27.31% 
411 0.0066 
     H ->L+2         73.6% 405    0.0153        H->L+2   67.97% 399  0.0097   
     H-1 ->L+1      82.2% 332   0.0001   H-1->L+1    58.27% 333   0.0305   
     H-13 ->L        22.8%  
     H-2 ->L           27.2% 
330  0.0404   H-15->L  17.00% 
H-12->L  12.88% 
330   0.0268   
     H-14 ->L        32.9%      326  0.0010   H-13->L  27.34% 326   0.0064   
     H-13 ->L         27.0% 325  0.0044   H-13->L  36.90% 323  0.0016   
 
* 2|coefficient|
2
> 0.2 
 
 
 
     For the isocyanide analogs 5 and 6, the first two excited states are mainly HOMO, 
HOMO-1 to LUMO (LMCT) transitions (Table 2.10) which occur at 413 nm ( = 
0.0016) and 392 nm ( = 0.0154) for 5 and 409 nm ( = 0.0011) and 387 nm ( = 0.0167) 
for 6. The participation of HOMO and HOMO-1 orbitals leads to slight hypsochromic 
shifts from 5 to 6, in agreement with the more stabilized HOMO in 6. Furthermore, their 
hypsochromic shifts, as compared to the CH3CN analogs 1 and 2, are attributed to the 
larger HOMO-LUMO energy gaps in 5, 6. The next series of bands involve HOMO, 
HOMO-1 to LUMO+1 and LUMO+2 transitions in the absorption region 320-350 nm. 
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Similar bathochromic shifts from 6 to 5 are observed for these transitions due to the 
involvement of the HOMO and HOMO-1 orbitals. The excited states 7-10, in the range 
295 to 300 nm, correspond to transitions from Rh2(π*), Rh2(σ) to Rh2(σ*) orbitals (MC), 
which renders them insensitive to the bridging ligand identity and thus gives rise to the 
same energies for both 5 and 6 (Table 2.10).  
 
 
 
Table 2.10 Excited states calculated by TD-DFT/PCM (CH3CN as the solvent) with 
major transitions* involved in the excitations, transition coefficients, vertical excitation 
energies (nm), and oscillator strengths () for 5 and 6. 
 
5 6 
Excitations E/ 
nm 
 excitations E/ 
nm 
 
H-1 ->L         20.17% 
H ->L            75.05% 
413  0.0016 H->L      77.15% 409  0.0011 
H-1 ->L         75.81% 
H ->L            20.77% 
392   0.0154 H-1->L   78.10% 387   0.0167 
H ->L+1         74.6%  348  0.0259 H ->L+1      76.39% 345  0.0211 
H ->L+2         68.89% 337   0.0037 H ->L+2      70.46% 334  0.0044 
H-1->L+1       63.51% 334  0.0501 H-1 ->L+1  64.84%          331  0.0386 
H-1->L+2       68.86% 326  0.0192   H-1 ->L+2  69.27% 324  0.0146   
H-12->L         21.07% 
H-2->L           44.98% 
301 0.1654   H-12 ->L     29.91% 
H-2 ->L         38.4% 
301  0.1480   
H-11->L         43.58% 298  0.0189   H-11 ->L     65.98%  299  0.0234   
H-2->L+1       50.98% 296  0.0403   H-2 ->L+1  46.97% 296  0.0192   
H-12->L         26.65%      
H-3->L           24.71% 
295  0.0349   H-12 ->L     25.90% 
H-2 ->L       25.93% 
295 0.1088   
* 2|coefficient|
2
> 0.2 
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     The lowest energy transition in 3 is of the same character as the transitions in 1 and 2 
and it occurs at λ = 538 nm ( = 0.0006) (Table 2.11). The second set of absorption 
bands in the region 440-450 nm corresponds to transitions from HOMO, HOMO-1 to 
LUMO, LUMO+1 orbitals. The excited states 4, 5 centered at λ ~ 425 nm, with low 
oscillator factors, mainly are Rh2(π*)Rh2(σ*) transitions. The bands in the region 340-
380 nm are predicted to be strong and originate from HOMO, HOMO-1 to the low lying 
orbitals including LUMO+1 to LUMO+4 orbitals. Similarly to 5 and 6, the first two 
electronic transitions for 7 are mainly HOMO and HOMO-1 to LUMO occurring at λ = 
413 and 388 nm ( = 0.0024 and 0.0008, respectively). These hypsochromic shifts, as 
compared to 3, are also due to the larger HOMO-LUMO energy gap. The excited states 
3-5 arise from HOMO, HOMO-1 to LUMO+1 and LUMO+2 transitions in the region 
340-360 nm, and have similar characters and energies to those in 5 and 6. 
     In the orthometalated complex 4, the lowest energy transition at 442 nm ( = 0.0223) 
corresponds to HOMO-4 and HOMO to LUMO transitions, rendering it 
Rh2(π*)Rh2(σ*) MC in character (Table 2.12). The absorption at ~ 360 nm involves a 
series of transitions from orbitals including the HOMO-4 and HOMOLUMO and thus 
they have dual LMCT and MC characters. The strong absorptions at ~320 nm are mainly 
transitions from orbitals with both bridging ligand and metal contributions to the LUMO, 
thus also rendering them LMCT/MC in character but with much stronger oscillator 
factors as compared to the transitions at ~360 nm. Remarkably, in the methyl isocyanide 
analog 8, the lowest energy transition is expected at 376 nm with a very strong oscillator 
factor  = 0.2222; this is mainly the HOMO Rh2(σ)LUMO Rh2(σ*) transition and it 
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has a high molar absorptivity because it is allowed by the Laporte rules (σgσu orbital 
transition). The absorption shoulder at ~ 310 nm arises from transitions from the HOMO 
to the vacant LUMO and LUMO+1 orbitals, whereas the absorption at ~ 290 nm 
involves transitions from the HOMO to orbitals ranging from LUMO+2 to LUMO+4. 
Depopulation of the high energy HOMO Rh2(σ) orbital essentially induces cleavage of 
the Rh-Rh bond, which explains the instability of compound 8 (vide supra).  
 
 
 
Table 2.11 Excited states calculated by TD-DFT/PCM (CH3CN as the solvent), with 
major transitions involved in the excitations, transition coefficients, vertical excitation 
energies (nm), and oscillator strengths () for 3 and 7. 
 
3 7 
excitations E/ 
nm 
 excitations E/ 
nm 
 
H ->L             94.15% 538    0.0006   H ->L         91.41% 413 0.0024 
H ->L+1         62.21% 452   0.0030   H-1 ->L      90.98% 388 0.0008 
H-1 ->L          56.63% 437  0.0029   H ->L+1      81.08% 361 0.0298 
H-10 ->L        81.03% 430  0.0003   H-1 ->L+1   72.77% 349 0.0060 
H-9 ->L          61.44% 
H-1 ->L         24.54% 
424   0.0005   H ->L+2      75.31% 336 0.0028 
H ->L+4         69.52% 
 
382    0.0107   H-2 ->L       47.27% 
H-1 ->L+2   30.88% 
325 
 
0.0282 
H-1 ->L+1      88.11% 366  0.0006   H-2 ->L+1    63.75% 318 0.0078 
H ->L+2         94.51% 347   0.0198   H-1 ->L+2    36.39% 315 0.0853 
H ->L+3         44.82% 340   0.1346   H ->L+3      52.51% 302 0.2781 
H-10 ->L+1    48.22% 331   0.0428   H-13 ->L     34.27% 
H-3 ->L       30.09% 
302 0.0175 
   * 2|coefficient|
2
> 0.2 
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Table 2.12 Excited states calculated by TD-DFT/PCM (CH3CN as the solvent), with 
major transitions involved in the excitations, transition coefficients, vertical excitation 
energies (nm), and oscillator strengths () for 4 and 8. 
 
4 8 
excitations E/ 
nm 
 excitations E/ 
nm 
 
H-4 ->L        24.82% 
H ->L           48.85% 
442  0.0223 H ->L              87.54% 
 
346   0.2222 
H-3 ->L        67.17% 
H-1 ->L        22.08% 
441   0.0000 H ->L+1         83.60% 
 
312  0.0012 
H-3 ->L        22.51% 
H-1 ->L        64.24% 
364  0.0012 H ->L+2         67.77% 
 
306    0.0183 
H-4 ->L        32.91% 
H-2 ->L        34.18% 
H ->L           20.00% 
359  0.0074 H-2 ->L         72.75% 294   0.0007 
H-14 ->L      15.07% 
H-2 ->L        18.65% 
327   0.1063 H ->L+2         20.60% 
H ->L+3         38.38% 
290  0.0108 
H-17 ->L      22.26% 322  0.0027   H-13 ->L         65.68% 288 0.0021   
H-2 ->L        26.04% 317  0.1262   H-3 ->L         50.27% 287  0.0349   
H ->L+1       44.44% 312  0.0017   H-1 ->L         43.00% 
H ->L+3         22.18% 
285  0.0959   
H ->L+2       29.04% 308  0.0009   H ->L+4         79.91% 284  0.0010   
H-3 ->L+1   32.76% 299  0.0056   H ->L+5         80.72% 269  0.0007   
     * 2|coefficient|
2
> 0.2 
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Infrared spectroscopy  
A summary of the ᴠ(NC) stretching frequencies for 5-8, and other reported Rh(II) and 
Rh(I) isocyanide compounds is provided in Table 2.13. As explained in the 
computational section (vide supra), the strength of the CN bond (and thus the stretching 
frequencies) in methyl isocyanide can be influenced by two interdependent factors: on 
the one hand, methyl isocyanide donates electron density to the Rh2(σ*) orbitals from its 
σ*(CN) orbital (HOMO), which is antibonding in character;138 this fact is expected to 
increase the ᴠ(NC) stretching frequency as compared to free CH3NC.
139
 Conversely, as a 
good π-acceptor, methyl isocyanide can accept electron density by backbonding from the 
Rh-Rh centers into the low lying π* molecular orbital, which results in elongation of the 
CN bond and a decrease in the ᴠ(NC) stretching frequencies as compared to free CH3NC 
(similar to π-backbonding for CO,75,79-80 e.g., ᴠ(CO) in Rh2(O2CC3H7)4(CO)2
79
 and cis-
[Rh2[Ph2P(C6H4)]2(O2CCH3)2(CO)(CH3CO2H)] is shifted to 2095 cm
-1
 and 2028 cm
-1
, 
respectively, as compared to 2143 cm
-1
 for free CO. In the case of compounds 5-8 (Table 
2.13), the net result is a large shift for ᴠ(NC) by ~60-80 cm-1 to higher frequencies as 
compared to CH3NC,
139 which reflects the dominant effect of σ-donation from the 
methyl isocyanide groups to the Rh2(σ*) orbital in these complexes.
80
  
 
 
 
 
 
(d) 
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Table 2.13 The ᴠ(NC) (cm-1) stretching bands for isocyanide groups in the free ligands 
and 5-8. 
Compound ѵ(NC) (cm
-1
)  Ref. 
CH3NC 2161
a
 139 
5 2241(s), 2265(s)
b
 This work 
6 2233(s)
b
 This work 
7 2244(s), 2264(s)
b
 This work 
8 2219(s)
b
 This work 
Rh2(O2CCH3)4•2CNC6H5
 c
 2139 84 
Rh2(O2CCH3)4•2(CNBu
t
)
 c
 2150, 2130(s)d 84 
Rh2(pz)2(CNBu
t
)4I2
 c
 2199, 2173 97 
[Rh2(pz)2(CNBu
t
)4(CH3CN)2][PF6]2
 c
 2224, 2203(s) 97 
[Rh2(CNC6H11)8Cl2][BF4]2
 c
 2219 96 
[Rh2(p-CH3C6H4NC)8I2][PF6]2 2194 95 
[Rh2(p-CH3C6H4NC)8Br2][PF6]2 2199 95 
[Rh2(dppm)2(CNCH3)4I2][BPh4]2
e
 2215f 92 
[Rh2(dppm)2(CNCH3)2(SCF3)2][PF6]2
e
 2214f 93 
[Rh2(dppm)2(CNCH3)4][PF6]2
d
 2174f 92 
[Rh2(dpam)2(CNCH3)4][BPh4]2
f
 2196, 2172b 93 
a
Sample at partial pressure 0.025 atm in N2 (1 atm). 
b
Nujol mull, KBr. 
cᴠ(NC) 
(cm
-1
): C6H5NC, 2117; Bu
t
NC, 2139; C6H11NC, 2138.
140 dIn CH2Cl2. 
e
dppm: 
(C6H5)2PCH2P(C6H5)2. 
f
dpam: (C6H5)2AsCH2As(C6H5)2. 
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     In dirhodium complexes with ax isocyanide groups only, e.g., 
Rh2(O2CCH3)4•2CNC6H5, Rh2(O2CCH3)4•2(NCBu
t
), there is a moderate shift of ᴠ(NC) 
of ~20 cm
-1
 to higher frequencies relative to the unperturbed isocyanide molecules 
84, 140
 
(Table 2.13). In the case of the methyl isocyanide complexes 5-8, however, the effect is 
more pronounced due to the σ-donation of both axially and equatorially bound 
isocyanide groups. Analogous large shifts of ᴠ(NC) by ~80 cm-1 to higher frequencies 
have been reported for other dirhodium complexes with eq isocyanide groups, e.g., 
[Rh2(pz)2(CNBu
t
)4(CH3CN)2][PF6]2, [Rh2(p-CH3C6H4NC)8I2][PF6]2, 
[Rh2(CNC6H11)8Cl2][BF4]2 and others (Table 2.13). This σ-donation from the eq bonds 
has a substantial effect, as it is well established for compounds with Rh-Rh bonds that 
the eq bonds to the Rh atoms are stronger than the ax interactions for the same ligand. 
Moreover, the strong σ-donation from the methyl isocyanide groups to the Rh2(σ*) 
orbital for Rh(II) complexes is also corroborated by the fact that the ѵ(NC) is smaller in 
Rh(I) complexes, as in these cases, the π-backbonding, which results in a weakening of 
the CN bond, is more prominent, e.g., the last two Rh(I) isocyanide compounds listed in 
Table 2.13.
92
 
     For complexes 1-4, the stretching frequencies ᴠ(CN) of CH3CN also shift to higher 
frequencies by ~60-80 cm
-1
 (Table 2.14) as compared to free CH3CN (2253 cm
-1
) which 
indicates a strengthening of the CN bond attributed to σ-donation from the nitrogen lone 
pair of the acetonitrile, which is antibonding in character, to the metal orbitals.
141
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Table 2.14 The ᴠ(CN) (cm-1) for the CH3CN stretches in the free ligand and 1-4. 
Compound ѵ(CN) (cm
-1
) 
CH3CN 2253 
1 2326(w), 2303(m), 2276(w)
a
 
2 2334(w), 2308(m), 2276(w)
a
 
3 2330(m), 2310(m), 2280(w)
a
 
4 2314(m), 2286(sh), 2268(m)
a
 
[Rh2(CH3CN)10][BF4]4
b
 2300(w), 2317(m), 2342(m)
c
 
[Rh2(CH3CN)10][CF3SO3]4
b
 2286(m), 2316(w), 2345(m)
c
 
a
Nujol mull, KBr. 
b
 Ref.142 
c
Nujol mull, CsI. 
 
 
 
Electrochemistry  
The electrochemical data for 1-8 are summarized in Table 2.15 and representative cyclic 
voltammograms are displayed in Figure 2.20 (for 2 and 6). The dirhodium compounds 1-
3 and 5-7, supported by N-N type bridging ligands, exhibit two metal-centered one-
electron reductions and two one-electron oxidation processes (the first oxidation event is 
reversible). There is a second reduction at ~ -1.20 V unlike the series of dirhodium 
substituted tetraformamidinate complexes reported by Ren et al.,
143
 an indication of the 
better π-accepting ability of both CH3NC and CH3CN vs. the formamidinate groups. The 
second reductions for 5-7 are irreversible, however, an indication that the doubly 
reduced species for these electron-rich adducts are unstable. Furthermore, the oxidation 
processes of 1-3 and 5-7 shift to higher potentials as compared to Rh2(DPhF)4, which 
further supports the effect of the π-accepting ability of the CH3NC and CH3CN ligands. 
In this respect, compounds 1-3 are easier to oxidize than the methyl isocyanide analogs 
5-7, respectively, which attests to the improved π-accepting ability of CH3NC relative to  
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Table 2.15 Electrochemical data (V) for 1-8 in CH3CN.
a
 
Compound  E1/2(red)1 
(V) 
E1/2(red)2 
(V) 
E1/2(ox)1 
(V) 
E1/2(ox)2 
(V) 
[Rh2(DTolF)2(CH3CN)6][BF4]2 1
b
 -0.50 -1.33 +0.98 +1.40 
[Rh2(F-form)2(CH3CN)6][BF4]2 2
b
 -0.47 -1.26 +1.13 +1.63 
[Rh2(NNN)2(CH3CN)6][BF4]2 3
b
 -0.35
e
 -1.22 +1.19 +1.49 
[Rh2[Ph2P(C6H4)]2(CH3CN)6][BF4]2 4
b,c
   +1.54  
[Rh2(DTolF)2(CNCH3)6][BF4]2 5
b
 -0.67 -1.20
f
 +1.13 +1.43 
[Rh2(F-form)2(CNCH3)6][BF4]2 6
b
 -0.61 -1.09
f
 +1.32 +1.70
f
 
[Rh2(NNN)2(CNCH3)6][BF4]2 7
d
 -0.58
f
 -1.18
e
 +1.28 +1.50 
[Rh2[Ph2P(C6H4)]2(CNCH3)6][BF4]2 8
b
 -1.38
f
  +1.23  
Rh2(DTolF)4
g
  -1.40  +0.17 +0.68 
 
a
Data collected in ~ 0.10 M [n-Bu4N][PF6] as supporting electrolyte at a scan rate of 
0.2 V/s at 25° C. 
b
vs. Ag/AgCl. 
c
In CH2Cl2. 
d
Glassy carbon working electrode. 
e
Quasi-
reversible. 
f
Irreversible. 
g
Ref.143  
 
 
 
 
 
 
Figure 2.20 Cyclic voltammograms of 2 and 6 vs. Ag/AgCl in CH3CN (~ 0.10 M [n-
Bu4N][PF6] as supporting electrolyte) at a scan rate of 0.2 V/s at 25°C. 
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CH3CN. Also, as expected, the methyl isocyanide analogs 5-7 are more difficult to 
reduce than the respective acetonitrile adducts 1-3 (the potentials for 5-7 shift to more 
negative values by ~ 0.15 V; Table 2.14) owing to the enhanced σ-donating ability of 
CH3NC as compared to CH3CN, which renders the dirhodium core more electron-rich in 
the isocyanide series.  
     The axial isocyanide adduct Rh2(DPhF)4(CNC6H5) is not reduced within the negative 
potential limit of CH2Cl2 (- 1.8 V) in contrast to Rh2(DPhF)4, which is reduced at - 1.21 
V under the same experimental conditions.
82
 Compounds 1 and 5 undergo more facile 
oxidations, as compared to 2 and 6, respectively, which is ascribed to the strong 
electron-withdrawing ability of the fluorine substituents on the formamidinate bridging 
ligands of the latter (based on the calculations, there is significant contribution to the 
HOMO from the bridging formamidinate ligands, Tables 2.5-2.7); similar trends were 
observed for the substituted Rh2(R-DPhF)4 series reported by Ren et al.,
143
 but the 
differences in the reduction potentials between 1, 2 and 5, 6 are much smaller, findings 
that are corroborated by the proximity between the LUMO orbitals of each set of 
complexes (Figure 2.19).  
     In the case of 4, there is only one reversible oxidation at ~ +1.54 V, whereas this 
oxidation is shifted to ~ +1.23 V for 8, indicating the destabilization of the HOMO. This 
oxidation is assigned to the Rh2(II,II)/Rh2(II,III) redox couple as in the case of cis-
Rh2[Ph2P(C6H4)2]2(O2CCH3)2.
 
No reduction was observed within the solvent limit for 
compound 4. A reduction for 8 occurs at ~ - 1.38 V but the irreversibility of the process 
indicates the instability upon reduction. The electrochemical behavior of 4 and 8, with 
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respect to reduction, is attributed to the strong σ-donating ability of the phosphine 
groups,
81
which increases the electron density of the dirhodium core. 
Discussion 
Two series of partial paddlewheel dirhodium compounds supported by σ-donating 
bridging N-N or orthometalated phosphine ligands and either monodentate acetonitrile 
(1-4) or methyl isocyanide (5-8) groups in the unoccupied eq/ax positions were 
synthesized and investigated by X-ray crystallography, 
1
H, 
31
P NMR, electronic and 
infrared spectroscopies, cyclic voltammetry and theoretical calculations. In each series, 
the dirhodium core is supported by substituted formamidinates, triazenide or phosphine 
bridging groups. The substitution of the acetonitrile for methyl isocyanide ligands in 5-8 
leaves the dirhodium core framework intact but results in substantial differences in the 
structural, spectrochemical and electrochemical behavior of the two classes of 
compounds. The findings from the X-ray crystallography, the electronic and infrared 
spectroscopies as well as the cyclic voltammetric and computational studies nicely 
converge and support the conclusions presented for the two series of complexes.  
     Compounds 5-8 are unprecedented partial paddlewheel Rh2(II,II) compounds with a 
single metal-metal bond, with four eq and two ax positions occupied by methyl 
isocyanide ligands. The substitution of the CH3CN ligands with CH3NC results in 
marked differences in the corresponding distances between the two series 1-4/5-8 and 
allows for pertinent correlations that reflect the differences in the electronic structures of 
the monodentate ligands. The distances to the atoms engaged in short contacts with the 
Rh2(II,II) units for 1-8 are summarized in Tables 2.16 and 2.17. It is important to note
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Table 2.16 Summary of important bond distances (Å) in 1-3 and 5-7. 
 
 Rh-Rh 
(Å) 
Rh-Lax 
(Å) 
Rh-Leq  
(Å)
c
 
Donor  
Atom
d
 
L (CN)
c,d 
(Å) 
Rh-N  
(Å)
c
 
1 2.5594(8) 2.208(7)
a
 
2.235(7) 
2.020(6)
a
 
2.029(7) 
N 1.132(9)
a
 
1.138(8) 
2.026(6) 
2.037(6) 
2 2.571(1) 2.195(4)
a
 
2.251(4) 
2.032(5)
a
 
2.040(5) 
N 1.134(8)
a
 
1.140(7) 
2.038(5) 
2.046(5) 
3 2.5135(9) 2.202(7)
a
 
2.225(7) 
2.004(6)
a
 
2.024(6) 
N 1.12(1)
a
 
1.13(1) 
2.024(6) 
2.023(6) 
5 2.6262(4) 2.080(2)
b
 
2.099(2) 
1.935(2)
b
 
1.948(2) 
C 1.137(3)
b
 
1.139(3) 
2.081(2) 
2.093(2) 
6 2.6104(9) 2.074(4)
b
 
2.133(4) 
1.937(5)
b
 
1.951(4) 
C 1.131(5)
b
 
1.143(5) 
2.081(3) 
2.094(3) 
7 2.5852(6) 2.089(4)
b
 
2.093(4) 
1.943(5)
b
 
1.950(5) 
C 1.137(7)
b
 
1.143(6) 
2.078(3) 
2.089(3) 
CH3CN     1.158
e
  
CH3NC     1.167
e
  
a
L is CH3CN. 
b
L is CH3NC. 
c
Representative distances are listed.
 d
Ax and eq ligands are 
the same. 
e
Distances within monodentate ligands; Ref. 144. 
 
 
 
 
Table 2.17 Summary of important bond distances (Å) in 4 and 8. 
 
Cmpd Rh-Rh  
(Å) 
Rh-Lax 
(Å) 
Rh-Leq 
(Å)
c,d
 
Donor Rh-C
e
 
(Å) 
Rh-P  
(Å) 
4-R 2.656(1) 2.196(6)
a
 2.104(6)
a 
2.142(6) 
N
c
 2.01(2) 2.232(7) 
4-S 2.655(1) 2.202(6)
a
 2.127(5)
a 
2.131(5) 
N
c
 2.024(5) 2.228(2) 
8-R 2.766(1) 2.033(3)
b 
2.040(2) 
2.005(3)
b
 
2.011(3) 
C
c
 2.096(3) 
2.099(3) 
2.078(2) 
2.090(3) 
2.3056(8) 
2.3076(8) 
8-S 2.7682(6) 2.023(4) 
2.037(4)
b
 
2.007(2)
b 
2.009(2) 
C
c
 2.2929(9) 
2.3077(9) 
a
CH3CN groups. 
b
CH3NC groups. 
c
Ax and eq ligands are the same.
 d
Representative 
bonds are listed. 
e
C atoms of bridging orthometalated phosphine groups. 
 f
 Ref.134 
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that, in contrast to compounds 5-8, which are the first of their kind to be prepared by 
substitutions of the ax/eq monodentate ligands with methyl isocyanide, the few reported 
Rh2(II,II) compounds with isocyanide groups occupying eq positions (Table 2.18) were 
synthesized by oxidative addition of halogens to Rh(I) isocyanide precursors 
93,94
 or by 
the reaction of Rh(I) and Rh(III) mononuclear complexes. 
92
 These compounds exhibit 
significantly different structural parameters than those found for 5-8 (Tables 2.16, 2.17). 
The dearth of the type of compounds of the type in this study is likely related to the fact 
that the stabilization of isocyanide metal-metal bonded compounds is non-trivial due to 
the non-innocent character of the isocyanide ligands, which leads to reduction of the 
metal centers and cleavage of the metal-metal bonds.
84  
 
 
 
Table 2.18 Summary of important bond distances (Å) in dirhodium compounds with 
isocyanide ligands. 
 
Compound Rh-Rh (Å) Rh-C (Å) Ref 
Rh2(O2CCH3)4•2CNC6H4N(CH3)2 2.4245(4) 2.148(4)
a
 133 
Rh2(O2CCH3)4•2CNC6H5 2.4271(3) 2.133(3)
a
 133 
Rh2(O2CCH3)4•2CNC6H5CF3 2.4182(3) 2.122(3)
a
 133 
Rh2(DPhF)4•(CNC6H5) 2.4798(4) 1.991(4)
a
 82 
Rh2(DPhF)4(CNC6H4NC)Rh2(DPhF)4 2.496(1) 1.988(9)
a
 82 
[{Rh2(μ-pz)2(I)(CN
t
Bu)4}2(η-
I)][CF3SO3] 
2.632(3) 
2.605(3) 
1.90(1)
b
 
1.93(1) 
97 
[Rh2(μ-dppm)2(pz)(CN
t
Bu)2Cl2][PF6] 2.768(1) 1.933(5) 98 
[Rh2[CN(CH2)3NC]4Cl2]Cl2 2.8377(9) 1.9887(7)
b
 89 
[Rh2(CNC6H11)8Cl2][BF4]2 2.6944(4) 1.980(3)
b
 96 
[Rh2(TMB)4Cl2][PF6]2
c
 2.773(2) 1.96(2)
b
 91 
[Rh2(DMB)4Cl2]Cl2
d
 2.8464(3) 1.982(4)
b
 100 
[Rh2(p-CH3C6H4NC)8I2][PF6]2 2.785(2) 1.97-1.99
b
 95 
a
Ax isocyanide groups. 
b
Eq isocyanide groups. 
c
TMB: 2,5-diisocyano-2,5-
dimethylhexane. 
d
DMB: 2,2-dimethyl-1,3-diisocyanopropane. 
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Dirhodium coordination sphere, σ-bonding and π-backbonding in 1-8  
It is notable that the Rh-Rh bond distances in 5-7 are elongated by up to ~ 0.07 Å 
relative to 1-3 (Table 2.16), respectively, and by ~0.10 Å in 8 as compared to 4 (Table 
2.17), which indicates stronger interactions between the ax CH3NC ligands and the 
rhodium centers in the isocyanide series. This fact is also confirmed by the shorter Rh-C 
(ax CH3NC) bond distances in 5-8 as compared to the Rh-N distances in 1-4 (Tables 
2.16, 2.17). The aforementioned findings are the result of two interdependent factors, 
which are reflected in the differences in the MOs of the two ligands. As noted earlier, the 
superior σ-donating ability of CH3NC relative to CH3CN is attributed to the fact that the 
HOMO of CH3NC is at higher energy than that of CH3CN, whereas the enhanced π-
accepting ability of CH3NC is due to the lower lying LUMO+1, LUMO+2 (Figure 2.10) 
orbitals. On the one hand, the strong σ-donation from the ax CH3NC groups to the 
Rh2(σ*) orbitals results in elongation of the Rh-Rh bond distances
145
 and shortening of 
the CN bond distances in CH3NC (the distances in the 5-8 are shorter than in the free 
ligand; Tables 2.16, 2.17) due to the π* antibonding character of the HOMO for CH3NC. 
On the other hand, the donation of electron density from the Rh2(π*) orbitals to the low-
lying π* orbitals of the CH3NC ligands, due to the good π-accepting ability of CH3NC, 
results in a reduction of the Rh-Rh bond distances and elongation of the CN bonds. The 
net elongation of the Rh-Rh bond distances in 5-8 and the shortening of the CN bonds by 
~ 0.02-0.04 Å as compared to free CH3NC (Tables 2.16, 2.17) strongly suggest that the 
σ-donation of the ax CH3NC ligands is more dominant than the backbonding in 5-8. This 
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conclusion is also clearly corroborated by the ᴠ(CN) frequencies of the methyl 
isocyanide groups in 5-8, which are higher by ᴠ~ 60-80 cm-1 as compared to free methyl 
isocyanide (Table 2.13); as explained earlier, this is due to donation of electron density 
from the σ* NC antibonding HOMO orbital to the Rh2(σ*) orbitals of the complexes, 
thus rendering the NC bonds in the bound methyl isocyanide groups shorter than the free 
ligand (Tables 2.16, 2.17). A similar shortening of the CN bonds in CH3CN is also 
observed for the acetonitrile series 1-4 (Table 2.16). The strengthening of the CN bonds 
in 1-4 is also in agreement with the observed increase in the stretching frequencies ᴠ(CN) 
by ~ 60-80 cm
-1
 of the bound ligand as compared to free CH3CN (Table 2.14).
141
 The 
contraction of the CN bonds for the bound CH3CN groups in 1-4, however, is less than 
the corresponding one in 5-8, as compared to the free ligands in each case (Tables 2.16, 
2.17), reflecting the better σ-donating ability of CH3NC as compared to CH3CN. 
     Apart from the aforementioned Rh-Rh and CN distances in 1-8, of pertinence to this 
discussion are the Rh-N and Rh-C distances in 1-4 and 5-8, respectively. Due to the 
smaller covalent radius of N vs. C, the Rh-N (CH3CN) distances in 1-4 would be 
expected to be shorter than the Rh-C (CH3NC) distances in 5-8, in the absence of π-
backbonding. In our series, however, the bond distances Rh-C (CH3NC) in 5-8 are 
considerably shorter as compared to Rh-N (to CH3CN) in 1-4 (Tables 2.16, 2.17), which 
strongly supports the presence of significant π-backbonding in the case of the methyl 
isocyanide series. An analogous shortening of the Rh-C bond distances has been 
observed for other reported dirhodium isocyanide complexes (Table 2.18) for which the 
Rh-C bond distances are typically in the range 1.98-2.1 Å, i.e., shorter by 0.20-0.5 Å 
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than the Rh-C bond distances in dirhodium complexes with weak π-donor molecules 
such as (-)-trans-caryophyllene (~2.46, 2.62 Å),
146
 other olefins, substituted alkynes, 
benzene and hexamethylbenzene, polycyclic aromatic hydrocarbons, and the geodesic 
polyarene corannulenes and hemibuckminsterfullerenes which exhibit considerably 
longer ax Rh-C bonds (~2.5-2.7 Å). In agreement with the presence of considerable π-
backbonding from Rh2(π*) to π* (CH3NC) and shorter Rh-C bond distances in 5-8, the 
Rh-Rh bond distances are also longer in the latter series as compared to 1-4 (Tables 2.16, 
2.17).
141 The presence of significant π-backbonding from the dirhodium core to the 
methyl isocyanide groups in 5-8 accounts for the more positive oxidation potentials of 5-
8 with respect to 1-4 (Table 2.15), as there is reduced electron density on the dirhodium 
core in 5-8, thus rendering it more difficult to oxidize the isocyanide series. On the other 
hand, the more negative reduction potentials for 5-8 are in accord with the enhanced σ-
donation of CH3NC.  
     As reported by Christoph et al. and Eagle et al., both the σ-donor and π-acceptor 
abilities of the ligands have an impact on the Rh-Rh and Rh-L (ax) structural 
parameters,
22,133
 which is clearly demonstrated by comparing 1-4 with 5-8. The strong 
trans influence that gives rise to the inverse relationship of the Rh-Rh and Rh-N/Rh-C 
(ax) distances,
22, 147
 namely isocyanide adducts with the shorter Rh-C ax bonds exhibit 
longer Rh-Rh distances as compared to the acetonitrile series with shorter Rh-Rh and 
longer ax Rh-N distances (Tables 2.16, 2.17). Furthermore, the trans influence is also 
obvious when comparing the Rh-L (eq) monodentate ligand and the Rh-N (bridge) 
distances between the two series. The shorter bond distances Rh-C (eq CH3NC) in 5-7, 
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indicating the stronger interactions between the Rh centers and the eq CH3NC ligands 
due to π-backbonding, result in the elongation of the trans Rh-N (bridging group) 
distances by ~0.05 Å as compared to their CH3CN analogs 1-3 with weaker Rh-N eq 
bonds to the acetonitrile ligands. The short bond distances Rh-C (eq CH3NC) in 5-7 (and 
thus stronger bonds) are also supported by the absence of CH3NC ligand exchange with 
the solvent in the 
1
H NMR spectra of the isocyanide complexes even after 1 week (e.g., 
Figure 2.7). Short Rh-C (CH3NC) contacts are also encountered in both isomers of 8 
with remarkably short Rh-C (ax CNCH3) bond distances that are only ~ 0.02 Å longer 
than the Rh-C (eq CNCH3) distances (Table 2.17). To the best of our knowledge, the 
latter finding is unprecedented for Rh2(II,II) compounds, as it is well-known that the ax 
ligands typically establish weaker contacts with the dirhodium core as compared to the 
same identity eq ligands, e.g., in the case of 1-3 the contacts to the eq CH3CN groups are 
up to 0.2 Å shorter than the ax distances, and in the cases of 4-7, the eq contacts are 
shorter by ~ 0.10 Å. In particular, the Rh-N (ax CH3CN) bond distances (2.202(6) and 
2.196(6) Å) for compound 4 are much longer than Rh-N (eq CH3CN) (in the range 
2.104(6)-2.142(6) Å). The extremely short Rh-C (ax CH3NC) bonds in 8 as well as the 
considerably shorter Rh-C (ax CH3NC) in 5-7, as compared to other dirhodium 
compounds with ax C atom donors,
146 146 
are correlated to the increased electron density 
on the dirhodium core (arising from the strong σ-donation of the orthometalated 
phosphine bridging groups,
 
which increases the degree of π-backbonding to the π-
acceptor isocyanide ligands and thus strengthens the Rh-C bonds). In this respect, for 
example, the Rh-C (ax CH3NC) bond distances in 5-7 are shorter than the distances in 
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the tetra-acetate adducts with isocyanide Rh2(μ-O2CCH3)4•2L (L = 2CNC6H4N(CH3)2, 
CNC6H5, CNC6H5CF3; ~ 2.14 Å) but longer than the corresponding ax distances in 
Rh2(DPhF)4(CNC6H5) and Rh2(DPhF)4(CNC6H4NC)Rh2(DPhF)4 (~ 1.99 Å; Table 10)
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as well as in 8 (~ 2.03 Å; Table 2.17). The previous Rh-C (ax CH3NC) bond distances 
decrease in the order of increasing number of strong σ-donor formamidinate or 
phosphine bridging ligands bound to the dirhodium core, rendering it progressively more 
electron-rich and thus a better candidate for π-backbonding and shorter Rh-C (ax 
CH3NC) distances. The higher degree of π-backbonding in the case of 8 as compared to 
5-7 is also reflected by the lower ᴠ(NC) frequency of the CH3NC groups in 8 (by ~20-30 
cm-1; Table 2.13) vs. 5-7.  
     As previously detailed, the short Rh-C (eq CNCH3) contacts and the concomitant 
significant π-backbonding from the dirhodium unit to the CH3NC ligands in 5-7 relative 
to 1-3 lead to the stabilization of the Rh2(π*) orbitals (due to the higher contribution 
from the low-lying π* orbitals of CH3NC in 5-7; Tables 2.4-2.7), which result in the 
Rh2(π*) being of lower energy than that of the Rh2(σ) level (Figures 2.11, 2.12). In the 
case of 8, however, apart from the strong eq CH3NC contacts, the strong Rh-C bonds 
with the ax CH3NC ligands, which are shorter by 0.05 Å as compared to 5-7, greatly 
destabilize the Rh2(σ) bond (Figure 2.14), which complies with the considerably longer 
Rh-Rh distances in 8 (~ 2.76 Å; Table 9) as compared to 4, as well as with the observed 
relative instability of 8 in solution, as evidenced by the 
1
H,
 31
P NMR data (Figure 2.8) 
and the ESI-MS fragmentation pattern. The previous findings are in accord with the 
strong trans influence of the ax Rh-C bonds on the Rh-Rh bond in 8. Similarly, the 
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shorter Rh-C (eq CNCH3) contacts in 8 exert a strong trans influence on the bridging 
orthometalated ligands, thus resulting in elongation of the Rh-C (bridge) and Rh-P bonds 
by ~0.1 and 0.08 Å, respectively (Table 9), as compared to the orthometalated adducts 
cis-[Rh2(O2CCH3)2[Ph2P(C6H4)]2]•2CH3CO2H and cis-
[Rh2(O2CCH3)2[Ph2P(C6H4)]2]•2C5H5N with bridging carboxylate groups.
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Molecular orbital energy levels, spectroscopic and electrochemical studies for 1-8  
The stronger σ-donating ability of the ax isocyanide groups in 5-8 leads to the 
destabilization of the LUMO Rh2(σ*) orbitals (Figures 2.11, 2.12 and 2.14) in 5-8 vs. 1-4. 
Furthermore, the non-bonding HOMOs of 5-7 are stabilized as compared to the 
antibonding HOMOs of their CH3CN analogs 1-3 (Figures 2.11, 2.12). The 
aforementioned shifts in the HOMO/LUMO relative energy levels, resulting in larger 
HOMO-LUMO energy gaps in 5-8 vs. 1-4 (Figures 2.11, 2.12), clearly account for the 
experimentally observed hypsochromic shifts of the lowest energy transitions in the visible 
spectra (~360-450 nm) of the isocyanide series 5-8, by ~80-100 nm, relative to the 
corresponding acetonitrile analogs 1-4 (comparisons between 1 and 5, 2 and 6, 3 and 7, 4 
and 8; Table 2.3); an increase in the lowest energy bands of the dirhodium core with 
increasing donor strength of the ax ligands was previously recorded.
148
 Importantly, the 
results from the TD-DFT calculations (Tables 2.9 – 2.12 and Figures 2.15, 2.16) provide 
strong support for the previous hypsochromic shifts of the low energy bands in the 
electronic spectra of 5-8 as compared to 1-4. In particular, in the case of 8, the TD-DFT 
calculations are not only in agreement with the experimentally observed hypsochromic 
shift of the low-energy MC band to 362 nm (from ~478 nm in 4), but they also support the 
86 
 
nearly 20-fold increase of the band intensity in 8 (ɛ ~ 104 M-1cm-1) with respect to 4 (ɛ ~ 6 
x 10
2
 M
-1 
cm
-1
; Table 2.3, Figure 2.9d)  based on the calculated strong oscillator factor for 
8 (Table 2.12). The MC band at 362 nm, which is assigned to the HOMO Rh2(σ)LUMO 
Rh2(σ*) transition in 8, exhibits a high molar absorptivity, as compared to a typical d-d 
electronic transition because it is allowed by the Laporte rules (σgσu transition). The 
stronger interactions of the dirhodium core with the ax CH3NC ligands increase the energy 
of the Rh2(σ) orbital considerably, rendering it the HOMO in 8 (Figure 2.14) as opposed to 
4 where the lowest energy transition is the HOMO Rh2(π*)LUMO Rh2(σ*) and thus of 
considerably lower intensity (Figure 2.9d, Table 2.3). The Rh2(σ) orbital has been reported 
to become the HOMO for dirhodium tetracarboxylate complexes with strong ax ligands, 
e.g., phosphines.
79,149-151
 Larger energy gaps for the MC Rh2(π*)Rh2(σ*) transitions 
were also rightfully anticipated by the TD-DFT calculations, which corroborate the 
hypsochromic shifts of the electronic transitions in 5-7 as compared to 1-3, respectively (in 
the range 425-440 nm for 1-3 vs. 295-300 nm for 5-7; Tables 2.9-2.12). Accordingly, the 
slight hypsochromic shift of the lowest energy HOMO-LUMO transition in 2 as compared 
to 1 (Table 2.3, Figure 2.9a) is in agreement with the TD-DFT calculations (Table 2.9) and 
is attributed to the greater stabilization of the HOMO (primarily of bridging formamidinate 
ligand character) in 2 (Figure 2.19) due to the electron-withdrawing F substituents on the 
formamidinate bridging ligands. 
     It is notable that the DFT calculations are also in excellent agreement with the 
findings from the electrochemical studies. In particular, the stabilization of the HOMO 
orbitals in compounds 5-7, as compared to 1-3 (Figure 2.19) is corroborated by the 
87 
 
higher oxidation potentials of the isocyanide series 5-7 vs. the acetonitrile analogs 1-3, 
respectively (Table 2.15); this is ascribed to the π-backbonding from the dirhodium core 
to the CH3NC groups. Correspondingly, the higher energy of the LUMO orbitals for 
compounds 5-7 (Figure 2.19) is in agreement with the isocyanide analogs 5-7 being 
more difficult than 1-3 to reduce as a result of the more electron-rich dirhodium cores in 
5-7, arising from the superior σ-donating ability of CH3NC as compared to CH3CN. 
Furthermore, the expected correlations are found by comparing the electrochemical 
behavior of 1 with 2 and 5 with 6, i.e., 1 and 5 more easily oxidized and less easily 
reduced than 2 and 6, respectively, which is reflected by the lower-lying LUMO and 
HOMO orbitals for 2 and 6 with respect to 1 and 5 (Tables 2.4 and 2.5, Figure 2.19) due 
to the strong electron withdrawing ability of the fluorine groups on the formamidinate 
bridging ligands. 
Concluding remarks 
In this comprehensive investigation, two analogous classes of dirhodium compounds 
with two strong σ-donating bridging groups and eq/ax monodentate acetonitrile (1-4) or 
isocyanide (5-8) ligands were synthesized and characterized by X-ray crystallography,
 
1
H, 
31
P NMR, electronic and infrared spectroscopies as well as electrochemical studies, 
the collective results of which are in agreement with the theoretical studies. The 
isocyanide analogs 5-8 are unprecedented with respect to their geometrical features and 
are a rarity in the metal-metal bond literature with isocyanide ligands given the synthetic 
challenges of isolating products that have not undergone reduction. The substitution of 
acetonitrile for isocyanide in the eq/ax positions leads to notable changes in the 
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isocyanide series 5-8 as compared to 1-4 and allows for intriguing correlations between 
the two classes of dirhodium compounds to be made. The combined experimental data 
gleaned from the crystallographic, spectroscopic and theoretical studies all converge to 
the conclusion that the improved σ-donating and π-accepting abilities of isocyanide vs. 
acetonitrile have a profound effect on the structural and spectroscopic features of 5-8. In 
particular, the longer Rh-Rh bonds (by up to ~ 0.07 Å) in 5-8 vs. 1-4 are in agreement 
with the better σ-donation of the ax CH3NC as compared to CH3CN; the latter 
conclusion is also supported by the short CN distances in CH3NC and the increase in the 
stretching frequencies ᴠ(CN) by ~ 60-80 cm-1 for the bound ligands in 5-8 vs. free 
CH3NC. Furthermore, the short Rh-C (ax CH3NC) distances in 5-8, which exert a strong 
trans influence on the Rh-Rh bonds, attest to the enhanced π-accepting ability of CH3NC 
as compared to CH3CN. The significant π-backbonding from the dirhodium core to the 
isocyanide groups in 5-8 is also evidenced by the shorter bond distances Rh-C (eq 
CH3NC), which result in elongation of the Rh-bridging group distances trans to the eq 
isocyanide groups, as compared to their CH3CN analogs 1-4 with longer Rh-N (eq 
CH3CN) bonds. In accord with the π-backbonding to the isocyanide groups for 5-8, are 
their more positive oxidation potentials and the lower energy levels of the HOMO 
orbitals as compared to 1-4. The more negative reduction potentials and the 
destabilization of the LUMO orbitals for 5-8 vs. 1-4 are consistent with the enhanced σ-
donation of CH3NC. Accordingly, the TD-DFT calculations are in excellent agreement 
with the larger HOMO-LUMO energy gaps in 5-7 vs. 1-3 as well as with the 
experimentally observed hypsochromic shifts of the lowest-energy transitions in the 
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isocyanide series 5-7 with respect to the corresponding acetonitrile analogs 1-3. 
Interestingly, for 8, the TD-DFT calculations corroborate the experimentally observed 
hypsochromic shift of the low energy MC band and the ~20-fold increase of the band 
intensity in 8 (ɛ ~ 104 M-1cm-1) with respect to 4. The latter increase originates from a 
Laporte allowed HOMO Rh2(σ)LUMO Rh2(σ*) transition due to the increase in the 
energy of the Rh2(σ) orbital with respect to 4, which renders it the HOMO in 8. This 
considerable destabilization of the Rh2(σ) in 8 is attributed to the stronger interactions of 
the dirhodium core with the ax CH3NC ligands. These interactions account for the 
weaker Rh-Rh bond (by ~ 0.1 Å relative to the acetonitrile analog 4) and the remarkably 
short ax Rh-C (CH3NC) distances (2.01-2.04 Å) in 8, and, in fact the latter become 
comparable in length to the eq Rh-C (CH3NC) contacts which is an unprecedented 
structural feature among all reported dirhodium(II,II) compounds.  
     To this stage, two series of partial paddlewheel dirhodium complexes featuring two 
electron-rich bridging ligands with the cis configuration have been developed, namely 
the acetonitrile complexes 1-4 and their corresponding methyl isocyanide anologs 5-8. 
The strong electron donating ability of the bridging ligands renders the CH3CN ligands 
trans to them labile, and conversely, due to π-backbonding, leads to substitutional 
inertness for CH3NC ligands. To achieve the dark stability and photolability of the eq 
monodentate ligands for this type of dirhodium complexes, further tuning of the ligand 
field around the dimetal center is required. The use of less electron accepting ligands, 
e.g. CF3NC and C6H5NC are promising for this purpose and these studies are currently 
in progress. 
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CHAPTER III  
INVESTIGATION OF PARTIAL PADDLEWHEEL DIRHODIUM COMPLEXES 
WITH ELECTRON ACCEPTOR LIGANDS
*
 
Introduction 
Photocatalytic reduction of H2O to generate H2 is one of the most promising and 
effective methods for meeting the demand for increasing global fuel consumption. 
Transition metal complexes hold great potential as molecular water reduction 
photocatalysts as exemplified by the extensive studies of Ni(II)
64
, Co(II)
152
, Pt(II)
153
, 
Pd(II)
154
, Rh(III)
155
 and Mo(III)
65
 complexes. Among the aforementioned catalysts, 
mononuclear Rh(III) complexes represent one of the earliest examples in this 
category.
156
 A few years ago Bernhard and co-workers reported a multicomponent H2O 
reduction system, [Rh(dtbbpy)3]
3+
 (dtbbpy = 4,4’-di-tert-butyl-2,2’-bipyridine) as the 
catalyst and [Ir(f-mppy)2(dtbbpy)]
+
 (f-mppy = 5-methyl-2-(4-fluorophenyl)pyridine) as 
the photosensitizer that achieves a turnover number (TON) of  > 5000 upon 22 h 
irradiation under optimal conditions.
157
 Another example relevant to the current study 
involves the series of dirhodium(II,II) complexes, cis–[Rh2(μ-O2CCH3)2(L)2][O2CCH3]2 
(L = bpy, phen; bpy = 2,2’-bipyridine, phen = 1,10-phenanthroline) which were recently 
shown to act as catalysts for H2 evolution from H
+
 in the presence of external 
photosensitizer, [Ir(ppy)2(dtbbpy)]
+
 (ppy = 2-phenylpyridine) and the sacrificial electron 
donor triethylamine (TEA).
14
 It was proposed by the researchers that the reduced 
                                                          
* Reprinted with permission from “Directional charge transfer and highly reducing and oxidizing excited states of new 
dirhodium(II,II) complexes: potential applications in solar energy conversion” by Zhanyong Li, Nicholas A. Leed, Nicole M. 
Dickson-Karn, Kim R. Dunbar and Claudia Turro, 2014. Chem. Sci,  5, 727-737, Copyright [2014] by The Royal Society of 
Chemistry (RSC). http://pubs.rsc.org/en/Content/ArticleLanding/2014/SC/C3SC52366G#!divAbstract 
91 
 
photosensitizer (this reduction is achieved by TEA) undergoes electron transfer process 
to the Rh2(II,II) catalysts to generate the active catalysts upon light irradiation; the 
identities of the active catalysts, however, remain unknown. Interestingly, the 
performance of this multicomponent system depends on the concentration of the 
catalysts. For example, at the concentration of 16.7 μM (cis-[Rh2(μ-O2CCH3)2(phen)2]
2+
), 
the TON for H2 production reached 2622 after 50 h of irradiation, which is the maximum  
efficiency for the system. Another series of excellent complexes in this vein are 
developed by Nocera and coworkers as shown earlier in chapter I. They were able to 
eliminate electron transfer steps between the sensitizer and the catalyst in the excited 
state because both the light absorber and the catalytic unit are in one molecule. 
15-17
 
     The present work in this chapter focuses on the synthesis and characterization of 
series of cis-[Rh2(μ-DTolF)2(L)2][BF4]2 and cis-[Rh2(μ-F-form)2(N-N)2][BF4]2 
complexes (DTolF = p-ditolylformamidinate, F-Form = di-pfluorobenzylformamidinate; 
N-N = chelating diimine ligands, dpq dipyrido[3,2-f:2',3'-h]-quinoxaline), dppz 
(dipyrido[3,2-a:2’,3’-c]phenazine) and dppn (benzo[i]dipyrido[3,2-a:2’,3’-
h]quinoxaline)). In addition, the computational modeling studies are also conducted for 
the better understanding of their photophysical properties. These complexes, the 
structural representation of which are depicted in Figure 3.1, were chosen based on our 
prior finding that Rh2(form)4 (form = formamidinate ligands with various substituents) 
exhibit highly reducing excited states capable of transferring electrons to alkyl halides 
via outer-sphere mechanism. The photophysical and redox properties of the new 
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complexes were also investigated, and the data reveal highly reducing and oxidizing 
ligand-to-ligand charge-transfer (LLCT) excited states. 
 
 
 
 
Figure 3.1 Schematic representations of the molecular structures of selected complexes. 
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Experimental section 
Starting materials  
The precursor (RhClCOD)2 was purchased from Pressure Chemicals and used without 
further purification. The compounds [Rh(F-form)(COD)]2, [Rh(DTolF)(COD)]2,
102
 dpq 
(dipyrido[3,2-f:2',3'-h]-quinoxaline), dppz (dipyrido[3,2-a:2’,3’-c]phenazine) and dppn 
(benzo[i]dipyrido[3,2-a:2’,3’-h]quinoxaline) 158  were synthesized by published 
procedures. The synthesis of cis-[Rh2(F-form)2(CH3CN)6][BF4]2 was achieved by 
adapting the published procedure for cis-[Rh2(DTolF)2(CH3CN)6][BF4]2.
104 
Acetonitrile 
was pre-dried over 3 Å molecular sieves and distilled under a nitrogen atmosphere. All 
reactions were conducted using standard Schlenk-line techniques unless otherwise stated. 
Filtration and further manipulation of the products were conducted in air. 
cis-[Rh2(DTolF)2(dpq)2(CH3CN)][BF4]2 (9). A sample of cis-
[Rh2(DTolF)2(CH3CN)6][BF4]2 (68 mg, 0.063 mmol) was dissolved in 10 mL of CH3CN 
and combined with 20 mL of CH3CN suspended with 37 mg (0.16 mmol) of the dpq 
ligand. The color of the solution changed gradually from red to dark brown and was 
refluxed under N2 for 48 h after which time it was concentrated to 5 mL and filtered 
through a medium frit to remove any insoluble materials. Addition of 20 mL of diethyl 
ether induced the precipitation of 68 mg of green product which was washed three times 
with 10 mL of diethyl ether and collected by filtration. It was dried under vacuum for 24 
h (yield: 79% based on rhodium). 
1
H NMR (CD3CN-d3) δ ppm: 9.02 (s, dpq), 8.88 (dd, 
dpq), 8.79(d, dpq), 8.29 (t, NCHN), 7.76 (dd, dpq), 7.10 (dd, phenyl H of DTolF), 2.28 
(s, -CH3 of DTolF), 1.96 (s, CH3CN). ESI-MS: [Rh2(DTolF)2(dpq)2]
2+
, 558.08. Anal. 
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Calcd for C62H55B2Cl4F8N13ORh2 (1•2CH2Cl2 •H2O): C 48.89, N 11.98, H 3.65%. Found 
C 48.84, N 12.10, H 3.56%. 
cis-[Rh2(DTolF)2(dppz)2(CH3CN)][BF4]2 (10). A sample of cis-
[Rh2(DTolF)2(CH3CN)6][BF4]2 (63 mg, 0.058 mmol) was dissolved in 10 mL of CH3CN 
and combined with 36 mg (0.13 mmol)  of dppz suspended in 20 mL CH3CN. The red 
solution was refluxed under N2 for 48 h which led to an eventual color change to dark 
brown. The volume was reduced to 5 mL and filtered through a medium frit to remove 
any insoluble impurities. A subsequent addition of 30 mL of diethyl ether induced the 
precipitation of 60 mg of the green product which was collected by filtration in air, 
washed with 3 x 10 mL of diethyl ether, and dried under vacuum for 24 h. The yield is 
72% based on rhodium. 
1
H NMR (CD3CN-d3) δ ppm: 8.97 (d, dppz), 8.81 (d, dppz), 
8.31 (t, NCHN), 8.05 (dd, dppz), 7.84 (dd, dppz), 7.12 (dd, phenyl H of DTolF), 2.28 (s, 
-CH3 of DTolF), 1.96 (s, CH3CN); ESI-MS: [Rh2(DTolF)2(dppz)2]
2+
, 608.12. Crystals 
suitable for X-ray diffraction were obtained by slow diffusion of diethyl ether into a 
CH3CN solution of the compound. Anal. Calcd for C69H55B2F8Cl2N13Rh2 (2•CH2Cl2): C 
54.61, N 12.01, H 3.66%. Found: C 54.27, N 11.75, H 3.78%. 
cis-[Rh2(DTolF)2(dppn)2(CH3CN)][BF4]2 (11). A sample of cis-
[Rh2(DTolF)2(CH3CN)6][BF4]2  (49 mg, 0.045 mmol) was added to 10 mL of CH3CN, 
mixed 20 mL of CH3CN containing a suspension of 38 mg (0.11 mmol) dppn and 
refluxed under N2 for 6 days. The dark red solution was concentrated to 5 mL and 
filtered through a medium frit to remove any insoluble solids. The red product was 
precipitated by adding 30 mL of diethyl ether to the concentrated solution. The yield is 
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55 mg (72% based on rhodium). 
1
H NMR (CD3CN-d3) δ ppm: 9.03 (d, dppn), 8.82 (d, 
dppn), 8.31 (t, NCHN), 8.22 (s, dppn), 7.90(dd, dppn), 7.82 (dd, dppn), 7.72 (dd, dppn), 
7.12 (dd, phenyl H of DTolF), 2.29 (s, -CH3 of DTolF), 1.96 (s, CH3CN); ESI-MS: 
[Rh2(DTolF)2(dppn)2]
2+
, 658.14; Anal. Calcd for C76 H57N13Rh2B2F8 (3): C 59.33, N 
11.65, H 3.86%. Found: C 59.56, N 11.89, H 3.75%. 
cis-[Rh2(F-form)2(dpq)2(CH3CN)2][BF4]2 (12). A sample of cis-[Rh2(F-
form)2(CH3CN)6][BF4]2 (53 mg, 0.049 mmol) was dissolved in 10 mL of CH3CN and 
combined with 20 mL of CH3CN that contained 32 mg (0.138 mmol) of  suspended dpq. 
The red solution was refluxed under N2 for 48 h, reduced in volume to 5 mL, and then 
treated with a copious volume of diethyl ether to precipitate the product along with a 
small amount of the free dpq ligand. Recrystallization by slow diffusion of diethyl ether 
into a CH3CN solution containing the product produced crystals which were used for 
further studies including X-ray diffraction. The overall yield is 50% based on rhodium. 
1
H NMR (CD3CN-d3) δ ppm: 9.02 (s, dpq), 8.88 (dd, dpq), 8.81(d, dpq), 8.27 (t, NCHN), 
7.79 (dd, dpq), 7.15 (m, phenyl H of F-form), 1.96 (s, CH3CN). Anal. Calcd for 
C59H44B2F12Cl2N14ORh2 (5•CH2Cl2•H2O): C 47.48, N 13.15, H 2.97%. Found: C 47.42, 
N 13.13, H 3.11%. 
cis-[Rh2(F-form)2(dppz)2(CH3CN)2][BF4]2 (13). A sample of cis-[Rh2(F-
form)2(CH3CN)6][BF4]2 (55 mg, 0.050 mmol) was dissolved in 10 mL of CH3CN  and 
combined with a suspension of 30 mL of CH3CN containing 34 mg (0.12 mmol) of dppz 
ligand. The solution was refluxed under N2 for ~ 72 h, concentrated to 5 mL and filtered 
to remove unreacted dppz. Addition of 30 mL of diethyl ether induced the precipitation 
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of 61 mg of the red product. The yield is 86% based on rhodium. Crystals suitable for X-
ray diffraction were produced from slow diffusion of diethyl ether to a CH3CN solution 
containing the product. 
1
H NMR (CD3CN-d3) δ ppm: 9.00 (d, dppz), 8.85 (d, dppz), 8.27 
(t, NCHN), 8.05 (dd, dppz) 7.84 (dd, dppz), 7.26 (m, phenyl H of F-form), 7.05 (m, 
phenyl H of F-form), 1.96 (s, CH3CN). Anal. Calcd for C67H48B2Cl2F12N14ORh2 
(6•CH2Cl2•H2O): C 50.53, N 12.32, H 3.04%. Found: C 50.71, N 11.93, H 2.76%. 
cis-[Rh2(F-form)2(dppn)2(CH3CN)2][BF4]2 (14). A quantity (55 mg, 0.050 mmol) of 
cis-[Rh2(F-Form)2(CH3CN)6][BF4]2 was dissolved in 10 mL of CH3CN and combined 
with a suspension of 20 mL of CH3CN containing 35 mg (0.1 mmol) dppn ligand. The 
solution was refluxed under N2 for 4 days and condensed to 20 mL after which time it 
was filtered through a fine frit. Subsequent addition of 40 mL of diethyl ether induced 
the precipitation of 54 mg of a red product, which was washed with 3 x 10 mL of diethyl 
ether and dried under vacuum for 24 h. The yield is 70% based on rhodium. Crystals 
suitable for X-ray diffraction were obtained by slow diffusion of diethyl ether into a 
CH3CN solution of the product. 
1
H NMR (CD3CN-d3) δ ppm: 9.06 (dd, dppn, 4H), 8.87 
(dd, dppn, 4H), 8.28 (t, NCHN, 2H), 7.91-7.84 (m, dppn, 8H), 7.71(dd, dppn, 4H) 7.26 
(m, phenyl of F-form, 8H), 7.06(m, phenyl of F-form, 8H), 1.96 (s, CH3CN). Anal. 
Calcd for C71N12H44B2F12Cl2Rh2 (7•CH2Cl2): C 53.55, N 10.56, H 2.79%. Found: C 
53.46, N 10.78, H 3.02%. 
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Instrumentation and methods 
X-ray data sets for 10, and 12-14 were collected on a Bruker CCD APEX diffractometer 
with graphite monochromated Mo Kα radiation (λ = 0.71073 Å). X-ray data for 9 and 11 
were collected at beamline 15-ID-B at the Advanced Photon Source at Argonne National 
Laboratory using synchrotron radiation (λ= 0.41328 Å). A hemisphere of data for 10, 
12-14 were collected by a combination of four sets of X-ray exposures. Each set used a 
different ϕ angle for the crystals and covered 0.5  in ω for 10 and 14, 0.3  for 12 and 13. 
The exposure times were 20 s for 10, 12 and 14 and 30 s for 13. Crystal data for 9 and 11 
were collected by a combination of two sets of X-ray exposures. The first set of data 
covers the whole sphere of the crystal whereas the second set of data covers the half 
sphere with an exposure time of 0.3 s. Crystal decay was monitored by analyzing 
duplicate reflections and was found to be less that 1%, therefore no decay corrections 
were applied. 
     Cyclic voltammetry and Uv-vis spectroscopic measurements were done in the similar 
fashion to the ones in the previous chapter II. The methods for the computational studies 
are also detailed in the same chapter.   
Results and discussion 
Synthesis and solution characterization 
The complex cis-[Rh2(DTolF)2(CH3CN)6]
2+
 reacts with the diimine ligands dpq, dppz, 
and dppn to produce cis-[Rh2(DTolF)2(dpq)2]
2+
 (9), cis-[Rh2(DTolF)2(dppz)2]
2+
 (10), and 
cis-[Rh2(DTolF)2(dppn)2]
2+
 (11), respectively. Similarly, cis-[Rh2(F-form)2(CH3CN)6]
2+
 
was used to produce cis-[Rh2(F-form)2(dpq)2]
2+
 (12), cis-[Rh2(F-form)2(dppz)2]
2+
 (13), 
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and cis-[Rh2(F-form)2(dppn)2]
2+
 (14).  The schematic representations of the structures of 
9-11 and 12-14 are shown in Figure 3.1. 
     The reaction of cis-[Rh2(DTolF)2(CH3CN)6][BF4]2 with 2.2 equivalents of dppz was 
monitored by 
1
H NMR spectroscopy as a function of reaction time; the aromatic regions 
of the spectra collected after 7 and 35 hours are shown in Figure 3.2. After refluxing for 
7 hours, the 
1
H NMR spectrum is consistent with a mixture of the starting material cis-
[Rh2(DTolF)2(CH3CN)6][BF4]2 and a new product (labeled as * and †, respectively, in 
Figure 3.2a). The new product, labeled †, exhibits resonances from bound dppz ligand at 
δ = 9.84, 9.43, 8.51, 8.25, 8.17 ppm, together with a new triplet at δ = 7.92 ppm arising 
from the NCHN on the [DTolF]
-
 ligand. The ratio between the integrations of the 
resonances at 9.84 and 7.92 ppm is approximately 1:1, consistent with the formation of 
the mono-dppz intermediate product cis-[Rh2(DTolF)2(CH3CN)3,4(dppz)][BF4]2 (†). This 
species with the dppz ligand bound in an eq-eq fashion is similar to those reported for 
the related complexes cis-[Rh2(DTolF)2(CH3CN)3,4(bpy)][BF4]2 and cis-
[Rh2(DTolF)2(CH3CN)3,4(phen)][BF4]2,
129
 but no eq CH3CN resonances were observed 
in this case, presumably due to their fast exchange with the CD3CN molecules. 
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Figure 3.2 Aromatic region of the 
1
H-NMR spectra of the products of the reaction 
between cis-[Rh2(DTolF)2(CH3CN)6](BF4)2  and 2.2 equiv of dppz in CD3CN after 
refluxing in CH3CN for (a) 7 hours and (b) 35 hours, where * = cis-
[Rh2(DTolF)2(CH3CN)6](BF4)2, † = cis-[Rh2(DTolF)2(CH3CN)3–4(dppz)](BF4)2, and ‡ = 
10. 
 
 
 
     After 35 hours the resonance at 7.52 ppm (labeled *) disappeared, indicating total 
consumption of the cis-[Rh2(DTolF)2(CH3CN)6][BF4]2 starting material. Moreover, the 
intensities of the resonances for the mono-dppz cis-
[Rh2(DTolF)2(CH3CN)3,4(dppz)][BF4]2 intermediate decreased (†), with concomitant 
appearance of a new set of dppz resonances at 8.97, 8.81, 8.05, 7.84, 7.80 ppm and 
bridgehead protons (NCHN) of [DTolF]
- 
at 8.31 ppm, corresponding to the final product 
(labeled ‡ in Figure 3.2b). The integration ratio between the resonances at 8.97 and at 
8.31 ppm is ~ 2:1, consistent with the formation of final product 10. Three days of 
refluxing followed by purification led to the generation of a single final product 
indicated by the appearance of only one set of dppz and bridgehead (NCHN) 
1
H-NMR 
resonances (Figure 3.3b) with the same chemical shifts as those labeled ‡ in Figure 3.2b.  
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X-ray crystallography confirmed the identity of 10 and will be discussed in the next 
section.  
      It is evident from Figure 3.3b that the resonances for the dppz ligands in 10 are 
shifted downfield as compared to those of the free ligand, but are positioned upfield 
relative to those of cis-[Rh2(DTolF)2(CH3CN)3,4(dppz)][BF4]2 (labeled † in Figure 3.2). 
These shifts are similar to those reported for the free dppz ligand, cis-[Rh2(μ-
O2CCH3)2(dppz)2]
2+
, and cis-[Rh2(μ-O2CCH3)2(dppz)(ƞ
1
-O2CCH3)(CH3OH)]
+
. 
45-47
 
     A slightly greater amount than two equivalents of dpq, dppz, dppn ligands were used 
in the reactions with cis-[Rh2(F-form)2(CH3CN)6][BF4]2 combined with refluxing 
conditions to induce the full substitution of all four eq CH3CN ligands by the diimine 
ligands. In general, the addition of excess diethyl ether to the CH3CN reaction mixture 
results in precipitation of the desired product along with an admixture of excess diimine 
ligand in some cases. In the latter instances, the pure products were obtained by 
recrystallization from slow diffusion of diethyl ether into the CH3CN solution. 
     The purity of compounds 9-14 was confirmed by 
1
H NMR spectroscopy. Upon 
coordination of the diimine ligands to the Rh2
4+
 core, the characteristic triplet resonance 
of the bridgehead protons (NCHN) on the [DTolF]
-
 ligands typically shift to lower field 
as compared to that in cis-[Rh2(DTolF)2(CH3CN)6][BF4]2 at 7.52 ppm, observed at  8.29, 
8.31 and 8.31 ppm in 9-11, respectively (Figure 3.3). Similarly, this triplet is observed at 
7.49 ppm in cis-[Rh2(F-form)2(CH3CN)6][BF4]2 as compared to 8.27, 8.27 and 8.28 ppm 
in 12-14, respectively (Figure 3.4). The resonance associated with the ax CH3CN ligands, 
is present at 1.96 ppm as free CH3CN due to the rapid exchange of them with CD3CN 
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Figure 3.3 The aromatic region of the 
1
H NMR spectra for 9-11 in CD3CN. 
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Figure 3.4 The aromatic region of the 
1
H NMR spectra for 12-14 in CD3CN. 
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solvent molecules, as is typical for Rh2(II,II) complexes.
21 
Only one set of resonances for 
the diimine ligands is observed in the 
1
H NMR spectra of 9-11 and 12-14, as illustrated 
in Figures 3.3 and 3.4 which supports the conclusion that the two diimine ligands are 
magnetically equivalent in each complex.  The major species in the mass spectra of 9, 10 
and 11 correspond to the intact 2
+
 cationic unit of the parent compound with the correct 
isotope distribution. 
X-ray crystallography 
cis-[Rh2(DTolF)2(dpq)2(CH3CN)][BF4]2 (9). Compound 9 crystallizes in the space 
group of Pbca. Its molecular structure consists of a cationic dirhodium unit bridged by 
two [DTolF]
–
 ligands in a cisoid disposition (Figure 3.5). Two outer-sphere [BF4]
–
 
anions are present as well. Each Rh(II) center is further chelated by a dpq ligand that 
occupies two eq positions (Figure 3.5). One of the two ax positions is occupied by a 
solvent acetonitrile molecule at a bond distance of 2.094(4) Å. The occupation of only 
one axial site is not uncommon for dirhodium(II,II) compounds equipped with [DTolF]
-
 
ligands and is attributed to its strong electron donating ability as well as the steric 
hindrance afforded by the bulky tolyl groups. The Rh-Rh bond distance is 2.5684(7) Å, 
which is comparable to that found in the related compounds cis-
[Rh2(DTolF)2(CH3CN)6][BF4]2,
104
 cis-[Rh2(DTolF)2(bpy)(CH3CN)3][BF4]2, and cis-
[Rh2(DTolF)2(bpy)2(CH3CN)][BF4]2.
129
 The Rh-N (dpq) bond distances are in a small 
range, from 2.029(4) to 2.064(4) Å. The two dpq ligands in the molecule adopted a 
staggered geometry to reduce the repulsion between them, with the dihedral angles 
defined by N5-Rh1-Rh2-N7 ~ 27.3(2)º. 
104 
 
 
 
  
 
Figure 3.5 Cationic unit of 9 drawn at 50% probability level. 
 
 
 
 
 
 
 
 
 
 
105 
 
cis-[Rh2(DTolF)2(dppz)2(CH3CN)][BF4]2 (10).  The molecular structure of 10 is similar 
to 9, with a distance of 2.158(6) Å for Rh-N (ax CH3CN) bond. The Rh-Rh bond 
distance is 2.597(1) Å, which is slightly longer than that was found in 9. The Rh-N bond 
distances (dppz) range from 2.040(5) to 2.060(2) Å, longer than those reported for cis-
[Rh2(μ-O2CCH3)2(dppz)2][O2CCH3]2.
46
 The longer Rh-diimine N bond in 10 is 
explained on the basis of a stronger trans influence induced by the more electron-rich 
[DTolF]
-
 ligand as compared to [CH3CO2]
-
 ligand. 
     The presence of the Rh-Rh single bond brings the two dppz ligands into close 
proximity, leading to the splay from a parallel alignment to reduce the steric repulsions. 
The twist angle of the two dppz ligands away from the eclipsed geometry is 15.6º, 
similar to the angle of 13º in cis-[Rh2(μ-O2CCH3)2(dppz)2][O2CCH3]2. The view along 
the b axis of the crystal packing diagram of 10 (Figure 3.6b), reveals π-stacking 
interactions of the dppz ligands between two adjacent dirhodium cations along the c axis. 
Since these ligands are not parallel to each other, no definitive distances can be 
determined between the two planes defined by them, but it is noted that the distances 
between C43 and C46 and the plane defined by C43-C44-C45-C46-C47-C48 in the 
adjacent dppz ligands are 3.47 and 3.42 Å, respectively, as depicted in Figure 3.6b. Such 
short intermolecular distances are indicative of π-stacking interactions between the two 
adjacent molecules. The crystal packing diagrams of 10 viewed along the b and c axes 
are provided in Figure 3.6c and 3.6d respectively. 
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Figure 3.6 Crystal structure of 10 showing (a) thermal ellipsoid plot of the cation drawn 
at 50% probability level and (b) the crystal packing of the cations showing 
intermolecular π-stacking; the [BF4]
-
 anions and hydrogen atoms are omitted for the sake 
of clarity. 
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cis-[Rh2(DTolF)2(dppn)2)Cl][BF4]•Et2O•3CH3CN (3•Et2O•3CH3CN). The cation in 
complex 11 crystallizes in the space group P-1 along with one [BF4]
-
 as well as three 
acetonitrile and one diethyl ether interstitial solvent molecules. The coordination sphere 
of the Rh(II) centers is similar to that found in 10 except that one ax position is occupied 
by a Cl
–
 ligand (Figure 3.7a). The Rh–Cl distance of 2.4562(7) Å is comparable to that 
reported for [Rh2(1,3-diisocyanopropane)4Cl2]Cl2, in which Rh-Cl (ax) is 2.4472(8) Å,
159
 
but is significantly longer than the Rh-N (ax CH3CN) bond length in 10, which is not 
surprising given the larger size of the Cl
–
 ion. The Rh-Rh bond distance is 2.5818(3) Å 
and the Rh-N (dppn) bond distances range from 2.032(2) to 2.053(3) Å, comparable the 
corresponding metrical parameters found in 9 and 10. The two dppn ligands are twisted 
away from the eclipsed configuration with a dihedral angle of ~ 28º. This value is 
significantly larger than was found for the dppz ligands in 10, indicating the stronger 
repulsions between the two adjacent dppn ligands in 11. 
cis-[Rh2(F-form)2(dpq)2(CH3CN)2)][BF4]2 (12). The molecular structure of the cationic 
unit of 12 depicted in Figure 3.7b is similar to that of 10, but with both ax positions 
being occupied by CH3CN ligands as a result of the smaller size and less electron-rich 
nature of the [F-form]
–
 vs. the [DTolF]
–
 ligands. The Rh-Rh distance is 2.599(1) Å and 
the Rh-N ([F-form]
-
) distances range from 2.034(5) to 2.052(5) Å, similar to that found 
in cis-[Rh2(F-form)2(CH3CN)6][BF4]2. The Rh-N (dpq) distances are in the range of 
2.035(3)-2.053(3) Å, similar to the Rh-N (dppz) lengths in 10. The internal twist angles 
away from the eclipsed geometry of the two dpq ligands defined by N5-Rh1-Rh2-N7 
and N6-Rh1-Rh2-N8 are -18.6(1)º and -18.9(1)º. 
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Figure 3.7 Thermal ellipsoid plot of (a) 11 an (b) 12 drawn at the 50% probability level; 
hydrogen atoms, [BF4]
-
 anion, and interstitial solvent molecules are omitted for the sake 
of clarity. 
 
 
 
 
 
Figure 3.8 Thermal ellipsoid plots drawn at the 50% probability level; the anions, 
hydrogen atoms and interstitial solvent molecules are omitted for the sake of clarity (a) 
13 (b) 14. 
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cis-[Rh2(F-form)2(dppz)2(CH3CN)2][BF4]2 (13). Compound 13 crystallizes in the P-1 
space group. The thermal ellipsoid plot of the cationic unit is shown in Figure 3.8a. Both 
ax positions of 13 are occupied by solvent CH3CN molecules with the distances of 
2.210(6) and 2.256(6) Å. The Rh-Rh bond distance of 2.6190(9) Å is slightly longer than 
the corresponding distances in 12. The Rh-N ([F-form]
-
) bond distances are in the range 
2.043(5)-2.065(5) Å, similar to those found in 12. The Rh-N (dppz) bond distances are 
~2.06 Å, similar to those in 10. The two dppz ligands in one molecule of 13 are twisted 
away from the eclipsed configuration with dihedral angles of 16.8(2)º  (defined by N7-
Rh2-Rh1-N5).  
cis-[Rh2(F-form)2(dppn)2(CH3CN)2)][BF4]2•2CH3CN (14•2CH3CN). As in the case of 
the dirhodium cations in 12 and 13, both ax positions are occupied by CH3CN ligands in 
14 with bond distances of 2.202(7) and 2.245(9) Å (Figure 3.8b). The Rh-Rh bond 
distance is 2.614(1) Å, slightly longer than those found in 12 but comparable to that in 
13. The Rh-N ([F-form]
-
) bond distances are in the range 2.047(5)-2.069(4) Å, similar to 
that for 12 and 13. The Rh-N (dppn) bond distances range from 2.042(8) to 2.064(6) Å, 
comparable to those in 12. Much larger distortions between the two diimine ligands is 
evident in 14 as compared to that of 12 and 13, with the angles defined by N5-Rh1-Rh2-
N7 and N6-Rh1-Rh2-N8 being -21.7(2)º and -21.8(2)º respectively, due to considerable 
repulsion between the two dppn ligands. 
     The detailed crystal refinement parameters are listed in Table 3.1 whereas the bond 
distances and dihedral angles are compiled in Table 3.2 
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Table 3.1 Crystallographic data and refinement parameters for 9-14. 
 
 9 10 11 Et2O•3CH3CN 12 13 14•2CH3CN 
Formula C60H49B2N13F8
Rh2 
C68H53B2N13F8
Rh2 
C80H63B1N15F4Cl1R
h2 
C58H40B2N14
F12Rh2 
C66H44B2N14
F12Rh2 
C78H54B2F12
N16Rh2 
Mol. Wt. 
(g/mol) 
1331.55 1431.67 1636.67 1388.46 1488.59 1670.81 
Space group Pbca C2/c P-1 P-1 P-1 P21/c 
a, b, c/ Å 13.964(3) 
19.803(4) 
40.072(8) 
50.745(10) 
19.810(4) 
13.614(3) 
10.0565(4) 
19.2440(7) 
19.4311(8) 
12.764(3) 
13.196(3) 
20.352(4) 
13.104(3) 
13.114(3) 
22.820(5) 
14.698(3) 
26.636(5) 
23.354(7) 
, , / º 90.00 90,  
99.70(3),  
90 
97.1760(10) 
94.0670(10) 
102.6250(10) 
83.78(3), 
72.12(3), 
66.51(3) 
73.63(3)  
86.21(3) 
66.42(3) 
90 
123.59(2) 
90 
Z 8 8 2 2 2 4 
2θ range for 
data 
collection/º 
49.47 50.02 58.26 53.67 49.43 48.14 
R(int)  0.1010 0.0737 0.0467 0.0368 0.0365 0.0960 
Completeness 
to  max/ % 
99.7 99.9 0.937 98.6 97.8 97.2 
Goodness-of-
fit (all data)
a
 
1.025 1.038 1.224 0.996 1.089 1.065 
R1,
b
 wR2
c
 (all 
data) 
R = 0.0754 
wR = 0.1076 
R = 0.0852 
wR = 0.1962 
R = 0.0611 
wR = 0.1485 
R =  0.0592 
wR = 0.1116 
R = 0.0760 
wR = 0.1752 
R = 0.0871 
wR = 0.1709 
a
Goodness-of-fit = {∑[w(Fo
2
- Fc
2
)
2
]/(n-p)}
1/2
, where n is the number of reflections and p is the total number of parameters 
refined.
 bR = ∑Fo-Fc/∑Fo. 
c
wR = {∑[w(Fo
2
 - Fc
2
)
2]/∑w(Fo
2
)
2
]}
1/2
. 
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Table 3.2 Selected bond distances and dihedral angles in 9-14.   
9 10 
Bond distances Å Bond distances Å 
Rh1-Rh2  2.5684(7) Rh1-Rh2  2.597(1) 
Rh1-N13  2.094(4) Rh1-N4  2.041(5) 
Rh1-N1  2.047(4) Rh1-N9  2.015(5) 
Rh1-N5  2.050(4) Rh1-N7  2.021(6) 
Rh1-N6  2.064(4) Rh1-N5  2.048(6) 
Rh1-N3  2.042(4) Rh2-N1  2.158(6) 
Rh2-N8  2.029(4) Rh2-N6  2.045(6) 
Rh2-N2  2.026(4) Rh2-N8  2.047(5) 
Rh2-N4  2.023(4) Rh2-N3  2.040(5) 
Rh2-N7  2.064(4) Rh2-N2  2.062(6) 
Dihedral angles º Dihedral angles º 
N3-Rh1-Rh2-N4  19.9(2) N4-Rh1-Rh2-N2  -15.6(2) 
N5-Rh1-Rh2-N7  27.3(2) N9-Rh1-Rh2-N8 -13.9(2) 
N1-Rh1-Rh2-N2  22.0(2) N7-Rh1-Rh2-N6  -15.7(2) 
N6-Rh1-Rh2-N8  27.2(2) N5-Rh1-Rh2-N3  -16.9(2) 
11 12 
Bond distances Å Bond distances Å 
Rh1-Rh2  2.5818(3) Rh1-Rh2  2.5991(9) 
Rh1-Cl1  2.4562(7) Rh1-N13  2.233(3) 
Rh1-N8  2.033(2) Rh1-N5  2.035(3) 
Rh1-N7  2.048(3) Rh1-N6  2.053(3) 
Rh1-N3  2.065(3) Rh1-N2  2.052(3) 
Rh1-N1  2.084(3) Rh1-N4  2.042(3) 
Rh2-N2  2.026(3) Rh2-N8  2.045(3) 
Rh2-N5  2.032(2) Rh2-N7  2.053(3) 
Rh2-N6  2.053(3) Rh2-N3  2.057(3) 
Rh2-N4  2.041(3) Rh2-N1  2.031(3) 
  Rh2-N14  2.200(3) 
Dihedral angles º Dihedral angles º 
N8-Rh1-Rh2-N6  28.29(9) N6-Rh1-Rh2-N8  -18.9(1) 
N7-Rh1-Rh2-N5  28.70(9) N5-Rh1-Rh2-N7  -18.6(1) 
N1-Rh1-Rh2-N2  25.8(1) N2-Rh1-Rh2-N1  -14.4(1) 
N3-Rh1-Rh2-N4  23.4(1) N4-Rh1-Rh2-N3  -14.7(1) 
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Table 3.2 Continued  
13 14 
Bond distances Å Bond distances Å 
Rh1-Rh2  2.6190(9) Rh1-Rh2  2.615(1) 
Rh1-N13  2.210(6) Rh1-N2  2.056(5) 
Rh1-N3  2.043(5) Rh1-N4  2.054(4) 
Rh1-N6  2.054(5) Rh1-N5  2.053(4) 
Rh1-N5  2.056(4) Rh1-N6  2.063(4) 
Rh1-N1  2.059(4) Rh1-N14  2.202(7) 
Rh2-N14  2.256(6) Rh2-N1  2.047(5) 
Rh2-N8  2.060(5) Rh2-N3  2.069(4) 
Rh2-N7  2.066(4) Rh2-N7  2.055(4) 
Rh2-N2  2.058(4) Rh2-N8  2.048(5) 
Rh2-N4  2.065(5) Rh2-N13  2.245(9) 
Dihedral angles º Dihedral angles º 
N3-Rh1-Rh2-N4  14.5(2) N2-Rh1-Rh2-N1  -17.4(2) 
N1-Rh1-Rh2-N2  14.0(2) N4-Rh1-Rh2-N3  -17.5(2) 
N5-Rh1-Rh2-N7  17.4(2) N5-Rh1-Rh2-N7  -21.7(2) 
N6-Rh1-Rh2-N8  16.8(2) N6-Rh1-Rh2-N8  -21.8(2) 
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Electronic absorption and electrochemistry 
Data regarding the photophysical properties of 9-14 in CH3CN are compiled in Table 3.3.  
The relatively distinct transitions in the region between 280 and 420 nm for all the 
complexes are attributed to the intramolecular 
1ππ* electronic transitions resulting from 
the free diimine ligands; e.g. the dpq ligand absorbs at 254 nm (ɛ = 53,000 M–1cm–1) in 
CHCl3, comparing well with the maxima of 9 and 12 at 289 nm (ɛ = 54,000 M
–1
cm
–1
) 
and 291 nm (ɛ = 50,000 M–1cm–1), respectively. Similarly, the dppz and dppn ligands 
exhibit absorption maxima at 370 nm (ɛ = 17,200 M–1cm–1) and 414 nm (ɛ = 12,500 M–
1
cm
–1
) respectively in CHCl3,
36
 similar to those measured for 10 and 13 (~ 370 nm) and 
11 and 14 (~ 418 nm), respectively (Table 3.3). It is also noted that these transitions are 
also observed in the related complexes cis-[Rh2(μ-O2CCH3)2(L)(η
1
-O2CCH3)(CH3OH]
+
 
(L = dpq, dppz, dppn), cis-[Rh2(μ-O2CCH3)2(dppz)2]
2+
, cis-[Rh2(μ-
O2CCH3)2(dppn)2]
2+
,
44-48
as well as in Ru(II) and Os(II) complexes containing dpq, dppz, 
and dppn ligands.
36, 37,160-163
 More intense bands are observed at higher energies in the 
250-280 nm rage, namely 256 nm for 9 and 12, 275 nm for 10 and 13, and 261 nm for 11 
and 14. Although a small dependence is apparent as a function of the diimine ligands, it 
is likely that these are metal-centered transitions involving orbitals participating in 
bonding interactions with the diimine ligands. Similar transitions are also observed in 
Rh2(F-form)4 at 230 nm (ɛ = 42,000 M
–1
cm
–1
) and 275 nm (ɛ = 23,900 M–1cm–1) and in 
Rh2(DTolF)4 at 265 nm (ɛ= 61,800 M
–1
cm
–1
) in CH3CN.   
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Table 3.3 Electronic absorption maxima, λabs, molar absorptivities, ɛ, and redox 
potentials for 9-14 in CH3CN. 
 
Complex λabs / nm (ɛ/ 10
3
 M
–1
cm
–1
) V
a
 
9 256 (98), 289 (54), 525 (1.3) –1.55, –1.36, –1.03,
b
 –0.40, +1.05, 
+1.59
c
 
10 276 (143), 368 (25), 541 (1.3) –1.49, –1.16, –0.94,
b
 –0.42, +1.06,b 
+1.64
c
 
11 261 (100), 314 (110), 418 
(17), ~553 (3.0) 
–1.50, –0.92, –0.67,b –0.40, +1.06,b 
+1.55
c
 
12 256 (116), 291 (50), 520 
(0.80) 
–1.55, –1.29, –0.98,b –0.45, +1.17,b 
+1.68
c
 
13 275 (107), 371 (17), 537 (1.0) –1.40, –1.13, –0.91,
b
 –0.39, +1.18,b 
+1.74
c
 
14 260 (92), 315 (101), 419 (14), 
~525 (1.8) 
–1.39, –0.88, –0.61,b –0.38, +1.16,b 
+1.73
c
 
a
vs. Ag/AgCl; 0.1 M [n-Bu4N][PF6]; 0.2 V/s.   
b
Quasi reversible.  
c
Irreversible.      
 
 
 
 
 
 
 
 
Figure 3.9 Electronic absorption spectra of 9 and 12 (left), 10 and 13 (middle), and 11 
and 14 (right) in CH3CN. 
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     In addition to the higher energy transitions there is a tail in the absorption profile for 
each complex that extends to lower energies as listed in Table 3.3 and illustrated in 
Figure 3.9. The dependence of the absorption maxima on the identity of the diimine 
ligands as well as the bridging formamidinate ligands for each series taken together with 
the intensities being in the ~ 1-3 x10
3
 M
–1
cm
–1
, points to the assignment of these lower 
energy bands as charge-transfer transitions from the formamidinate to the diimine 
ligands. Such charge-transfer features are also observed in the related cis-[Rh2(μ-
O2CCH3)2(L)2]
2+
 complexes where L is dpq, dppz and  dppn with maxima in the range 
609-620 nm with similar intensities ( ɛ = 1,100-3,800 M–1cm–1).48 The increased electron 
donation from the formamidinate ligands to the bimetallic core as compared to acetate is 
consistent with the lower energies of these charge-transfer transitions in 9-11 and 12-14. 
In addition, these transitions are observed at lower energies for the [DTolF]
-
 complexes 
as compared to the corresponding [F-form]
-
 compounds, which is in accord with  that the 
formamidinate ligands participate in the transition. 
     The observed redox couples measured for 9-11 and 12-14 are compiled in Table 3.3.  
A redox couple is observed at approximately – 0.4 V vs. Ag/AgCl in 9-11 and 12-14 
(Table 3.3, Figure 3.10 for complex 13). This process represents oxidation of the 
complexes which has been confirmed by a color change observed in the presence of 
oxidizing agents such as TCNQ, 7,7,8,8-tetracyanoquinonedimethane, (E' = – 0.14 vs. 
SCE in CH3CN, ΔG = – 0.30 V), AgBF4 in CH3CN (E' = + 0.44 V vs. SCE, ΔG = – 0.88 
V) and NOBF4 ( E' = + 1.03 V vs. SCE, ΔG = – 1.47 V ).
164
  Following the oxidation of 
9 and 10 with TCNQ, an IR stretch at ~ 2186 cm
–1
 is observed which is known to 
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correspond to the TCNQ radical anion, TCNQ
•–
.
165
 The product of the reaction of 10 
with NOBF4 was isolated; the absorption spectrum is shown in Figure 3.11. The facile 
oxidation of these dirhodium(II,II) complexes is not unexpected given the presence of 
the electron-rich formamidinate ligands. 
     The second oxidation process is at ~ +1.06 V vs. Ag/AgCl for the [DTolF]
-
 
complexes 9-11 and ~ + 1.17 V vs. Ag/AgCl for the [F-form]
-
 series 12-14 (Table 3.3). 
This couple is reversible in the case of 9 and quasi-reversible for 10-11, and 12-14 and is 
independent of the nature of the diimine ligand in each series but dependent on the 
substituents on the formamidinate ligand. As expected, the complexes with [DTolF]
-
 
ligands are more easily oxidized than those containing the electron withdrawing fluoride 
substituents, viz., [F-form]
-
 (Table 3.3). The difference of ~ 0.1 V for the [DTolF]
-
 and 
 
 
 
  
 
Figure 3.10 Cyclic voltammogram (top) and differential pulse voltammogram (bottom) 
of complex 13 in ~ 0.1 M [n-Bu4N][PF6] CH3CN solution at room temperature. 
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Figure 3.11 Comparison of the electronic absorption spectra of [9]
+
 and 9 (left) and of 
[10]
+
 and 10 (right) in CH3CN. 
 
 
 
[F-form]
-
 complexes is similar to the difference in the second oxidation potentials of 
Rh2(DTolF)4 and Rh2(F-form)4 of 0.14 V; the E1/2 values are + 0.85 V and + 0.99 V vs. 
SCE, respectively.
143 
The third oxidation process is irreversible for all the complexes 
with Epa ~ + 1.6 V vs. Ag/AgCl for 9-11 and ~ + 1.7 V vs. Ag/AgCl for 12-14 (Table 
3.3). The 0.1 V difference between the two series is consistent with this oxidation 
correspondent to the removal of one electron from orbital with significant formamidinate 
character.  
     The first reduction occurs at – 1.03 V, – 0.94 V, and – 0.67 V vs. Ag/AgCl for 9, 10, 
and 11 (Table 3.3), respectively, and is clearly dependent on the nature of the diimine 
ligand. These values are similar to those found for the corresponding [F-form]
-
 
complexes 12, 13, and 14, at – 0.98, – 0.91, and – 0.61 vs. Ag/AgCl (Table 3.3). The 
trends for each series of complexes, considering the fact that the diimine ligand L is 
easier to reduce in the order dppn > dppz > dpq, is consistent with the first reduction 
being centered on this ligand. These values are also comparable to those reported for 
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Ru(II) complexes with dpq, dppz, and dppn ligands.
166
 The potential of the second 
reduction process is also dependent on the diimine ligand L(Table 3.3), which is also the 
case for Ru(II) complexes, and may be assigned to the placement of an electron on the 
remaining neutral diimine ligand. A third reduction process is observed in the range of – 
1.39 to – 1.55 V vs. Ag/AgCl for 9-11 and 12-14, in accord with a metal-centered 
reduction. On the basis of the typical electronic structure of d
7–d7 paddlewheel 
complexes, it is reasonable to expect that the third reduction corresponds to the 
population of the Rh2(σ*) orbital.
21 
These values are similar to the corresponding data 
for Rh2(DTolF)4 at – 1.23 V vs. Ag/AgCl that do not possess diimine ligands.
143
 
Electronic structure calculations 
Computational studies of the [DTolF]
-
 and [F-form]
-
 series of compounds
 
were 
performed in order to gain a deeper understanding of their electronic structures. 
Geometric parameters for the gas phase optimizations were obtained from the crystal 
structures. For the calculations of 9-11, two CH3CN ligands were placed in both ax 
positions given that only one set of dpq, dppz and dppn resonances was observed in the 
solution 
1
H NMR spectra, indicating a symmetrical coordination environment. The 
calculated structures of 12-14 are depicted in Figure 3.12.  
     The calculated MO diagrams of 9-11 and 12-14 are shown in Figure 3.13, and the 
contributions to the orbitals from the metal and the ligands are listed in Tables 3.4 and 
3.5. 
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Figure 3.12 Calculated structures for complexes 12-14. 
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Figure 3.13 Calculated MO diagrams for 9-14.  
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Table 3.4 Orbital contributions for 9-11 predicted by DFT calculations in CH3CN. 
 
 9 10 11 
HOMO-5 77 Rh  
10 DTolF  
7 ax CH3CN  
6 dpq 
78 Rh,  
11 dppz,  
9 DTolF 
77 Rh    
10 ax CH3CN  
7 dppn  
6 DTolF 
HOMO-4 91 DTolF 91 DTolF 66 DTolF  
30 Rh 
HOMO-3 78 Rh  
9 ax CH3CN  
7 dpq  
6 DTolF 
78 Rh,  
10 ax CH3CN  
7 dppz  
6 DTolF 
100 dppn 
HOMO-2 65 DTolF,  
30 Rh 
66 DTolF  
30 Rh 
100 dppn 
HOMO-1 83 DTolF,  
11 Rh 
85 DTolF  
10 Rh 
82 DTolF  
11 Rh  
5 dppn 
HOMO 63 DTolF  
33 Rh 
64 DTolF  
32 Rh 
62 DTolF   
32 Rh  
5 dppn 
LUMO 89 dpq  
8 Rh 
98 dppz 99 dppn 
LUMO+1 88 dpq 
11 Rh 
79 dppz 
 21 Rh 
80 dppn  
20 Rh 
LUMO+2 94 dpq 86 dppz  
10 Rh 
86 dppn  
10 Rh 
LUMO+3 82 dpq  
15 Rh 
63 dppz  
36 Rh 
65 dppn  
33 Rh 
LUMO+4 58 dpq  
41 Rh 
97 dppz 97 dppn 
LUMO+5 96 dpq 96 dppz 96 dppn 
LUMO+6 66 Rh  
15 ax CH3CN  
11 DTolF  
9 dpq  
66 Rh  
15 ax CH3CN  
11 DTolF  
8 dppz 
66 Rh  
15 ax CH3CN  
11 DTolF  
9 dppn 
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Table 3.5 Orbital contributions for 12-14 predicted by DFT calculations in CH3CN. 
 
 12 13 14 
HOMO-5 72 Rh  
16 F-form  
10 dpq  
69 F-form  
25 Rh 
61 F-form  
35 Rh 
HOMO-4 76 Rh  
10 Fform    
7 ax CH3CN  
7 dpq 
61 Fform  
35 Rh 
79 Rh  
9 ax CH3CN    
8 dppn 
HOMO-3 61 F-form  
35 Rh 
79 Rh  
9 ax CH3CN    
7 dppz 
91 dppn  
7 F-form 
HOMO-2 79 Rh  
9 ax CH3CN  
7 dpq 
79 Rh  
9 ax CH3CN  
7 dppz 
100 dppn 
HOMO-1 84 F-form  
10 Rh 
85 F-form  
10 Rh 
79 F-form 
 10 Rh  
9 dppn 
HOMO 63 F-form,  
33 Rh 
63 F-form  
33 Rh 
63 F-form  
33 Rh 
LUMO 89 dpq  
8 Rh 
98 dppz 99 dppn 
LUMO+1 87 dpq  
11 Rh 
80 dppz  
20 Rh 
81 dppn  
18 Rh 
LUMO+2 94 dpq 86 dppz  
10 Rh 
86 dppn  
10 Rh 
LUMO+3 85 dpq  
13 Rh 
62 dppz  
36 Rh 
65 dppn  
33 Rh 
LUMO+4 58 dpq   
41 Rh 
97 dppz 96 dppn 
LUMO+5 96 dpq 96 dppz 95 dppn 
LUMO+6 66 Rh 
15 ax CH3CN  
11 F-form  
9 dpq 
66 Rh  
15 ax CH3CN  
11 F-form  
8 dppz 
66 Rh  
15 ax CH3CN  
11 F-form  
9 dppn 
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     The HOMO and HOMO-1 are of all the complexes are calculated to contain 
significant contributions from the formamidinate ligands. In general, the HOMO of each 
complex exhibits ~63% contribution from the [DTolF]
-
 or [F-form]
-
 ligand and ~33% 
from Rh, whereas the HOMO-1 typically contains ~84% formamidinate and ~10% Rh 
character (Tables 3.4 and 3.5). Consistent with the ligand contributions to these orbitals, 
the relative energy of the HOMO and HOMO-1 vary with the nature of the 
formamidinate ligand by ~0.1 eV. The HOMO-2 has ~65% [DTolF]
-
 and 30% Rh 
contributions in 9 and 10, but this orbital is metal-centered in 12 and 13, with 79% Rh2(σ) 
character and 9% contribution from the ax CH3CN ligands. In the dppn complexes 11 
and 14, however, the HOMO-2 is completely localized on the dppn ligand.  
     It is evident from Tables 3.4 and 3.5 that the LUMO to LUMO+5 orbitals in 9-14 are 
centered on the corresponding diimine ligand. The relative energies of the LUMOs are 
consistent with the ease of reduction of the complexes, i.e., 9 and 12 are more difficult to 
reduce than 10 and 13, and 11 and 14 are easier to reduce (Table 3.3). In each complex, 
the LUMO+6 is calculated to possess 66% Rh2(σ*) character with 15% contribution 
from ax CH3CN ligands.  The HOMO, LUMO and LUMO+6 levels of 9 are depicted in 
Figure 3.14 and are representative of the ones calculated for 10, 11, and 12-14.      
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Figure 3.14 Electron density maps of the HOMO, LUMO and LUMO+6 of 9 drawn 
with iso-value = 0.04. 
 
 
 
   The vertical energies and orbital contributions for the lowest eight singlet excited 
states of 9-11 and 12-14 are listed in Tables 3.6 and 3.7, respectively. In all complexes, 
the major contribution to the lowest energy singlet excited state (≥82% in 9- 11 and ≥78% 
in 12-14) corresponds to the transfer of electron density from the HOMO to the LUMO 
of each complex. Because the HOMO exhibits a high degree of formamidinate character 
(~66%) and the LUMO is localized on the corresponding diimine ligands, this state may 
be assigned as a ligand-to-ligand charge transfer (
1
LLCT). The calculated oscillator 
strengths, , of the vertical transitions from the ground state, 1GS, to the lowest energy 
state, 
1
LLCT state listed in Tables 3.6 and 3.7 are relatively low in 9 ( = 0.0014), 10 ( 
= 0.0004), 12 ( = 0.0012), and 13 ( = 0.0004), but the calculated transition energies are 
in good agreement with the experimental maxima in these complexes (Table 3.3).  For 
example, the calculated energy of the 
1
GS1LLCT transitions in 9 and 12 are 536 nm 
and 518 nm, which compare well with the estimated experimental maxima of 525 nm
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Table 3.6 Vertical energies of the singlet excited states, λ (in nm), oscillator strengths, ƒ, and major orbital contributions a 
calculated for 9-11 in CH3CN (H = HOMO; L = LUMO). 
Excited 
State 
9 10 11 
1 536 nm, ƒ = 0.0014   
H  L (91.0%) 
562 nm, ƒ = 0.0004 
H  L (82.0%) 
611 nm, ƒ = 0.0000 
H  L (96.7%) 
2 514 nm, ƒ = 0.0000 
H  L+6 (91.2%)  
528 nm, ƒ = 0.0002 
H  L+1 (87.6%) 
580 nm, ƒ = 0.0001 
H  L+1 (97.7%)        
3 493 nm, ƒ = 0.0003 
H  L+1 (82.5%)  
 518 nm, ƒ = 0.0011 
H  L+2 (79.6%) 
 523 nm, ƒ = 0.0022 
H  L+3 (94.5%) 
4 461 nm, ƒ = 0.0009 
H  L+3 (80.4%) 
  
518 nm, ƒ = 0.0000 
H  L+6  (89.0%) 
516 nm, ƒ = 0.0001 
H–3  L (70.6%),  
H–2  L+1 (25.7%) 
5 457 nm, ƒ = 0.0015, 
H–5  L+4 (32.9%),  
H–3  L+4 (34.0%),  
H  L+2 (20.2%)  
478 nm, ƒ = 0.0001 
H  L+3 (89.1%)  
 
515 nm, ƒ = 0.0275 
H–3  L+1 (25.6%),  
H–2  L (72.9%) 
6 454 nm, ƒ = 0.0005 
H  L+2 (70.3%) 
470 nm, ƒ = 0.0108 
H–1  L (90.6%) 
 515 nm, ƒ = 0.0001 
H  L+6 (92.0%) 
7 446 nm, ƒ = 0.0130 
H–1  L (48.8%),  
H–6  L+6 (28.8%) 
458 nm, ƒ = 0.0026 
H–7  L+6 (43.8%), 
 H–3  L+6 (45.9%) 
507 nm, ƒ = 0.0102 
H–1 L (95.6%) 
8 438 nm, ƒ = 0.0022 
H  L+3 (94.9%) 
447 nm, ƒ = 0.0017 
H–1  L+1 (95.2%) 
486 nm, ƒ = 0.0013 
H–1  L+1 (97.9%) 
 
aOnly contributions of ≥20% are listed.  
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Table 3.7 Vertical energies of the singlet excited states, λ (in nm), oscillator strength, ƒ, and major orbital contributions a 
calculated for 12-14 in CH3CN  (H = HOMO; L = LUMO). 
Excited 
State 
12 13 14 
1 518 nm, ƒ = 0.0012 
H  L (92.1%) 
537 nm, ƒ = 0.0004 
H  L (78.2%),  
H  L+2 (20.6%) 
579 nm, ƒ = 0.0000 
H  L (96.2%) 
2 511 nm, ƒ = 0.0000 
H  L+6 (92.4%) 
514 nm, ƒ = 0.0001 
H  L+6 (88.6%) 
551 nm,  ƒ = 0.0002 
H  L+1 (97.3%) 
3 475 nm, ƒ = 0.0003 
H  L+1 (85.0%) 
504 nm, ƒ = 0.0002 
H  L+1 (86.4%) 
 
517 nm, ƒ = 0.0003 
H–3  L (66.0%),  
H–2  L+1 (26.8%) 
4  459 nm, ƒ = 0.0016 
H–4  L+6 (36.5%),  
H–2  L+6 (51.5%) 
497 nm, ƒ = 0.0010 
H  L (21.0%),  
H  L+2 (76.2%) 
 
517 nm, ƒ = 0.0287 
H–3  L+1 (24.5%),  
H–2  L (72.3%) 
5 447 nm, ƒ = 0.0002 
H–5  L+6 (25.7%),  
H  L+3 (41.8%) 
461 nm, ƒ = 0.0001 
H  L+3 (86.8%) 
509 nm, ƒ = 0.0001 
H  L+6 (92.7%) 
6 443 nm, ƒ = 0.0047 
H–4  L+6  (34.4%),  
H  L+3  (44.2%) 
460 nm, ƒ = 0.0021 
H–6  L+6 (31.4%),  
H–2  L+6 (50.0%) 
503 nm, ƒ = 0.0011 
H  L+2 (93.7%) 
7 438 nm, ƒ = 0.0002 
H  L+2 (91.3%) 
451 nm, ƒ = 0.0122 
H–1  L (73.5%) 
483 nm, ƒ = 0.0104 
H–1  L (91.4%) 
8 427 nm, ƒ = 0.0091 
H–1  L (82.5%) 
 
444 nm, ƒ = 0.0000 
H–5  L+6 (50.9%) 
477 nm, ƒ = 0.0030 
H–3  L+1 (64.2%),  
H–2  L (26.9%) 
aOnly contributions of ≥20% are listed.  
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and 520 nm, respectively (Table 3.3 and Figure 3.9a). We also note that the only other 
transitions calculated with a greater oscillator strength in the visible region are those at 
457 nm ( = 0.0015), 446 nm ( = 0.013) and 438 nm ( = 0.0022) for 9 and 459 nm ( 
= 0.0016), 447 nm ( = 0.0047), and 427 nm ( = 0.0091) for 12. These calculated 
values are consistent with the increasing intensity of the absorption at λ < 500 nm, but, 
because these are shoulders, it is difficult to estimate an experimental maxima.  
     The calculated maxima for the lowest energy 
1
GS1LLCT transitions at 562 nm and 
537 nm for 10 and 13, respectively, are bathochromic shifted from those of 9 and 12 
(Tables 3.6 and 3.7), consistent with ease of reduction for the diimine ligands in the 
former as compared to the latter compounds (Table 3.3). This trend is also observed in 
the maxima of the lowest energy transitions of 10 and 13 at 541 nm and 537 nm, 
respectively, which compare well with the calculated values. In addition to the lowest 
energy transition, absorptions are also predicted to occur between 447 nm and 518 nm 
for 10, the strongest of which is at 470 nm ( = 0.0108), listed in Table 3.6. Similarly, 
transitions at 497 nm ( = 0.0010), 460 nm ( = 0.0021), and 451 nm ( = 0.0122) are 
calculated for 13 (Table 3.7). 
     A value of  = 0.0000 is calculated for the 1GS1LLCT lowest energy transitions of 
11 and 14 at 611 nm and 579 nm, respectively (Tables 3.6 and 3.7); accordingly these 
transitions are not expected to have significant intensity. It should be noted, however, 
that the absorption spectrum of 11 (Figure 3.9) extends beyond 600 nm whereas that of 
14 does not (Figure 3.9), a trend that is consistent with the calculated values. Other 
stronger electronic transitions are predicted at 523 nm ( = 0.0022) and 515 nm ( =  
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0.0275) for 11 and 517 ( = 0.0287) for 14 which are consistent with the estimated 
maxima of the shoulders at ~553 nm and ~525 nm for 11 and 14, respectively (Table 
3.3). The low energy transitions of 11 are red-shifted relative to those of 14, which is 
rationalized by the fact that [DTolF]
-
 is a better electron donor than is [F-form]
-
 which 
influences the transitions that involves depletion of electron density from the 
formamidinate ligands (Tables 3.6 and 3.7). 
Concluding remarks 
The two series of dirhodium complexes in this chapter exhibit unusual photophysical 
properties involving low energy Ligand-to-Ligand Charge Transfer (LL’CT) transitions. 
This conclusion was confirmed by both experimental and theoretical data. The oxidation 
of these complexes is facile, as evidenced by their cyclic voltammetric diagrams. This is 
also in accord with the results of a series of chemical oxidation experiments. The data 
obtained in this project indicate that electronic properties tuning of dirhodium complexes 
can be readily achieved by a systematic ligand design approach. 
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CHAPTER IV  
STUDY OF PARTIAL PADDLEWHEEL DIRHODIUM COMPLEXES WITH 
PYRIDINATE BRIDGING LIGANDS 
Introduction 
The serendipitous discovery of the anticancer activity of cisplatin (cis-Pt(NH3)2Cl2) 
launched a new era of metals in medicinal research
167,168
 which was approved officially 
by the FDA in 1978 for the treatment of testicular and ovarian cancers. It has been well 
documented that the complex undergoes hydrolysis upon administration to generate the 
active aqua species cis-[Pt(NH3)2Cl(H2O)]
+
 and cis-[Pt(NH3)2(H2O)2]
2+
, which 
preferentially bind to the N-7 guanine site in DNA to form 1,2-intrastrand crosslinks.
169-
180
 These lesions induce DNA distortions, inhibit transcription and the DNA replication 
process and ultimately lead to the cell death.
169-180
 In spite of the efficacy of the drug, 
severe nephrotoxicity as well as intrinsic and acquired resistance
181-186
 have necessitated 
the development of second and third generation platinum-based anticancer drugs. During 
the past three decades, only two other platinum drugs, namely carboplatin
187,188
 and 
oxaliplatin,
189,190
 were approved for clinical use by the FDA in addition to several other 
platinum based drugs being approved in other countries.
191
 Considering the fact that 
platinum-based anticancer agents are highly effective and are the leading drugs for the 
current cancer therapy, there is a pressing need for new platinum-containing anticancer 
agents.
192-205
 Despite the efficacy of platinum anticancer drugs, other transition metal 
containing complexes also deserve further exploration, e.g. various dirhodium(II,II) 
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compounds that are active towards cisplatin-resistant cancer cell lines as well as some 
anticancer active complexes that are operative in different modes from cisplatin.
 3-7,10
 
     Photodynamic Therapy (PDT)
 
has emerged as a promising treatment for cancer as 
well as some other diseases with the advantage over conventional chemotherapy being 
that active toxic species are generated only in selectively irradiated tissues. The 
clinically approved drug for PDT treatment, Photofrin

, functions by the production of 
reactive oxygen species including 
1
O2 (singlet oxygen) upon irradiation with visible light 
(~630 nm).
206
 These cytotoxic species damage subcellular organelles and 
macromolecules, leading to apoptosis and/or necrosis of the affected cells.
206 
The low 
concentration of O2 or the slow diffusion of O2 from adjacent tissues, however, restricts 
the use of these drugs in dense hypoxic tumors.
207-209
 A different approach to the same 
problem can be to use transition metal complexes which can also produce 
1
O2 but which 
can also bind covalently to relevant biomolecules upon irradiation due to the dissociation 
of photo-labile ligands in the excited states via an O2 independent pathway.
210 - 219
 
Moreover, biologically active molecules can be attached to the metal complexes as the 
photo-labile ligands which, when released upon irradiation, will generate two active 
species, namely a metal complex with an open coordination site and an organic drug, 
from a single precursor.
220-222
 
     A recent study by the Turro group revealed the potential of the partial paddlewheel 
dirhodium(II,II) compound cis-[Rh2(µ-O2CCH3)2(CH3CN)6][BF4]2 as a PDT agent 
(Scheme 4.1). It is postulated that the photo-lability of the stable eq CH3CN ligands in 
the dark is crucial for the formation of the active species upon light irradiation.
9 
As such, 
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different dirhodium(II,II) complexes with photo-labile CH3CN ligands were jointly 
developed by our research groups, e.g. head to head (H-H), head to tail (H-T) cis-
[Rh2(NHOCCH3)2(CH3CN)6][BF4]2 
223
 and unbridged [Rh2(phen)2(CH3CN)6][BF4]4 
(phen: 1,10-phenanthroline)
224
 and found to have promising potential as effective PDT 
anticancer agents. To construct a structure/activity relationship for the dirhodium(II,II) 
partial paddlewheel complex with monodentate CH3CN ligands, the substituted 
oxopyridine (Scheme 4.1b) ligands were chosen as bridging ligands in the current study 
due to the easy tuning of the ligand field in these complexes. The results in this chapter 
involve the syntheses and characterization of series of dirhodium(II,II) complexes 
featuring two cis 6-R-oxo-pyridinate (R = -CH3, 6-methyl-oxo-pyridine, mhp; R = -Cl, 
6-chloro-oxo-pyridine, chp; R = -F, 6-fluoro-oxo-pyridine, fhp.) bridging ligands; the 
investigation of their potential as PDT agents is also presented.   
 
 
 
 
Scheme 4.1 Structural representation of (a) active species generated from cis-[Rh2(µ-
O2CCH3)2(CH3CN)6]
2+
 upon irradiation;  (b) bridging 6-R-oxo-pyridine ligands. 
132 
 
Experimental section 
Starting materials  
The compound Rh2(μ-O2CCH3)4•2CH3OH was either purchased from Pressure Chemical 
Company or synthesized from RhCl3•3H2O as reported.
225
 The ligands 2-hydoxy-6-
methylpyridine (Hmhp), 2-hydroxy-6-chloropyridine (Hchp) were purchased from 
Sigma Aldrich and used as received whereas 2-hydroxy-6-fluoropyridine was purchased 
from VWR and used without further purification. The reagent Et3OBF4 (1 M in CH2Cl2) 
was purchased from Sigma Aldrich. The solvents acetonitrile, dichloromethane, diethyl 
ether, chlorobenzene, dimethyl sulfoxide (DMSO) and tetrahydrofuran (THF) were of 
ACS grade and used as received. The NMR solvents D2O (d2) and CD3CN (d3) were 
purchased from Cambridge Isotope Laboratory. The compound Rh2(mhp)4 (15) was 
synthesized according to a slightly modified literature procedure.
226
  
Preparation of Rh2(chp)4 (16). A quantity of ~ 4.4 equivalents of Hchp ligand (220 mg, 
1.70 mmol) was mixed with 50 mL of chlorobenzene suspended with Rh2(μ-
O2CCH3)4•2CH3OH (195 mg, 0.39 mmol) and refluxed for 36 h, forming a slightly 
green colored solution with a large quantity of yellow precipitate. The solid was 
collected by filtration and then washed with copious volumes of CH3OH (50 mL) to 
remove unreacted Hchp ligand. The yield is 235 mg, which is 85% based on rhodium. 
Preparation of Rh2(fhp)4 (17). A quantity of ~ 4.1 equivalents of Hfhp ligand (186 mg, 
1.65 mmol) was mixed with a suspension of Rh2(μ-O2CCH3)4•2CH3OH (200 mg, 0.40 
mmol) in 50 mL of chlorobenzene and refluxed for 48 h. The resulting teal colored 
solution which contained a large amount of green precipitate was dried under vacuum 
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after which time 50 mL CH3OH was added and the solution was filtered through a 
medium frit to remove unreacted Hfhp ligand. The product was collected as a green solid 
(240 mg, 93% yield). Crystals suitable for X-ray diffraction were obtained from slow 
evaporation of an acetone solution containing the product in the presence of several 
drops of DMSO. 
1
H-NMR ((CD3)2CO~d6): 7.29 (m, fhp), 6.22 (d, fhp), 6.09(d, fhp).  
Preparation of cis-[Rh2(mhp)2(CH3CN)6][BF4]2 (18). An amount of Rh2(mhp)4 (81 mg, 
0.13 mmol) was added to 30 mL of a mixture of CH3CN:CH2Cl2 (v:v = 1:2). An aliquot 
of 0.5 mL of Et3OBF4 (1.0 M in CH2Cl2) was added to this suspension, leading to 
instantaneous formation of a clear green solution which eventually turned into red color 
over the course of 6 hours. The solution was stirred at room temperature for 24 h and 
then concentrated to 5 mL and treated with 50 mL of diethyl ether which led to the 
precipitation of the product in an oily form. The oil was washed with copious quantities 
of diethyl ether and recrystallized by slow diffusion of diethyl ether into the CH3CN 
solution of the product at room temperature. The yield is 82mg (75% based on rhodium). 
X-ray quality crystals were obtained in a similar fashion. 
1
H NMR (CD3CN-d3) δ ppm: 
7.21 (t, 2H, mhp), 6.36 (d, 2H, mhp), 6.22 (d, 2H, mhp), 2.63 (s, 6H, -CH3 of mhp), 2.47 
(s, 6H, eq CH3CN), 2.46 (s, 6H, eq CH3CN).  
Preparation of H-T (19) and H-H (20) cis-[Rh2(chp)2(CH3CN)6][BF4]2. An amount of 
Rh2(chp)4 (90.4 mg, 0.13 mmol) was suspended in 30 mL of CH2Cl2/CH3CN( v:v = 1:2) 
and a 0.4 mL aliquot of Et3OBF4 (1 M in CH2Cl2) was then added to the flask. The 
solution gradually became clear over the course of the next 6 h and was then stirred at 
room temperature for a total of 28 h. The solution eventually became clear red and was 
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concentrated to 5 mL and treated with 80 mL of diethyl ether, which led to the formation 
of an oily residue which was washed with copious diethyl ether to obtain a red powder 
(98 mg). As evidenced by 
1
H-NMR spectroscopy, this solid contains both H-H and H-T 
isomers of cis-[Rh2(chp)2(CH3CN)6][BF4]2. The material was redissolved in 5 mL of 
CH3CN and slow diffusion of diethyl ether into this solution at -4ºC led to the 
crystallization of the H-T isomer and the yield is 50 mg (44% based on rhodium). The 
crystals were collected by filtration and the filtrate was condensed to 2 mL. The 
recrystallization of the H-H isomer was achieved by slow diffusion of diethyl ether into 
the CH3CN solution at room temperature. H-T isomer (19): 
1
H NMR (CD3CN-d3) δ ppm: 
7.44 (t, 2H, chp), 6.71 (d, 2H, chp), 6.33 (d, 2H, chp), 2.57 (s, 6H, eq CH3CN, trans to 
N), 2.38 (s, 6H, eq CH3CN, trans to O), 1.96(s, ax CH3CN). H-H isomer (20): 
1
H NMR 
(CD3CN-d3) δ ppm: 7.38 (t, chp), 6.74 (d, chp), 6.57 (d, chp), 2.55 (s, eq CH3CN, trans 
to N), 2.48 (s, eq CH3CN, trans to O), 1.96(s, ax CH3CN).  
Preparation of cis-[Rh2(fhp)2(CH3CN)6][BF4]2 (21). An amount of Rh2(fhp)4 (184 mg, 
0.28 mmol) was suspended in 30 mL of CH3CN/CH2Cl2 (v:v = 1:1).  An aliquot of 1.2 
mL of Et3OBF4 (1 M CH2Cl2) was added and the mixture was stirred for 4 days at room 
temperature. The initially green turbid mixture changed to violet and finally to red. The 
reaction solution was filtered to remove any insoluble materials and the filtrate was 
concentrated to 5 mL and treated with 50 mL of diethyl ether which led to precipitation 
of the desired product which was washed with copious amounts of diethyl ether to obtain 
a red powder. Yield: 194 mg, 81%. 
1
H-NMR (CD3CN-d3) δ ppm: 7.49 (dd, fhp), 6.29(d, 
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fhp), 6.21(d, fhp), 2.49 (eq CH3CN, trans to N), 2.48(eq CH3CN, trans to O), 1.96 (free 
CH3CN). 
Instrumentation and methods 
X-ray data sets for all the complexes were collected on a Bruker CCD APEX 
diffractometer with graphite monochromated Mo Kα radiation (λ = 0.71073 Å). 
Hemispheres of data for 15 and 18-20 were collected by a combination of four sets of X-
ray exposures. Each set used a different ϕ angle for the crystals and covered 0.3  in ω for 
all the complexes. The exposure times were 10s for 15, 20 s for 18, 19 and 30 s for 20. 
The crystal parameters and information pertaining to the data collection and refinement 
of the crystals for 15, 18-20 are summarized in Table 4.1.  
Results and discussion 
Synthesis and solution characterization  
Molten reactions were performed for the syntheses of 15 and 16 with an excess of Hmhp 
and Hchp ligands. After completion of the reactions, the excess ligands were removed by 
dissolution in CH3OH which led to the formation of pure (trans, syn-2, 2) isomers as 
evidenced by 
1
H-NMR spectra (Figures 4.1, 4.2 respectively), and X-ray 
crystallographic studies which are detailed in the following section. The crystal 
structures of both complexes were published in previous reports,
 226
 but the structure 
obtained herein for compound 15 exhibits different unit cell parameters from the 
published one. Therefore, the detailed crystal data parameters are also provided in Table 
4.1. Compound 17 was synthesized by a different method from the published one and in 
improved yields. 
227
 Unlike the complex reported previously, it is only slightly soluble in
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Table 4.1 Crystallographic data for  Rh2(mhp)4 (15), cis-[Rh2(mhp)2(CH3CN)6][BF4]2 (18), H-T cis-
[Rh2(chp)2(CH3CN)6][BF4]2•CH3CN (19•CH3CN) and H-H cis-[Rh2(chp)2(CH3CN)6][BF4]2•2CH3CN(20•2CH3CN). 
 15 18 19 20 
Formula C24H24N4Rh2O4 C24H30N8O2Rh2B2F8 C24H27N9O2Cl2Rh2B2F8 C24H27N9Rh2Cl2O2B2F8 
Formula 
weight 
(g/mol) 
638.29 841.97 923.86 923.86 
Space group Pbca P212121 P21/c P-1 
a, b, c/ Å 15.489(3) 
15.961(3) 
18.567(4) 
12.194(2) 
12.462(3) 
22.014(4) 
16.222(3) 
12.319(3) 
21.796(4) 
11.609(2) 
11.712(2) 
15.189(3) 
, , / º 90,90,90 90, 90, 90 
 
90.00, 96.88(3), 90.00 70.72(3), 76.07(3), 
86.12(3) 
Z 8 4 4 2 
2θ range for 
data 
collection/º 
57.44 54.83 46.53 57.31 
Completeness 
to  max/ % 
95.3 99.9 99.5 90.1 
R1,
a
 wR2,
b
 
[I >4(I)] 
R = 0.0191, 
wR = 0.0464 
R = 0.0314, 
wR = 0.0912 
R = 0.0796, 
wR = 0.2067 
R = 0.0301 
wR = 0.0794 
R1,
a
 wR2,
b
 
(all data) 
R = 0.0231 
wR = 0.0485 
R = 0.0334, 
wR = 0.0930 
R =  0.1013, 
wR = 0.2173 
R = 0.0342, 
wR = 0.0817 
Goodness-of-
fit parameter 
(all data)
c
 
1.042 1.061 0.964 1.060 
aR = ∑||Fo|-|Fc||/∑|Fo|. 
b
wR = {∑[w(Fo
2 
- Fc
2
)
2]/∑w(Fo
2
)
2
]}
1/2
. 
c
Goodness-of-fit = {∑[w(Fo
2
 -Fc
2
)
2
]/(n-p)}
1/2
, where n is the 
number of reflections and p is the total number of parameters refine
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Figure 4.1 
1
H-NMR spectrum of compound 15 in CDCl3. 
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Figure 4.2 
1
H-NMR spectrum of compound 16 in CDCl3. 
 
 
 
THF, acetone and ethanol. With the presence of several drops of DMSO, several pink 
solutions containing 17 with THF, acetone and ethanol were obtained.  
     The alkylating agent Et3OBF4 was used to synthesize the partial paddlewheel 
complex cis-[Rh2(xhp)2(CH3CN)6][BF4]2 (18-21), similar to the method adopted by 
Turro et al. to prepare H-H and H-T cis-[Rh2(HNOCCH3)2(CH3CN)6][BF4]2.
223
 The 
reaction between Et3OBF4 and Rh2(mhp)4 produces only one isomer as indicated by its 
1
H-NMR (Figure 4.3) spectrum which was identified as the H-T isomer by an X-ray 
crystallographic study. The synthetic route adopted for cis-[Rh2(chp)2(CH3CN)6][BF4]2, 
however, resulted in the formation of both the H-H and H-T isomers as indicated by 
1
H-
NMR spectroscopy (Figure 4.4). This finding indicates that the alkylating agent Et3OBF4 
does not react discriminately with the two chp ligands in the cis-positions leading to the 
139 
 
formation of 19, but also with the two bridging ligands occupying trans-positions which 
then undergo rearrangement into the more stable cis isomer to produce compound 20. 
Compound 21 was synthesized by a similar procedure to the one used for complexes 18 
and 19 but with much longer reaction times due to the low solubility of 17 in the solvent. 
Many trials to obtain a single crystal of compound 21 were unsuccessful. From the 
structure of precursor 17, however, we can conclude that compound 21 adopts the H-H 
configuration.  
 
 
 
 
Figure 4.3 
1
H-NMR spectra for compounds 18 and 21. 
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Figure 4.4 
1
H-NMR spectra of a mixture of 19 * and 20 ‡ (top) and pure 19 * (bottom) 
in the aromatic region in CD3CN. 
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X-ray crystallographic studies  
cis-[Rh2(mhp)2(CH3CN)6][BF4]2 (18). The compound crystallizes in the chiral space 
group P212121 and the cation contains two cis bridging mhp ligands in a H-T fashion. 
Six CH3CN ligands complete the pseudo-octahedral coordination sphere of the central 
rhodium atoms (Figure 4.5) and there are two [BF4]
- 
present as counterions. One of the 
eq CH3CN ligands and a [BF4]
-
 counterion are disordered between two different 
positions with site occupancies of 0.6366/0.3634 and 0.3765/0.6235 respectively. 
Racemic twinning was refined during the last cycle, with the flack parameter 0 and the 
esd value 0.9416. The Rh-Rh bond distance is 2.4794(5) Å, which is ~ 0.12 Å longer 
than that found for 15 which we ascribe to the less sterically demanding bridging mhp 
ligands in 18. The Rh-N (ax CH3CN) bond distances are 2.234(4) and 2.201(4) Å, 
significantly longer than the Rh-N (eq CH3CN) bond distances which are in the range of 
1.999(4)-2.014(4) Å. The Rh-N (mhp) and Rh-O (mhp) bond distances are comparable 
to the corresponding distances in 15 respectively. The distorted eq CH3CN and mhp 
ligands away from the eclipsed confirmation reflect the repulsion between them. The 
dihedral angles defined by N5-Rh1-Rh2-N7 and N6-Rh1-Rh2-N8 are -36.5(1)º and -
36.9(2)º respectively, larger than those in cis-[Rh2(DTolF)2(CH3CN)6][BF4]2 and cis-
[Rh2(F-form)2(CH3CN)6][BF4]2.
229
 Slightly smaller distortions are obserbved for the two 
mhp bridging ligands, with the dihedral angles defined by O1-Rh1-Rh2-N2, N1-Rh1-
Rh2-O2 being -30.3(1) and -30.8(1)º. 
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Figure 4.5 Thermal ellipsoid plot of the cationic part of compound 18 at the 50% 
probability level; the anions and hydrogen atoms are omitted for the sake of clarity.  
 
 
 
 
 
 
 
Figure 4.6 Thermal ellipsoid graph of the cationic unit in compound 19 at the 50% 
probability level; the anions and hydrogen atoms are omitted for the sake of clarity. 
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H-T cis-[Rh2(chp)2(CH3CN)6][BF4]2•CH3CN (19•CH3CN): Compound 19 crystallizes 
in the space group of P21/c with a coordination sphere similar to that of compound 18 as 
seen in Figure 4.6. One of the eq CH3CN ligands is disordered over two positions with a 
site occupancy of 0.5199/0.4801. The Rh-Rh bond distance is 2.492(1) Å, ~ 0.11 Å 
longer than that of Rh2(chp)4 due to the less constraints from the two bridging ligands in 
19. The Rh-N (ax CH3CN) bond distances are 2.21(1) and 2.25(1) Å, longer than the Rh-
N (eq CH3CN) bond distances ranging from 1.97(1) to 2.031(9) Å. Similar distortions 
from the eclipsed configuration of the eq CH3CN ligands occur, with larger distortions 
for the eq CH3CN ligands than those defined by the chp ligand.  
H-H cis-[Rh2(chp)2(CH3CN)6][BF4]2•2CH3CN (20): Compound 20 crystallizes in the 
space group P-1. The thermal ellipsoid plot of the cationic unit is displayed in Figure 4.7 
and can be seen to consist of two cisoid bridging chp ligands in the H-H fashion, four eq 
CH3CN ligands and one ax CH3CN coordinated to the Rh center that is bonded to the O 
atoms of the bridging chp ligands. The Rh-Rh bond distance is 2.505(1) Å, slightly 
longer than those in 18 and 19. The Rh-N (ax CH3CN) bond distance is 2.114(2) Å, ~ 
0.1 Å shorter than that in 18, 19 and H-T cis-[Rh2(HNOCCH3)2(CH3CN)6][BF4]2.
223 
 The 
Rh-N (eq CH3CN) bond distances fall in a small range of 1.989(3) to 2.002(2) Ǻ, similar 
to those in 18 and 19. Much smaller distortions from the eclipsed configuration defined 
by the eq CH3CN ligands in 20 occur as compared to that found for 18 and 19, with the 
dihedral angles defined by N4-Rh1-Rh2-N6 and N3-Rh1-Rh2-N5 being 23.55(9)º and 
23.51(9)º. Distortions of the bridging chp ligands are only slightly smaller, with the 
angles being 19.35(9)º and 21.74(8) º respectively.  
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Figure 4.7 Thermal ellipsoid graph of the cationic part in compound 20 at the 50% 
probability level; the anions and hydrogen atoms are omitted for the sake of clarity. 
 
 
 
1
H-NMR investigations of compounds 18, 19 and 21 
The exchange process of the monodentate eq CH3CN ligands in 18, 19, and 21 with the 
NMR solvent molecule CD3CN or D2O in the dark was monitored by 
1
HNMR 
spectroscopy and the results are detailed in the following section. 
     As shown in Figure 4.8, three different resonances in the aliphatic region are present 
in the 
1
H-NMR spectrum of 18 obtained ~2 min after dissolution in CD3CN, with 
chemical shifts of 2.63, 2.47 and 2.46 ppm, respectively. The peak at ~2.63 ppm is 
assigned to the –CH3 groups on the mhp ligands since its intensity does not change over 
the course of the experiment (vide infra). The other two closely spaced resonances are 
attributed to the two different sets of eq CH3CN ligands which are trans to O and N 
atoms of the mhp ligands respectively. After 15 min, a distinct decrease in intensity for  
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Figure 4.8 
1
H-NMR spectral changes of complex 18 in the dark in CD3CN. 
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the resonance ~ 2.47 ppm is observed, attributed to fast exchange with the CD3CN 
molecules. This peak disappeared after 75 min in the dark, indicating the much faster 
exchange process with the CD3CN molecules than that in cis-[Rh2(μ-
O2CCH3)2(CH3CN)6][BF4]2 .
8
 
     The investigation of the lability of the eq CH3CN ligands in compound 19 was 
conducted in a similar fashion. In this case, two resonances at 2.57 and 2.38 ppm were 
observed corresponding to the eq CH3CN ligands trans to O and N atoms of the chp 
ligand respectively. As shown in Figure 4.9, the intensity of both peaks decrease 
simultaneously over the course of 65 h with the exchange rate for the latter resonance 
being much faster than that for the former one. Both exchange processes are much 
slower, however, than that of compound 18, presumably due to the weaker trans effect 
exerted by bridging chp ligands owing to the presence of electron withdrawing Cl 
substituents in 19. 
     For compound 21, the two types of eq CH3CN ligands, namely either trans to the N 
or to the O atoms of the fhp ligands, exhibit only slightly different chemical shifts (δ = 
2.49 and 2.48 ppm). The former resonance disappears over a period of ~ 340 h, 
indicating its complete substitution by CD3CN molecules whereas the latter one has only 
negligible changes in intensity during the same period of time (Figure 4.10). These 
features are ascribed to the much stronger electron withdrawing ability of the F 
substituents on the bridging fhp ligands. 
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Figure 4.9 
1
H-NMR spectral changes in complex 19 in the dark in CD3CN; only the 
region involving the change in the spectra is shown. 
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Figure 4.10 
1
H-NMR spectral change for complex 21 in the dark in CD3CN; only the 
region involving the changes in the spectra are shown. 
 
 
 
     The exchange of eq CH3CN with H2O molecules in 18 was also monitored by 
1
H-
NMR spectroscopy in the dark. Upon dissolution in D2O the solution turns green in 
contrast to its red color in CD3CN. A very fast substitution process involving the D2O 
molecules is apparently occurring, a fact that is further corroborated by the very 
complicated 
1
H-NMR spectrum and the intense signal at 2.06 ppm for free CH3CN 
(Figure 4.11). Similarly, for both compounds 19 and 21, there is also exchange of eq 
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CH3CN ligands with D2O molecules but at a significant slower rate as compared to that 
in compound 18 as indicated by Figures 4.12 and 4.13 respectively.   
 
 
 
 
Figure 4.11 
1
H-NMR spectrum of 18 after dissolution in D2O for 10 min, indicating 
very fast exchange of eq CH3CN with D2O molecules. 
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Figure 4.12 
1
H-NMR spectral changes of 19 after its dissolution in D2O over the course 
of 140 min. 
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Figure 4.13 Changes in the 
1
H-NMR spectra of 21 after dissolution in D2O over the 
course of 140 min. 
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Electronic absorption and electrochemical studies 
The electronic absorption spectra of compounds 18, 19 and 21 were measured at room 
temperature in both CH3CN and H2O respectively and are summarized in Table 4.2. 
     Compounds 18, 19 and 21 exhibit similar electronic absorption spectroscopic 
properties in CH3CN at room temperature. The transitions at λ ~ 498 nm in 18, λ ~ 473 
nm for 19 and λ ~ 491 nm for 21 have very similar low molar absorptivities (Table 4.2). 
They are tentatively assigned as the Rh2(π*) to Rh2(σ*) charge-transfer bands but with 
minor LMCT character due to the dependence on the bridging ligands. Another weak but 
distinct feature of this series of compounds is the absorption in the region of 380-390 nm, 
similar to the transitions at ~350 nm for both the H-H and H-T isomers of cis-
[Rh2(HNOCCH3)2(CH3CN)6][BF4]2
223 
and the transition at ~363 nm in cis-
[Rh2(OOCCH3)2(CH3CN)6][BF4]2.
8
 These features are ascribed to combinations of 
 
 
 
Table 4.2 Photophysical properties of 18, 19 and 21 in CH3CN and H2O at room 
temperature. 
 
 λ (nm), (ε x 10
3
(M
-1•cm-1)) in 
CH3CN 
λ (nm), (ε x 103 (M-1•cm-1)) in H2O 
18 239 (36.9), 259 (29.0), 303 (6.0), ~ 
389 (0.78), 498 (0.20) 
N/A 
19 239(31.5), 256(21.2), 294 (7.5), ~ 
382 (0.68) ~ 473 (0.22) 
236(20.0), 259(17.4), 302(3.4), 381 
(0.37), 550 (0.12) 
21 230(39.8), 257(31.4),  291 (5.8), ~ 
380 (0.61), 491 (0.20) 
226 (35.9), 257(33.5), 294(4.8), 
397(0.47), 558 (0.18) 
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electronic transitions from Rh2(π*) to Rh-CH3CN(eq) (σ*) and Rh2(σ*) orbitals. As 
shown in Table 4.2 and Figure 4.14a, medium intensity absorptions at ~ 290-300 nm are 
also present in all three compounds. Due to the independence of the energies on the 
bridging ligands, these bands are also assigned as metal-centered (MC) transitions. Since 
they have slightly higher molar absorptivities, they correspond to the transitions 
originating from Rh2(π), Rh2(σ) to Rh-CH3CN(eq) (σ*), Rh2(σ*) orbitals. The electronic 
absorption spectra of compounds 19 and 21 in H2O are displayed in Figure 4.14b. The 
electronic absorption spectrum of compound 18, however, was not possible to obtain due 
to the fast exchange of eq CH3CN with H2O upon dissolution (vide supra). Slight 
bathochromic shifts of the lowest energy transitions occur for both compounds 19 and 21 
when dissolved in H2O as compared to their CH3CN solutions (Table 4.2). This is 
similar to the situation for cis-[Rh2(OOCH3)2(CH3CN)6][BF4]2 in H2O as compared to 
CH3CN solution.
8 
The transitions at ~ 380-390 nm, however, are not shifted, in accord 
with the involvement of only the eq CH3CN ligands but not the ax ones. 
     The redox potentials of the synthesized compounds as well as the free bridging 
ligands were determined by cyclic voltammetry with the detailed results listed in Table 
4.3. 
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Figure 4.14 Electronic absorption spectra of: (a) compounds 18, 19 and 21 obtained in 
CH3CN and (b) compounds 19 and 21 obtained in H2O. 
 
 
 
Table 4.3 Electrochemical data of complexes 15-19, 21 as well as the free ligands mhp, 
chp and fhp. 
 
  Epc, 1 Epc, 2 Epc,3 Eox, 1 Eox,2 
mhp     1.51
a
  
chp  -1.03 -1.44  1.85
a
  
fhp  -0.92     
Rh2(mhp)4
b
 15 -1.36
c
   0.91  
Rh2(chp)4
d
 16 -1.20
c
   1.23  
Rh2(fhp)4
d
 17 -1.49   0.99
a
 1.20
c
 
cis-[Rh2(mhp)2(CH3CN)6][BF4]2 18 -0.45 -1.27  1.61
e
  
cis-[Rh2(chp)2(CH3CN)6][BF4]2 19 -0.24 -1.13 -1.44   
cis-[Rh2(fhp)2(CH3CN)6][BF4]2 21 -0.66 -1.18 -1.34 1.27
e
 1.48
e
 
a.
 Irreversible. 
b.
 in CH2Cl2 
c.
 reversible 
d.
 in CH3CN, with the presence of drops of 
DMSO 
e.
 quasi-reversible 
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     The strong electron donating ability of the mhp ligands renders the dimetal center 
electron-rich, thus leading to a cathodic shift of the first oxidation potential by ~ 0.30 V 
in 15 as compared to that in Rh2(μ-O2CCH3)4.
21
 On the other hand, it occurs at a more 
positive potential ~ 1.23 V in 16, most likely due to the electron withdrawing Cl groups 
on the bridging chp groups. Both 15 and 16 exhibit one reversible reduction at -1.36 and 
-1.20 V respectively, attributed to the Rh2
4+
/ Rh2
3+ 
redox couple. The more difficult 
reduction for 15 is also in accord with the electron donating -CH3 groups resulting in an 
electron-rich dimetal core. Complex 17 exhibits different electrochemical properties as 
compared to 15 and 16, presumably because of the different ligand configuration. It 
exhibits one irreversible reduction at -1.49V, one irreversible oxidation at ~ 0.99 V and 
another quasi-reversible oxidation at ~ 1.20 V. For the partial paddlewheel Rh2(II,II) 
compounds 18, 19 and 21, there are two irreversible reductions for compound 18 and 
three irreversible reductions for compounds 19 and 21. The two reductions for 18, the 
first two reductions for 19 as well as the first and third reductions for 21 are ascribed to 
stepwise reductions of the dimetal center, namely the Rh2
4+
/Rh2
3+
 and Rh2
3+
/Rh2
2+
 redox 
couples respectively. The third reduction in 19 and second reduction in 21 are tentatively 
assigned as bridging-ligand based redox events since similar features occur for the free 
chp and fhp ligands at -1.44 and -0.92 V respectively. One quasi-reversible oxidation 
appears for 18 and two for 21, tentatively assigned as a metal-centered oxidation but 
with contributions from the bridging ligands unlike the case of 19. 
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Computational studies 
To aid in the interpretation of the electronic structures of 18, 19 and 21, computational 
studies of their cationic units were conducted. For 18 and 19, the gas phase 
optimizations began with the cationic units from the crystal structures respectively while 
for 21, it was built in ‘agui’ by the modification of the crystal structure for 20 but with 
both ax positions occupied by CH3CN ligands. The calculated structures are very similar 
to the experimental ones for both 18 and 19, indicating the accuracy of the levels of 
theory chosen and the basis sets. Important bond parameters are summarized in Table 
4.4 and graphic representations of the calculated structures are displayed in Figure 4.15. 
TD-DFT calculations using both CH3CN and H2O as solvents were conducted based on 
the gas phase optimized structures. One issue that needs to be pointed out is that, due to 
the lability of the ax CH3CN upon solvation in H2O, the TD-DFT calculations in H2O 
were started from the optimized cis-[Rh2(chp)2(CH3CN)4(H2Oax)2]
2+
 and cis-
[Rh2(fhp)2(CH3CN)4(H2Oax)2]
2+
 for 19 and 21 respectively. 
     As can be seen in Tables 4.5 and 4.6, the MO compositions of all three compounds 
are very similar in the two different solvents (Table 4.5 for results in CH3CN and Table 
4.6 for results in H2O). Thus, only the results from using CH3CN as solvent are 
presented in the following section. Orbitals HOMO and HOMO-1 are mainly the 
bridging ligands (mhp in 18, chp in 19 and fhp in 21) characters (~ 75% in HOMO, ~ 85% 
in HOMO-1); conversely, orbitals ranging from HOMO-8 to HOMO-2 are mainly Rh 
based orbitals. For the unoccupied orbitals, the LUMO is mainly rhodium based and the 
visualization indicates Rh2(σ*) character. The LUMO+1 and LUMO+2 have significant  
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Table 4.4 Comparisons between the calculated structures and X-ray crystallographic 
data for 18 and 19. 
 
 18 
 Experimental Calculated 
Bond Å Å 
Rh1-Rh2 2.4794(5) 2.515 
Rh1-N1 2.057(4) 2.074 
Rh1-O1 2.007(3) 2.001 
Rh2-N2 2.050(4) 2.073 
Rh2-O2 2.006(3) 2.001 
Rh1-N4 2.201(4) 2.243 
Rh1-N5 1.999(4) 2.013 
Rh1-N6 2.012(4) 2.028 
Rh2-N7 2.014(4) 2.014 
Rh2-N8 2.008(4) 2.028 
Rh2-N3 2.234(4) 2.244 
Dihedral º º 
O1-Rh1-Rh2-N2 -30.3(1) -30.1 
N1-Rh1-Rh2-O2 -30.8(1) -30.1 
N5-Rh1-Rh2-N7 -36.5(1) -37.3 
N6-Rh1-Rh2-N8 -36.9(2) -37.3 
 19 
 Experimental Calculated 
Bond Å Å 
Rh1-Rh2 2.492(1)  2.518 
Rh1-N2 2.071(8)  2.085 
Rh1-O1 2.005(6) 2.004 
Rh2-N1 2.080(8) 2.085 
Rh2-O2 2.017(7) 2.004 
Rh1-N3 2.21(1) 2.222 
Rh1-N7 1.987(9) 2.016 
Rh1-N8 2.031(9) 2.010 
Rh2-N4 2.25(1) 2.221 
Rh2-N5 1.97(1) 2.016 
Rh2-N6 1.996(9) 2.010 
Dihedral º º 
O1-Rh1-Rh2-N1 30.9(3) 29.3 
N2-Rh1-Rh2-O2 30.7(3) 29.2 
N5-Rh1-Rh2-N8 37.6(4) 36.1 
N6-Rh1-Rh2-N7 36.4(4) 36.2 
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Figure 4.15 Optimized cationic units for compounds 18 (left) and 19 (right); hydrogen 
atoms were omitted for the sake of clarity. 
 
 
 
 
 
Figure 4.16 MO visualizations of 18 in the solvation model with CH3CN as the solvent, 
generated by agui with iso-value = 0.04; H = HOMO, L = LUMO. 
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Table 4.5 MO components (%) of the frontier orbitals related to the electronic 
transitions based on the TD-DFT calculation using CH3CN as the solvent. 
 
 18 in CH3CN 19 in CH3CN 21 in CH3CN 
HOMO-8 71 Rh 
19 mhp    
8 eq CH3CN 
72 Rh    
15 mhp    
10 eq CH3CN 
69 Rh 
19 fhp 
9 eq CH3CN 
HOMO-7 62 Rh 
28 mhp 
6 eq CH3CN 
61 Rh    
28 chp    
9 eq CH3CN 
55 Rh 
35 fhp 
7 eq CH3CN 
HOMO-6 66 Rh 
28 mhp 
65 Rh    
26 chp    
8 eq CH3CN 
73 Rh 
16 fhp 
11 eq CH3CN 
HOMO-5 52 Rh 
44 mhp 
48 Rh    
45 chp    
6 eq CH3CN 
63 Rh 
28 fhp 
7 eq CH3CN 
HOMO-4 76 Rh 
11 ax CH3CN 
7 eq CH3CN 
6 mhp 
78 Rh 
12 ax CH3CN  
7 eq CH3CN 
71 Rh 
12 fhp 
11 ax CH3CN 
6 eq CH3CN 
HOMO-3 85 Rh 
8 mhp 
6 eq CH3CN 
85 Rh 
7 chp 
6 eq CH3CN 
85 Rh 
7 fhp 
5 eq CH3CN 
HOMO-2 80 Rh 
8 mhp 
7 ax CH3CN 
79 Rh 
9 ax CH3CN 
8 chp 
82 Rh 
8 ax CH3CN 
5 fhp 
5 eq CH3CN 
HOMO-1 89 mhp 
9 Rh 
89 chp 
9 Rh 
83 fhp 
13 Rh 
HOMO 74 mhp 
23 Rh 
75 chp 
23 Rh 
75 fhp 
23 Rh 
LUMO 69 Rh 
14 ax CH3CN 
10 mhp 
7 eq CH3CN 
68 Rh 
13 ax CH3CN  
11 chp 
8 eq CH3CN 
70 Rh 
14 ax CH3CN 
9 fhp 
7 eq CH3CN 
LUMO+1 46 Rh 
35 mhp 
19 eq CH3CN 
44 Rh 
37 chp 
19 eq CH3CN 
47 Rh 
33 fhp 
20 eq CH3CN 
LUMO+2 45 Rh 
32 mhp 
22 eq CH3CN 
46 Rh 
34 chp 
20 eq CH3CN 
51 Rh 
25 eq CH3CN 
24 fhp 
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Table 4.6 MO components (%) of the frontier orbitals related to the electronic 
transitions based on the TD-DFT calculation using H2O as the solvent. 
 
 18 in H2O 19 in H2O 21 in H2O 
HOMO-8 69 Rh    
20 mhp    
10 eq CH3CN 
72 Rh    
17 mhp    
11 eq CH3CN 
70 Rh 
19 fhp 
11 eq CH3CN 
HOMO-7 60 Rh    
27 mhp    
9 eq CH3CN 
57 Rh    
32 chp    
8 eq CH3CN 
55 Rh 
36 fhp 
7 eq CH3CN 
HOMO-6 71 Rh    
19 mhp    
7 eq CH3CN 
69 Rh    
21 chp    
10 eq CH3CN 
71 Rh 
18 fhp 
11 eq CH3CN 
HOMO-5 57 Rh    
35 mhp    
7 eq CH3CN 
50 Rh    
42 chp    
7 eq CH3CN 
69 Rh 
17 fhp 
7 eq CH3CN 
6 ax H2O 
HOMO-4 70 Rh 
14 mhp 
9 ax H2O 
7 eq CH3CN 
76 Rh 
13 ax H2O 
6 eq CH3CN 
69 Rh 
17 fhp 
8 ax H2O 
6 eq CH3CN 
HOMO-3 87 Rh 
6 mhp 
6 eq CH3CN 
87 Rh 
6 eq CH3CN 
6 chp 
87 Rh 
6 fhp 
6 eq CH3CN 
HOMO-2 83 Rh 
7 mhp 
6 ax H2O 
82 Rh 
7 ax H2O 
6 chp 
83 Rh 
8 ax H2O 
HOMO-1 90 mhp 
8 Rh 
90 chp 
8 Rh 
88 fhp 
10 Rh 
HOMO 73 mhp 
24 Rh 
72 chp 
25 Rh 
72 fhp 
25 Rh 
LUMO 77 Rh 
9 ax H2O 
9 mhp 
5 eq CH3CN 
75 Rh 
10 ax H2O 
9 chp 
6 eq CH3CN 
76 Rh 
10 ax H2O 
8 fhp 
6 eq CH3CN 
LUMO+1 45 Rh 
35 mhp 
20 eq CH3CN 
43 Rh 
38 chp 
19 eq CH3CN 
47 Rh 
33 fhp 
21 eq CH3CN 
LUMO+2 43 Rh 
34 mhp 
22 eq CH3CN 
42 Rh 
37 chp 
20 eq CH3CN 
51 Rh 
25 eq CH3CN 
24 fhp 
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anti-bonding interactions between the Rh and eq CH3CN ligands (Figure 4.16), similar 
to those found in cis-[Rh2(μ-O2CCH3)2(CH3CN)6][BF4]2.
8
 
     As displayed in Figure 4.17, the orbitals in 19 lie slightly lower than the 
corresponding ones in 18, probably due to the stabilization by the electron-withdrawing 
Cl groups on the bridging ligands (Table 4.5). However, different levels of stabilization 
occur for each orbital set, a result of different degrees of contributions from the bridging 
ligands to those orbitals. For example, the HOMO in 19 is ~ 0.25 eV lower than that in 
18 while the LUMO is only by ~ 0.08 eV lower. This, therefore, leads to a larger 
HOMO-LUMO gap in 19 as compared to 18. For compound 21, its MO compositions, as 
listed in Table 4.5, are very similar to those in 18 and 19; however, no trend was 
observed for the energy of each orbital as compared to the corresponding ones in 18 and 
19 presumably due to the H-H orientation of two bridging ligands in 21. Nevertheless, 
its HOMO-LUMO gap was predicted to be ~ 0.05 eV smaller than that of 19, while ~ 
0.12 eV larger than that of 18.    
     On the basis of TD-DFT calculations using CH3CN as the solvent, the lowest energy 
bands mainly correspond to the HOMO, HOMO-3 to LUMO charge-transfer transition 
as shown in Tables 4.7-4.9, rendering it dual MC and MLCT characters. It is predicted at 
λ = 485, 462 and 473 nm respectively for 18, 19 and 21, in accord with the experimental  
data (vide supra). The bands in the region of 390-400 nm in all three compounds are 
predicted to be the transitions to the LUMO+1 σ*[Rh-CH3CN(eq)]. Therefore, the 
population of the LUMO+1 orbital leads to labilization of eq CH3CN ligands. The 
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absorption bands in the 330-360 nm region correspond to the transitions from HOMO-6, 
HOMO-3 to LUMO, LUMO+1, thus mainly of MC character. 
 
 
 
     
Figure 4.17 MO diagram of 18, 19 and 21 obtained from DFT calculations using 
CH3CN as solvent. 
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Table 4.7 First ten electronic transitions of 18 predicted by TD-DFT calculations in 
solvation model with CH3CN and H2O as solvents respectively, H=HOMO, L=LUMO. 
 
 18 in CH3CN 18
 
in H2O 
1 485 nm  =0.0002 
H-3 ->L         29.47% 
H ->L         59.20% 
537 nm  =0.0005 
H-3 ->L         54.70% 
H ->L         34.91% 
2 461 nm  =0.0033 
H-2 ->L         73.92% 
523 nm  =0.0022 
H-2 ->L         80.48% 
3 451 nm  =0.0003 
H-3 ->L         62.28% 
H ->L        31.02% 
497 nm  =0.0004 
H-3 ->L        39.39% 
H ->L         52.44% 
4 422 nm  =0.0019 
H-1 ->L         90.75% 
447 nm  =0.0008 
H-1 ->L         93.99% 
5 391 nm  =0.0030 
H ->L+1         56.54% 
385 nm  =0.0029 
H ->L+1         49.24% 
6 373 nm  =0.0023 
H ->L+2         35.63% 
371 nm  =0.0047 
H-4 ->L         36.48% 
7 353 nm  =0.0065 
H-6 ->L         26.19% 
H-4 ->L         24.97% 
368 nm  =0.0027 
H ->L+2         31.81% 
 
8 338 nm  =0.0028 
H-2 ->L+1         36.60% 
H-1 ->L+1        29.36% 
346 nm  =0.0011 
H-8 ->L         33.78% 
 
9 332 nm  =0.0000 
H-3 ->L+2         29.00% 
343 nm  =0.0044 
H-6 ->L         47.29% 
10 332 nm  =0.0022 
H-6 ->L         30.47% 
H-3 ->L+1         46.73% 
337 nm  =0.0003 
H-5 ->L         37.07% 
H-2 ->L+1       29.05% 
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Table 4.8 First ten electronic transitions of 19 predicted by TD-DFT calculations in 
solvation model with CH3CN and H2O as solvents respectively, H=HOMO, L=LUMO. 
 
 19 in CH3CN 19 in H2O 
1 462 nm  =0.0002 
H-3 ->L         49.52% 
H ->L         38.09% 
511 nm  =0.0004 
H-3 ->L         71.81% 
H ->L         20.01% 
2 447 nm  =0.0023 
H-4 ->L        23.91% 
H-2 ->L         66.52% 
496 nm  =0.0014 
H-2 ->L         74.37% 
3 430 nm  =0.0000 
H-3 ->L        39.83% 
H ->L         50.31% 
463 nm  =0.0000 
H-3 ->L        21.89% 
H ->L         68.23% 
4 401 nm  =0.0014 
H-1 ->L         67.97% 
412 nm  =0.0007 
H-1 ->L         89.65% 
5 391 nm  =0.0034 
H-1 ->L        25.82% 
H ->L+1         38.21% 
387 nm  =0.0032 
H ->L+1         48.72% 
 
6 377 nm  =0.0023 
H ->L+2         34.48% 
373 nm  =0.0026 
H ->L+2         34.84% 
7 350 nm  =0.0030 
H-3 ->L+1         34.95% 
361 nm  =0.0069 
H-4 ->L         23.03% 
8 340 nm  =0.0014 
H-2 ->L+1         55.37% 
344 nm  =0.0004 
H-8 ->L        30.07% 
H-3 ->L+2         34.10% 
9 337 nm  =0.0007 
H-3 ->L+2        39.67% 
341 nm  =0.0026 
H-6 ->L         27.07% 
H-3 ->L+1         47.43% 
10 332 nm  =0.0083 
H-6 ->L         35.38% 
H-3 ->L+1         30.87% 
341 nm  =0.0007 
H-2 ->L+1         62.83% 
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Table 4.9 First ten electronic transitions of 21 predicted by TD-DFT calculations in 
solvation model with CH3CN and H2O as solvents respectively. H=HOMO, L=LUMO. 
 
 21 in CH3CN 21 in H2O 
1 473 nm  =0.0007 
H-3 ->L        28.80% 
H ->L         51.34% 
516 nm  =0.0011 
H-2 ->L         33.51% 
H ->L         31.03% 
2 458 nm  =0.0022 
H-2 ->L         62.36% 
506 nm  =0.0014 
H-3 ->L        29.52% 
H-2 ->L         38.63% 
3 430 nm  =0.0010 
H-3 ->L         51.81% 
H ->L         35.57% 
461 nm  =0.0009 
H-3 ->L         45.70% 
H ->L        41.87% 
4 402 nm  =0.0052 
H ->L+1         46.19% 
397 nm  =0.0050 
H ->L+1         34.17% 
H ->L+2        18.21% 
5 374 nm  =0.0087 
H-1 ->L         76.17% 
386 nm  =0.0041 
H-1 ->L         66.03% 
6 355 nm  =0.0022 
H-5 ->L+2        16.81% 
H ->L+2         22.07% 
356 nm  =0.0019 
H ->L+2         17.63% 
7 347 nm  =0.0003 
H-2 ->L+1         24.03% 
H-2 ->L+2        15.95% 
352 nm  =0.0007 
H-2 ->L+1        11.86% 
H-2 ->L+2         13.62% 
8 339 nm  =0.0035 
H-3 ->L+1         25.89% 
H-2 ->L+1        13.93% 
343 nm  =0.0059 
H-8 ->L         17.22% 
H-2 ->L+2         10.35% 
9 330 nm  =0.0031 
H-5 ->L         17.35% 
H-2 ->L+1         19.96% 
342 nm  =0.0021 
H-5 ->L         28.71% 
H-2 ->L+1         23.14% 
10 326 nm  =0.0076 
H-3 ->L+1         22.86% 
H-2 ->L+2         11.59% 
335 nm  =0.0035 
H-4 ->L        17.45% 
H-2 ->L+1         17.91% 
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Concluding remarks 
A series of partial paddlewheel dirhodium complexes of general formula cis-
[Rh2(xhp)2(CH3CN)6][BF4]2 (xhp = mhp, chp and fhp ) were synthesized and fully 
characterized by X-ray diffraction and 
1
H NMR spectroscopy. The eq CH3CN ligands in 
this family of compounds were determined to be kinetically labile upon dissolution in 
CH3CN or H2O in the dark, as indicated by the 
1
H NMR and electronic spectroscopic 
studies. Importantly, the lability of the eq CH3CN ligands can be tuned through judicious 
choice of the substituents on the bridging ligands and in this case the ligand lability 
decreases in the order mhp> chp> fhp, which is in agreement with the hypothesis that the 
stronger electron donating ligands exert stronger trans effects. Irradiation of the aqueous 
solutions of compounds 19 and 21 with white light significantly accelerates the 
exchange rate of eq CH3CN ligands for the solvent H2O molecules. This is well 
understood from the TD-DFT calculation results, which indicate that population of the 
σ* Rh-N (eq CH3CN) bonds occurs in their excited states. Consequently, compounds 19 
and 21 hold great potential as PDT agents for cancer, investigations that are currently in 
progress. 
 
 
167 
 
CHAPTER V  
INVESTIGATION OF PARTIAL PADDLEHWEEL DIRHODIUM COMPLEXES 
BRIDGED BY ORTHOMETALATED PHOSPHINE LIGANDS 
Introduction  
Our previous studies revealed the exciting results that partial paddlewheel Rh2(II,II) 
complexes with electron-rich bridging formamidinate and chelating electron-accepting 
diimine ligands, namely cis-[Rh2(DTolF)2(N-N)2]
2+
 and cis-[Rh2(F-form)2(N-N)2]
2+
 (N-
N = dpq, dppz, dppn) exhibit directional Ligand-to-Ligand-Charge-Transfer (LLCT) 
excited states. Comprehensive experimental and computational studies indicate that the 
excited states of these complexes exhibit superior reducing and oxidizing abilities than 
the commonly used Ru(II) mononuclear complexes.
230
 To better understand the nature of 
these intriguing excited states, it is imperative to investigate the charge distributions in 
the excited states by time-resolved techniques (transient infrared and transient absorption 
spectroscopies). It is also important to design other Rh2(II,II) complexes with similar 
structural features but with different bridging ligands. The orthometalated phosphine 
ligand [Ph2P(C6H4)]
-
 discussed in chapter II is another excellent example of an electron-
rich bridging ligand for dirhodium(II,II) compounds. It was shown by Cotton and 
coworkers that compound cis-[Rh2[Ph2P(C6H4)]2(CH3CN)6][BF4]2 is an excellent 
synthetic precursor for a series of supramolecular arrays because the eq CH3CN ligands 
are highly labile due to the strong trans effect exerted by the two bridging [Ph2P(C6H4)]
-
 
ligands.
105
 As such, we chose the compound and one of its derivatives, namely, tris(4-
methoxyphenyl)phosphine (PMP) as bridging ligands and synthesized two series of 
168 
 
partial paddlewheel complexes and fully characterized them by NMR spectroscopy and 
X-ray crystallography. In addition, theoretical calculations were conducted which 
provide useful insight into the electronic structures of those complexes.  
Experimental section 
Starting materials  
The starting material Rh2(μ-O2CCH3)4•2MeOH was purchased from Pressure Chemical 
and purified by recrystallization from CH3OH. The ligands tris(4-
methoxyphenyl)phosphine (PMP) and triphenylphosphine (PPh3) were obtained from 
Sigma Aldrich and used as received. The ligands dpq (dipyrido[3,2-f:2',3'-h]-
quinoxaline), dppz (dipyrido[3,2-a:2’,3’-c]phenazine) and dppn (benzo[i]dipyrido[3,2-
a:2’,3’-h]quinoxaline) were synthesized according to published procedures and their 
purities were confirmed by 
1
H-NMR spectroscopy. The compound cis-[Rh2(PMP)2(μ-
O2CCH3)2(CH3CN)2] was synthesized according to a slightly modified published 
procedure.
 228
 The solvents acetic acid, diethyl ether and acetonitrile are of ACS grade 
and were used as received whereas dry CH3CN was obtained by distillation over 3 Å 
molecular sieves under a flow of dry N2. The CH2Cl2 was pre-dried over 4 Å molecular 
sieves and distilled over P2O5 under a flow of dry N2.  
Synthesis of cis-[Rh2[Ph2P(C6H4)]2(dpq)2(CH3CN)][BF4]2 (22). A quantity of cis-
[Rh2[Ph2P(C6H4)]2(CH3CN)6][BF4]2 (51 mg, 0.044 mmol) was added to 20 mL of  a 
suspension of the dpq ligand CH2Cl2/CH3CN (a 1:1/v:v mixture) (23 mg, 0.098 mmol) in 
the dark. The solution was stirred at room temperature for 72 h, after which time the 
color was observed to have changed to dark red. The solution was then concentrated to 5 
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mL under reduced pressure and filtered through a medium frit to remove any insoluble 
materials. The addition of 50 mL of diethyl ether to the filtrate led to the precipitation of 
the desired product as a red solid; upon drying under vacuum for 24 h, an amount of 54 
mg green product was obtained. The yield is 55 mg, ~ 85% based on rhodium. 
1
H-NMR 
(CD3CN-d3) δ ppm: 9.38(d, dpq), 9.10 (d, dpq), 8.90 (d, dpq), 8.73(s, dpq), 8.12(m, 
Ph2P(C6H4)), 7.84 (dd, dpq), 7.50 (m, Ph2P(C6H4)), 7.30(m, Ph2P(C6H4)), 7.19 (m, 
Ph2P(C6H4)), 7.17 (dd, dpq),  6.73 (t, Ph2P(C6H4)), 6.27 (dd, Ph2P(C6H4)), 6.21 (d, 
Ph2P(C6H4)); 
31
P-NMR (CD3CN-d3) δ ppm: 19.59 ppm 
1
J (Rh-P) = 330 Hz, 
2
J (Rh-P) = 
45 Hz. Anal. Calcd for Rh2C64H44P2N8B2F8•2CH2Cl2: C, 51.74; N, 7.99; H, 3.26 %. 
Found: C, 51.42; N, 7.71; H, 3.69%.  
Synthesis of cis-[Rh2[Ph2P(C6H4)]2(dppz)2(CH3CN)2][BF4]2 (23). A sample of cis-
[Rh2[Ph2P(C6H4)]2(CH3CN)6][BF4]2 (50 mg, 0.043 mmol) was added to 20 mL of a 
1:1/v:v CH2Cl2/CH3CN mixture containing 27 mg (0.097 mmol) of suspended dppz. The 
resulting orange solution which was stirred in the dark at room temperature for 72 hours 
eventually turned to red and was concentrated to 5 mL and filtered through a medium frit 
to remove any insoluble materials. The addition of 50 mL diethyl ether to the filtrate led 
to the precipitation of the desired product as a brown solid, yielding 60 mg of green 
product after drying under vacuum for 24 h (90% based on rhodium). 
1
H-NMR 
(CD3CN-d3) δ ppm: 9.51 ppm (d, dppz), 8.74 (s, dppz), 8.43(d, dppz), 8.14(m, 
Ph2P(C6H4)), 8.02 (dd, dppz), 7.86 (dd, dppz), 7.38 (m, dppz), 7.33 (m, Ph2P(C6H4)), 
7.35 (m, Ph2P(C6H4)), 7.22(m, Ph2P(C6H4)), 6.73 (t, Ph2P(C6H4)), 6.27 (dd, Ph2P(C6H4)), 
6.21 (d, Ph2P(C6H4)); 
31
P-NMR (CD3CN-d3) δ ppm: 19.36 ppm 
1
J (Rh-P) = 330 Hz, 
2
J 
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(Rh-P) = 45 Hz. Anal. Calcd for Rh2C72H48P2N8B2F8•CH2Cl2•H2O-CH3CN: C, 55.90; N, 
7.83; H, 3.44 %. Found: C, 55.63; N, 7.54; H, 3.53%.Crystals suitable for X-ray 
diffraction were obtained by slow diffusion of diethyl ether into a CH3CN solution 
containing the product. 
Synthesis of cis-[Rh2[Ph2P(C6H4)]2(dppn)2(CH3CN)][BF4]2 (24). An orange slurry of 
cis-[Rh2[Ph2P(C6H4)]2(CH3CN)6][BF4]2 (50 mg, 0.044 mmol) in 10 mL of CH3CN 
solution was mixed with a red slurry of dppn ligand (32 mg, 0.097 mmol) in 15 mL 
CH2Cl2 in the dark. The red slurry was stirred at room temperature for 72 h and was then 
concentrated to 5 mL and filtered through a medium frit to remove the insoluble 
materials. To the mother liquor was added 50 mL diethyl ether, which led to the 
precipitation of the desired product as a red solid. The material was collected by 
filtration and dried under vacuum, yielding 63 mg of desired product (87% based on 
rhodium). 
1
H-NMR (CD3CN-d3) δ ppm: 9.49(d, dppn), 9.11(s, dppn), 8.74 (s, b, dppn), 
8.43(d, dppn), 8.10 (d, Ph2P(C6H4)), 7.84 (m, dppn), 7.80 (m, dppn), 7.36(m, 
Ph2P(C6H4)), 7.21(m, Ph2P(C6H4)) 7.18 (m, Ph2P(C6H4)), 6.77(t, Ph2P(C6H4)), 6.34 (dd, 
Ph2P(C6H4)), 6.21(d, Ph2P(C6H4)). 
31
P-NMR (CD3CN-d3) δ ppm:  19.43 ppm 
1
J (Rh-P) = 
330 Hz, 
2
J (Rh-P) = 45 Hz. Anal. Calcd for Rh2C80H52P2N8B2F8•2CH2Cl2: C, 57.04; N, 
7.22; H, 3.64 %. Found: C, 57.16; N, 6.91; H, 3.74%. 
Synthesis of cis-[Rh2(PMP)2(CH3CN)6][BF4]2 (25). A quantity of 70 mg of cis-
[Rh2(PMP)2(μ-O2CCH3)2(CH3CN)2] was added to 30 mL of CH3CN to form a 
suspension. Upon addition of 0.8 mL of Et3OBF4 (1.0 M solution in CH2Cl2), the 
solution gradually became a clear orange color which was stirred under N2 for an 
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additional 12 h after which time it was evaporated to dryness under reduced pressure. 
The orange residue was re-dissolved in 3 mL of CH3CN. Subsequent addition of 50 mL 
of diethyl ether to the solution induced the precipitation of the desired product as an 
orange solid which was washed with copious quantities of diethyl ether. The yield is 84 
mg (85% based on rhodium). 
1
H-NMR (CD3CN-d3) δ ppm: 7.68(t, PMP), 7.10(dd, PMP), 
6.45(dt, PMP), 5.98(t, PMP), 3.85(s, OCH3 of PMP), 3.78(s, OCH3 of PMP), 3.34(s, 
OCH3 of PMP). 
31
P-NMR (CD3CN-d3) δ ppm: 19.36 ppm 
1
J (Rh-P) = 330 Hz, 
2
J (Rh-P) 
= 45 Hz. 
Synthesis of cis-[Rh2(PMP)2(dpq)2(CH3CN)2][BF4]2 (26). An amount of cis-
[Rh2(PMP)2(CH3CN)6][BF4]2 (40 mg, 0.030 mmol) was added to 20 mL of a 1:1/v:v 
mixture of CH2Cl2 and CH3CN which contained a suspension of 16 mg dpq (0.067 mmol) 
ligand. The mixture was stirred in the dark for 72 h resulting in the formation of a dark 
red solution. The solution was then concentrated to 3 mL under reduced pressure and 
filtered through a medium frit to remove any insoluble materials. The addition of 30 mL 
diethyl ether into the filtrate induced the precipitation of the desired product as a reddish 
brown solid. It was collected by filtration and dried under vacuum for 24 h. The yield is 
88% (43mg) based on rhodium. 
1
H-NMR (CD3CN-d3) δ ppm: 9.39 (d, dpq), 9.10 (d, 
dpq), 8.90 (d, dpq), 8.80 (s, dpq), 8.14 (d, dpq), 7.89(dd, dpq), 7.08 (m, PMP), 6.74(d, 
PMP), 6.51(s, PMP), 6.27(m, PMP), 3.90 (s, OCH3 of PMP), 3.80 (s, OCH3 of PMP), 
3.35 (OCH3 of PMP). 
31
P-NMR (CD3CN-d3) δ ppm: 16.90 ppm 
1
J (Rh-P) = 330 Hz, 
2
J 
(Rh-P) = 45 Hz. Anal. Calcd for Rh2C74H62N10O6P2B2F8•CH3CN•3CH2Cl2: C, 48.30; N, 
8.16; H, 3.79%. Found: C, 48.35; N, 7.96; H, 3.94%.  
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Synthesis of cis-[Rh2(PMP)2(dppz)2(CH3CN)(H2O)][BF4]2 (27). An amount of cis-
[Rh2(PMP)2(CH3CN)6][BF4]2 (40 mg, 0.030 mmol) was added into 20 mL of a 1:1/v:v 
mixture of CH2Cl2 and CH3CN which contained a suspension of 20 mg of dppz (0.072 
mmol) ligand. The solution rapidly turned to dark red and was stirred for 72 h in the dark. 
The solution was concentrated to 5 mL under reduced pressure with subsequent addition 
of 30 mL diethyl ether leading to the precipitation of the desired product. The solid was 
collected by filtration and dried under vacuum to yield 46 mg (89% based on rhodium) 
of the desired product. Slow diffusion of diethyl ether into a CH3CN solution containing 
27 led to the formation of crystals that were suitable for X-ray diffraction studies. 
1
H-
NMR (CD3CN-d3) δ ppm: 9.53 (d, dppz), 8.81 (s, dppz), 8.11-8.17 (m, dppz), 8.03 (dd, 
dppz), 7.90 (dd, dppz), 7.08 (m, PMP), 6.74(d, PMP), 6.51(s, PMP), 6.27(m, PMP), 3.92 
(s, OCH3 of PMP), 3.81 (s, OCH3 of PMP), 3.39 (OCH3 of PMP). 
31
P-NMR
 
(CD3CN-d3) 
δ ppm: 16.73 ppm 1J (Rh-P) = 330 Hz, 2J (Rh-P) = 45 Hz. Anal. Calcd for 
Rh2C80H65P2N9O7B2F8•CH2Cl2: C, 54.30; N, 7.04; H, 3.77%. Found: C, 54.37; N, 7.06; 
H 3.98%.   
Synthesis of cis-[Rh2(PMP)2(dppn)2(CH3CN)(H2O)][BF4]2 (28). An orange slurry of 
10 mL of dry CH3CN containing cis-[Rh2(PMP)2(CH3CN)6][BF4]2 (50 mg, 0.037 mmol) 
was treated with 20 mL of CH2Cl2 which contained 28 mg of undissolved dppn ligand 
(0.085 mmol). The was stirred in the dark for 72 h, after which time it was concentrated 
to 5 mL under reduced pressure and filtered through a medium frit to remove any 
insoluble materials. The addition of 30 mL of diethyl ether to the filtrate led to the 
precipitation of the desired product as a red solid which was collected by filtration and 
173 
 
dried under vacuum for 24 h to yield 61 mg (90% based on rhodium) of the desired 
product. 
1
H-NMR (CD3CN-d3) δ ppm: 9.51 (d, dppn), 9.12 (s, dppn), 8.81(s, dppn), 8.44 
(d, dppn), 8.12 (d, dppn), 7.94 (m, PMP), 7.87 (m, dppn), 7.10-7.17 (m, PMP), 6.75(d, 
PMP), 6.62(m, PMP), 6.45-35(m, PMP), 3.94 (s, OCH3 of PMP), 3.81 (s, OCH3 of 
PMP), 3.41 (OCH3 of PMP). 
31
P-NMR (CD3CN-d3) δ ppm: 16.64 ppm 
1
J (Rh-P) = 330 
Hz, 
2
J (Rh-P) = 45 Hz. Anal. Calcd for Rh2C88H69P2N9O7B2F8•CH2Cl2: C, 56.50; N, 6.67; 
H, 3.79%. Found: C, 56.65; N, 6.79; 3.96%. 
Instrumentation and methods 
Hemispheres of data for 22, 23 and 27 were collected by a combination of four sets of 
X-ray exposures. Each set used a different ϕ angle for the crystals and covered 0.5  in ω 
for 22 and 0.3  for 23 and 27. The exposure times were 45 s for 22 and 20 s for 23 and 
27. The electron density corresponding to heavily disordered solvent molecules observed 
during the data refinement was removed using the SQUEEZE routine implemented in 
PLATON. 
Results and discussion 
Syntheses and characterization  
The synthetic route for compound 25 follows the published procedure for cis-
[Rh2[Ph2P(C6H4)]2(CH3CN)6][BF4]2.
105
 A slight excess of Et3OBF4 was used to replace 
each bridging [O2CCH3]
-
 group with two monodentate CH3CN ligands by alkylation of 
the carboxylates to the corresponding ester. The purity of 25 was confirmed by 
1
H-NMR 
and 
31
P-NMR spectroscopic data. The 
1
H-NMR spectrum of cis-
[Rh2[Ph2P(C6H4)]2(CH3CN)6][BF4]2 in CD3CN, i.e., indicated all four eq CH3CN ligands 
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in compound 25 undergoes fast exchange process with the CD3CN solvent molecules, as 
evidenced by the presence of only free CH3CN resonances in its 
1
H-NMR spectrum.  
     Syntheses of 22-24, 26-28 (structural representation shown in Figure 5.1) followed a 
similar procedure as described below.  
 
 
 
 
Figure 5.1 Schematic representations of the complexes 22-24 and 26-28. 
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     A suspension of slightly more than two equivalents of diimine (dpq, dppz, dppn) 
ligands in CH3CN/CH2Cl2 solution was mixed with the CH3CN solution of cis-
[Rh2[Ph2P(C6H4)]2(CH3CN)6][BF4]2 or 25. An immediate color change to dark red was 
observed. Stirring at room temperature for 72 h led to full substitution of the four labile 
eq CH3CN ligands with the corresponding diimine ligands, as evidenced by the 
31
P-
NMR spectra of the products. The purity of each compound was also confirmed by 
1
H-
NMR spectroscopy. 
X-ray crystallography 
The crystal parameters and information pertaining to the data collection and refinement 
are summarized in Table 5.1. 
cis-[Rh2[Ph2P(C6H4)]2(dpq)2(CH3CN)][BF4]2. Compound 22 crystallizes in the space 
group P-1. The two rhodium centers are bridged by two cisoid  [Ph2P(C6H4)]
-
 ligands in 
the H-T fashion with P and C atoms as the coordination sites, akin to the starting 
material cis-[Rh2[Ph2P(C6H4)]2(CH3CN)6][BF4]2.
105 
Each rhodium center is further 
chelated by one dpq ligand but with only one of the ax positions being occupied by 
CH3CN solvent molecule (Figure 5.2). As is the case for the compounds cis-
[Rh2[Ph2P(C6H4)]2(CH3CN)6][BF4]2
105
 and cis-[Rh2[Ph2P(C6H4)]2(CNCH3)6][BF4]2 
229
, 
the product is a racemic mixture of both R and S isomers and they are related to each 
other by an inversion center. The Rh-Rh bond distance is 2.702(2) Å, ~ 0.04 Å longer 
than those in cis-[Rh2[Ph2P(C6H4)]2(CH3CN)6][BF4]2 and ~ 0.06 Å shorter than those in 
cis-[Rh2[Ph2P(C6H4)]2(CNCH3)6][BF4]2. 
229
 The Rh-P and Rh-C bond distances are ~ 
2.24 and ~ 2.02 Å respectively. The Rh-N (dpq, trans to C) bond length is ~ 0.05 Å 
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Table 5.1 Crystal data for compounds 22•(CH3)2CO, 23•CH3CN•C4H10O and 27. 
 
 22•(CH3)2CO 23•CH3CN•C4H10O 27 
Formula C69N9O1B2F8P2 
Rh2 H53 
C82H67B2N11 
F8P2Rh2O1 
C82H66N10Rh2 
P2O6B2F8 
Space group P-1 P21/c P-1 
a, b, c/ Å 12.097(9)  
12.996(10)  
21.095(16) 
16.067(3) 
15.486(3) 
29.969(6) 
13.871(3) 
14.085(3) 
23.870(5) 
, , / º 85.270(10)  
82.340(10)  
70.230(9) 
90.00 
102.08(3) 
90.00 
87.84(3) 
79.11(3) 
66.22(3) 
V/Å
3 3091(4) 7292(3) 4187.1(15) 
Z 2 4 2 
2θ range for data collection/º 52.93 46.49 48.11 
Independent reflections 12351 10457 13057 
Completeness to  max/ % 96.8 99.9 98.6 
Goodness-of-fit parameter 
(all data)
a
 
0.935 1.051 1.060 
Residual factors [I >4(I)]b R = 0.0602  
wR = 0.1441 
R = 0.0338 
wR = 0.0811 
R = 0.0388 
wR = 0.0921 
Residual factors (all data)
c
 R = 0.1151  
wR = 0.1661 
R = 0.0409 
wR = 0.0859 
R = 0.0537 
wR = 0.0969 
a
Goodness-of-fit = {∑[w(Fo
2
- Fc
2
)
2
]/(n-p)}
1/2
, where n is the number of reflections and p is the total number of parameters 
refined.
 bR = ∑Fo-Fc/∑Fo. 
c
wR = {∑[w(Fo
2
 - Fc
2
)
2]/∑w(Fo
2
)
2
]}
1/2
. 
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Figure 5.2 Thermal ellipsoid plot for compound 22 at the 50% probability level; anions 
[BF4]
-
, hydrogen atoms and interstitial solvent molecules omitted for the sake of clarity. 
 
 
 
longer than the Rh-N (dpq, trans to P), with the former distance being ~ 2.20 Å. Quite 
noticeably, the Rh-N (ax CH3CN) is 2.106(6) Å, which is shorter than the Rh-N (dpq) 
bond distances. The internal twists from the eclipsed configuration occur for the two dpq 
ligands to reduce the steric repulsion between them, with the dihedral angle values of 
28.82º and 28.42º. This is larger than those found for cis-
[Rh2(Fform)2(dpq)2(CH3CN)2][BF4]2 (~ 19º), indicating the stronger repulsions operative 
in this compound.
230
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cis-[Rh2[Ph2P(C6H4)]2(dppz)2(CH3CN)2][BF4]2. Compound 23 crystallizes in the space 
group P21/c. The coordination spheres of the rhodium centers are similar to that of 22, 
except that both ax positions are occupied by CH3CN ligands as shown in Figure 5.3. As 
in the case of 22, compound 23 is a racemic mixture, but the two isomers are related to 
each other by glides located at 1/4b and 3/4b. The Rh-Rh bond distance is 2.7186(6) Å, 
comparable to that in 22. The Rh-P and Rh-C bond distances are ~ 2.2503(4) and ~ 
2.0400(3) Å, similar to those in cis-[Rh2[Ph2P(C6H4)]2(CH3CN)6][BF4]2 and 22, but 
shorter than those found in cis-[Rh2[Ph2P(C6H4)]2(CNCH3)6][BF4]2.
229
 The Rh-N (dppz, 
trans to C atoms) bond distances are ~ 2.19 Å, ~ 0.05 Å longer than the Rh-N (dppz, 
trans to P atoms) bond distances. On average, both of them are longer than those in cis-
[Rh2(μ-O2CCH3)2(dppz)2(η
1
-O2CCH3)(CH3CH2OH)][BF4]
46
 (from 2.005(4) to 2.016(4) 
Å) and cis-[Rh2(DTolF)2(dppz)2(CH3CN)][BF4]2 (from 2.040(5) to 2.060(2) Å),
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indicating the much stronger trans influence of the bridging orthometalated phosphine 
ligands. The Rh-N (ax CH3CN) bond distances are 2.2437(5) and 2.1953(5) Å, 
respectively, in a similar range to Rh-N (dppz, trans to C atoms). The internal twist 
angles from the eclipsed configuration for two dppz ligands are - 21.65º and - 21.61º, 
which are larger than those in cis-[Rh2(μ-O2CCH3)2(dppz)2(η
1
-
O2CCH3)(CH3CH2OH)][BF4] (~ 13º) and cis-[Rh2(DTolF)2(dppz)2(CH3CN)][BF4]2 (~ 
16º). 
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Figure 5.3 Thermal ellipsoid representation of compound 23 at the 50% probability 
level; anions and hydrogen atoms were omitted for the sake of clarity.  
 
 
 
cis-[Rh2[PMP]2(dppz)2(CH3CN)2][BF4]2. Compound 27 crystallizes in the triclinic P-1 
space group, with the coordination environment around the two rhodium centers similar 
to 23 being depicted in Figure 5.4a. Compound 27 is also a racemic mixture with the 
isomers related to each other by an inversion center. The Rh-Rh bond distance is 2.723(1) 
Å, in a similar range to that found for 22 and 23. The Rh-N (dppz) bond distances trans 
to the P atoms are ~2.12 Å while those trans to C atoms are ~2.19 Å, and both distances 
are in a similar range to those in 23. The Rh-N (ax CH3CN) bond distances are ~2.19 Å, 
similar to the Rh-N (dppz, trans to C) bond distances. Distortions from the eclipsed 
configuration for the two dppz ligands also occur in the crystal structure, and the 
dihedral angles defined by N1-Rh1-Rh2-N3 and N2-Rh1-Rh2-N4 are -24.5(1)º and -
24.4(1)º respectively. As shown in Figure 5.4b, intermolecular π-π stacking interactions 
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are present in the crystal packing diagram of 27, with a distance of ~ 3.36 Å from C75 to 
the plane that is defined by the dppz ligand from another molecule. 
 
 
  
 
Figure 5.4 (a) Thermal ellipsoid representation of compound 27 at the 50% probability 
level; anions and hydrogen atoms were omitted for the sake of clarity; (b) crystal 
packing representations of 27, indicating the π-π stacking interactions between two dppz 
ligands in two adjacent molecules.  
 
 
 
 
 
181 
 
Electronic absorption and electrochemical studies 
Since there are structural similarities between 22/26, 23/27, 24/28, respectively, each 
pair is expected to exhibit analogous electronic properties in CH3CN at room 
temperature (Figures 5.5 and 5.6) which are detailed in this section. Although the ɛ 
values are low, two distinct shoulder peaks are observed in the region λ> 410 nm for all 
the complexes. The first shoulder peak, at ~420 nm for 22/26, ~440 nm for 23/27 and 
~470 nm for 24/28 (Table 5.2), is clearly dependent on the identity of the diimine 
ligands with the absorption bands for compounds containing more conjugated π system 
ligands occurring at relative lower energies. Therefore, they can be assigned as the 
electronic transitions from the metal centers to the diimine ligands (MLCT). As featured 
in Figure 5.5 and Table 5.2, the lowest energy transitions in 22 and 23 are of nearly the 
same energy with similar molar absorptivities (~ 477 nm, ɛ = 1250 M–1cm–1 in 22 and ~ 
474 nm, 1250 M
–1
cm
–1 
in 23). For compound 24, however, the transition occurs at a 
lower energy with a slightly higher molar absorptivity (~ 518 nm, ɛ = 2000 M–1cm–1), an 
indication of the different character in 24. Furthermore, as shown in Figure 5.6 and 
Table 5.2, the lowest energy transitions in 26 and 27 also occur in a very similar energy 
range as compared to that of 22 and 23. The independence of these transitions on both 
the bridging and chelating ligands indicates that they are MC dd transitions, not 
uncommon for Rh2(II,II) compounds.
21
 The relatively high ɛ value (~ 1000 M-1cm-1), 
however, indicates that they are likely of different characters from the lowest energy 
transition band in Rh2(μ-OOCCH3)42H2O ( ~ 584 nm, ~ 240 M
-1
cm
-1
 in H2O) which 
corresponds to the Rh2(π*) to Rh2(σ*) transition. The absorptions at λ ~ 302 and 339 nm 
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for 22, 361 and 378 nm for 23, 398 and 418 nm for 24 are assigned as the diimine 
centered intramolecular 
1ππ* transitions, given that similar absorption bands are also 
present in the free dpq ligand at ~ 326-340 nm, the free dppz ligand at ~ 340-370 nm and 
the free dppn ligand at ~ 390 and 414 nm. In addition, similar absorptions are also 
observed for compounds 26-28 with similar molar absorptivities, the series of Rh2(II,II) 
compounds with different bridging ligands ([DTolF]
-
, [F-form]
-
 and [OAc]
-
), as well as 
 
 
 
Table 5.2 Electronic absorption maxima, λabs, molar absorptivities, ɛ, and redox 
potentials for 22-24 and 26-28 in CH3CN. 
 
Complex λabs/nm (ɛ10
3
 M
–1
cm
–1
) Potential/ V 
22 257 (66), 302 (31), 339 (14), 415 
(3.2),  ~ 477 (1.25) 
1.44(Epa), -0.76, -1.03, -1.49, 
-1.77 
23 275 (115), 361 (25), 378 (22), 441 
(2.5) ~ 484 (1.15) 
1.33(Epa) 
24 242 (92), 261 (71), 313 (128), 398 
(17.7), 418 (17.4), 470 (5.0), ~ 518 
(2.0) 
1.36(Epa) 
26 252 (117), 301 (45), 347 (15), 420 
(3.3), ~ 474 (1.25) 
1.35(Epa), -0.86, -1.08, -1.52,   
27 274 (127), 361 (28), 378 (24), 444 
(2.8), ~ 490 (1.05) 
1.24(Epa) 
28 241 (110), 261 (77), 313 (118), 398 
(16.5), 418 (16.4), 470 (4.6), ~ 
518(1.7) 
1.27(Epa) 
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Figure 5.5 Overlay of the electronic absorption spectra of compounds 22-24 in CH3CN 
at room temperature. 
 
 
 
 
Figure 5.6 Comparisons of the electronic absorption spectra between 22/26, 23/27 and 
24/28. 
 
 
 
several Ru(II) compounds containing these diimine ligands.
36,37,44-48, 230  
Other strong 
absorption maxima in these compounds are located at λ ~ 250 nm in 22 and 26, ~ 270 
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nm in 23 and 27, ~ 260 nm in 24 and 28, ascribed to the electronic transitions between 
the metal based orbitals but perturbed by mixing with the diimine ligands.   
     Upon a strong reducing potential to the working electrode of CH3CN solutions 
containing compounds 23, 24, 27 and 28, changes in the cyclic voltammogram were 
observed, indicating the decomposition of those complexes; positive voltages do not 
casue degradation. Of all the compounds, there is one quasi-reversible oxidation, 
occurring at ~1.30 V for compounds 22-24, and at ~1.25 V for compounds 26-28. A 
similar process is also observed in cis-[Rh2[Ph2P(C6H4)]2(CH3CN)6][BF4]2 at ~1.41 V, 
assigned as the Rh2
4+
/Rh2
5+
 redox couple.
105 
In the case of compounds 22-24, 26-28, 
these events are independent of the diimine ligands while electron-donating groups on 
the bridging ligands result in a cathodic shift which idicates a Rh2
4+
/Rh2
5+
oxidation 
process influenced by the bridging ligands. 
     There are four consecutive reduction processes for compounds 22 and 26. The first 
two reduction processes occur at ~ -0.76 and -1.03 V in 1, -0.86 and -1.08 V in 26, 
tentatively assigned as the stepwise reductions of the two diimine ligands. Compared to 
22, these processes for compound 26 occur at a more negative potential (~ 0.1 V), 
underscoring the involvement of the bridging ligands which is also in accord with the 
electron donating groups resulting in greater difficulty to reduce them. The third and 
fourth reduction events are tentatively assigned to the stepwise reduction of the dimetal 
centers, namely, the Rh2
4+
/Rh2
3+
 and Rh2
3+
/Rh2
2+
 redox couples. 
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Computational studies 
DFT and TD-DFT calculations of the cationic units in 22-24, 26-28 were conducted to 
gain further understanding of their electrochemical and photophysical properties. 
Geometric parameters for the gas phase optimizations were obtained from the crystal 
structures of 22, 23, 27 with appropriate modifications of the diimine ligands for 
different compounds (dpq for 26, dppn for 24 and 28). The optimized cationic units of 
23 and 27 are shown in Figure 5.7. The comparisons of the bond distances and bond 
angles between the calculated structures and the crystal structures are listed in Table 5.3. 
     In all six compounds, orbitals ranging from LUMO to LUMO+5 are mainly diimine 
based orbitals, whereas the LUMO+6 is mainly of Rh2(σ*) character (Table 5.4). For the 
HOMOs in 22-24, different compounds vary in character and they are detailed as 
follows. For 22 and 23, they possess similar compositions, mainly Rh2(σ) character with 
small contributions from ax CH3CN (~10%) and bridging ligands (~10%), whereas it is a 
dppn-centered orbital in 24. The HOMO-1 in 24, on the other hand, has the same 
character as the HOMOs in 22 and 23 (Rh2(σ) orbital). Metal-centered Rh2(π*) orbitals 
are HOMO-3, HOMO-4 in 22 and 23 (Table 5.4) and HOMO-5 [83% (Rh), 9% 
(Ph2PC6H4)] and HOMO-6 [70% (Rh), 22% (Ph2PC6H4)] in 24. For the HOMOs in 26-
28, they are mainly Rh2(σ) character (70% Rh2, 15% PMP and 10% ax CH3CN). The 
metal-centered Rh2(π*) orbitals are HOMO-9 in 26 [72% (Rh), 19% (PMP)] and 27 [71% 
(Rh), 22% (PMP)] and HOMO-11 in 28. One point worth mentioning is that the HOMO-
1 and HOMO-2 in 28, are mainly dppn-based orbitals. 
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Figure 5.7 Calculated cationic structures of compounds 23 and 27; the hydrogen atoms 
were omitted for the sake of clarity. 
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Table 5.3 Comparisons of the structural parameters in compounds 23 and 27 between  
the calculated structures and X-ray diffraction data. 
 
23 Experimental Calculated 
Bond distances (Å) Bond distances (Å) 
Rh1-Rh2 2.7186(6)  2.7110 
Rh1-P1 2.2391(4) 2.285 
Rh1-C1 2.0313(3) 2.032 
Rh2-C19 2.0400(3) 2.032 
Rh2-P2 2.2503(4) 2.285 
Rh1-N9 2.2437(5) 2.226 
Rh2-N10 2.1953(5) 2.226 
Rh1-N1 2.2026(4) 2.239 
Rh1-N2 2.1300(4) 2.162 
Rh2-N5 2.1983(4) 2.161 
Rh2-N6 2.1413(4) 2.240 
 Experimental Calculated 
 Dihedral angle (º) Dihedral angle (º) 
P1-Rh1-Rh2-C19  -9.28 -14.9 
C1-Rh1-Rh2-P2  -9.34 -14.9 
N1-Rh1-Rh2-N6  -21.61 -29.2 
N2-Rh1-Rh2-N5 -21.65 -29.3 
27 Experimental Calculated 
Bond distances (Å) Bond distances (Å) 
Rh1-Rh2 2.723(1)  2.7116 
Rh1-N9 2.196(4) 2.233 
Rh2-N10 2.185(4) 2.211 
Rh1-P1 2.252(1) 2.284 
Rh1-C22 2.029(4) 2.030 
Rh2-C6 2.043(3) 2.030 
Rh2-P2 2.252(1) 2.284 
Rh1-N1 2.182(3) 2.165 
Rh1-N2 2.123(3) 2.237 
Rh2-N3 2.126(3) 2.169 
Rh2-N4 2.195(3) 2.239 
 Experimental Calculated 
 Dihedral angle (º) Dihedral angle (º) 
P1-Rh1-Rh2-C6  -10.3(1) -16.9 
C22-Rh1-Rh2-P2  -10.9(1) -16.9 
N1-Rh1-Rh2-N3   -24.5(1) -32.1 
N2-Rh1-Rh2-N4   -24.4(1) -32.1 
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Table 5.4 Compositions of the orbitals related to the electronic transitions in compounds 22-24, 26-28 calculated by TD-DFT 
calculations in the solvation model with CH3CN as the solvent. 
 
 22 23 24 26 27 28 
HOMO-4 69 Rh 
23 Ph2PC6H4 
5 dpq 
70 Rh 
22 Ph2PC6H4 
5 dppz 
56 Ph2PC6H4 
40 Rh 
48 PMP 
47 Rh 
56 PMP 
39 Rh 
79 PMP 
19 Rh 
 
HOMO-3 82 Rh 
10 Ph2PC6H4 
5 dpq 
84 Rh 
9 Ph2PC6H4 
6 dppz 
50 Ph2PC6H4 
46 Rh 
78 PMP 
20 Rh 
80 PMP 
17 Rh 
71 PMP 
15 Rh 
14 dppn 
HOMO-2 57 Ph2PC6H4 
39 Rh 
56 Ph2PC6H4 
40 Rh 
68 dppn 
25 Rh 
80 PMP 
19 Rh 
78 PMP 
19 Rh 
75 dppn 
22 PMP 
HOMO-1 49 Ph2PC6H4 
47 Rh 
51 Ph2PC6H4 
45 Rh 
60 Rh 
24 dppn 
8 CH3CN 
8 Ph2PC6H4 
79 PMP 
17 Rh 
81 PMP 
15 Rh 
91 dppn 
9 PMP 
 
HOMO 74 Rh 
10 CH3CN 
10 Ph2PC6H4 
6 dpq 
75 Rh 
10 CH3CN 
10 Ph2PC6H4 
5 dppz 
99 dppn 71 Rh 
16 PMP 
9 CH3CN 
71 Rh 
14 PMP 
10 CH3CN 
5 dppz 
71 Rh 
15 PMP 
10 CH3CN 
 
LUMO 80 dpq 
13 Rh 
6 Ph2PC6H4 
73 dppz 
17 Rh 
10 Ph2PC6H4 
85 dppn 
14 Rh 
79 dpq 
15 Rh 
6 PMP 
80 dppz 
19 Rh 
80 dppn 
16 Rh 
 
LUMO+1 86 dpq 
9 Rh 
86 dppz 
11 Ph2PC6H4 
97 dppn 81 dpq 
9 Rh 
8 PMP 
96 dppz 93 dppn 
 
LUMO+2 83 dpq 
11 Ph2PC6H4 
6 Rh 
84 dppz 
11 Rh 
85 dppn 
11 Rh 
87 dpq 
6 Rh 
6 PMP 
78 dppz 
11 Rh 
9 PMP 
85 dppn 
11 Rh 
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Table 5.4 Continued  
 
 22 23 24 26 27 28 
LUMO+3 63 dpq 
31 Rh 
5 Ph2PC6H4 
72 dppz 
24 Rh 
74 dppn 
22 Rh 
57 dpq 
34 Rh 
8 PMP 
66 dppz 
26 Rh 
7 PMP 
72 dppn 
25 Rh 
 
LUMO+4 95 dpq 
 
93 dppz 95 dppn 
 
84 dpq 
13 PMP 
94 dppz 95 dppn 
LUMO+5 86 dpq 
7 Rh 
7 Ph2PC6H4 
84 dppz 
9 Ph2PC6H4 
6 Rh 
81 dppn 
9 Ph2PC6H4 
9 Rh 
78 dpq 
16 PMP 
6 Rh 
85 dppz 
10 PMP 
88 dppn 
6 PMP 
LUMO+6 57 Rh 
25 Ph2PC6H4 
11 ax CH3CN 
7 dpq 
57 Rh 
24 Ph2PC6H4 
11 CH3CN 
8 dppz 
55 Rh 
24 Ph2PC6H4 
11 CH3CN 
10 dppn 
58 Rh 
24 PMP 
12 CH3CN 
6 dpq 
58 Rh 
25 PMP 
12 CH3CN 
5 dppz 
58 Rh 
23 PMP 
12 CH3CN   
7 dppn 
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     For all six compounds, the energies for the orbitals ranging from LUMO to LUMO+5 
are closely related to the diimine ligands as displayed in Figure 5.8 due to their diimine 
ligand characters, which is similar to the observation in the other two series of dirhodium 
compounds equipped with [DTolF]
-
 and [F-form]
-
 ligands.
230 
On the other hand, the 
LUMO+6 orbitals lie in very close energy range for all the complexes due to their 
Rh2(σ*) character. The HOMOs in 22 and 23 and the HOMO-1 in 24 are of very similar 
energies due to their comparable Rh2(σ) character (Table 5.4). The HOMO and HOMO-
2 in 24 (dppn-centered orbital) also lie in a very similar range as the HOMO-1 in 24 as 
depicted in Figure 5.8. The HOMOs in 26-28 lie very close in energy as displayed in 
Figure 5.8, but are of slightly higher energy than the HOMOs in 22-23 and HOMO-1 in 
24 (Table 5.4), ascribed to the electron donating –OMe groups on the phenyl rings of the 
bridging ligand which is a minor component of the HOMOs in all six compounds. The 
HOMO-1 and HOMO-2 in 28 are of very similar energy to the HOMO and HOMO-2 in 
24 due to their same dppn ligand character (Table 5.4).  
     The vertical energies, the orbital contributions and oscillating factors for the first 10 
excited states in 22-24, 26-28 are listed in Tables 5.5 and 5.6, respectively. The lowest 
energy transitions in 22-23, 26-27 have similar character, mainly the electronic 
transitions from Rh2(σ)/Rh2(π*) orbitals to Rh2(σ*) orbital (Tables 5.5 and 5.6).     
Therefore, they occur within a very small energy range of 470 to 475 nm with a similar 
oscillating factor of  ~ 0.02; the lowest energy transitions for 24 and 28, however, occur 
at ~ 500-510 nm and they are of dual 
1ππ* dppn-centered and metal to dppn ligand 
charge transition character (MLCT) as revealed by the TD-DFT calculations. 
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Figure 5.8 MO diagrams for 22-24, 26-28 predicted by TD-DFT calculations with 
CH3CN as the solvent. 
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Table 5.5 Electronic transitions in 22-24 predicted by TD-DFT calculations with 
CH3CN as the solvent; only major transitions (2|coefficient|
2
>20%) are listed in the table; 
H = HOMO, L = LUMO. 
  
 22 23 24 
1 474 nm  =0.0211 
H-4 -> L+6       32.1% 
H -> L+6        48.8% 
476 nm  =0.0187 
H-4 -> L+6        33.2% 
H -> L+6        47.5% 
508 nm  =0.0017 
H-2 -> L+1        23.9% 
H -> L        66.0% 
2 455 nm  =0.0005 
H-3 -> L+6        67.5% 
457 nm  =0.0008 
H-3 -> L+6        72.9% 
507 nm  =0.0311 
H-2 -> L        40.8% 
H -> L+1        42.9% 
3 430 nm  =0.0239 
H -> L+1        88.1% 
449 nm  =0.0035 
H -> L        91.4% 
488 nm  =0.0027 
H-2 -> L        25.4% 
H-1 -> L        71.5% 
4 419 nm  =0.0079 
H -> L        72.6% 
H -> L+3       24.6% 
442 nm  =0.0218 
H -> L+1        80.7% 
477 nm  =0.0192 
H-2 -> L+1        23.9% 
H-1 -> L+1        71.0% 
5 384 nm =0.0004 
H -> L+4        87.9% 
413 nm  =0.0078 
H -> L+2        78.0% 
473 nm  =0.0226 
H-5 -> L+6        31.4% 
H-1 -> L+6        34.8% 
6 382 nm  =0.0072 
H-3 -> L+1       24.5% 
H-1 -> L+1        30.5% 
404 nm  =0.0050 
H -> L+3        88.5% 
461 nm  =0.0002 
H-2 -> L       32.4% 
H -> L+1        56.4% 
7 379 nm  =0.0039 
H-1 -> L+6        51.3% 
392 nm  =0.0175 
H-1 -> L        68.3% 
460 nm  =0.0000 
H-2 -> L+1        50.2% 
H -> L       33.4% 
8 378 nm  =0.0184 
H -> L+3        39.4% 
389 nm  =0.0115 
H-1 -> L+1        43.7% 
454 nm =0.0000 
H-5 -> L+6       68.9% 
9 375 nm  =0.0010 
H-3 -> L+1        29.2% 
H-2 -> L+6        21.8% 
385 nm  =0.0322 
H-3 -> L        65.6% 
 
423 nm  =0.0136 
H-3 -> L        79.7% 
10 374 nm  =0.0019 
H -> L+2        86.2% 
384 nm  =0.0104 
H-3 -> L+1        42.5% 
419 nm  =0.0199 
H-2 -> L+2        23.0% 
H-1 -> L+2        66.1% 
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Table 5.6 Electronic transitions in 26-28 predicted by TD-DFT calculations with 
CH3CN as the solvent; only major transitions (2|coefficient|
2
>20%) are listed in the table. 
H = HOMO, L = LUMO. 
 
 26 27 28 
1 476 nm  =0.0207 
H-9 -> L+6       29.0% 
H -> L+6        43.3% 
472 nm  =0.0204 
H-9 -> L+6        30.4% 
H -> L+6        41.3% 
511 nm  =0.0033 
H -> L        94.64% 
 
2 457 nm  =0.0011 
H-7 -> L+6        26.4% 
H-4 -> L+6        32.1% 
468 nm  =0.0063 
H -> L        89.2% 
 
507 nm  =0.0015   
     H-2 -> L+1        26.00% 
     H-1 -> L        67.48% 
3 438 nm  =0.0232 
H -> L+1        76.9% 
458 nm  =0.0196 
H -> L+1        54.3% 
505 nm  =0.0294   
     H-2 -> L        50.49% 
     H-1 -> L+1        40.72% 
4 429 nm  =0.0069 
H -> L        67.3% 
H -> L+3       24.5% 
451 nm  =0.0057 
H-7 -> L+6       24.8% 
H -> L+1        23.9% 
497 nm  =0.0192   
     H -> L+1        92.43% 
  
5 391 nm  =0.0004 
H -> L+4        90.8% 
426 nm  =0.0081 
H -> L+2        71.0% 
474 nm  =0.0256   
     H-11 -> L+6        
29.58% 
     H -> L+6        43.76% 
6 390 nm  =0.0019 
H -> L+3        33.5% 
418 nm  =0.0003 
H-1 -> L        76.2% 
460 nm  =0.0003   
     H-2 -> L       39.22% 
     H-1 -> L+1        56.99%  
7 388 nm  =0.0043 
H-2 -> L+1        26.5% 
413 nm  =0.0036 
H-2 -> L        72.7% 
459 nm  =0.0000   
          H-2 -> L+1        
60.10% 
     H-1 -> L       31.01% 
8 385 nm  =0.0224 
H -> L+3        23.6% 
412 nm  =0.0082 
H -> L+3        84.1% 
455 nm  =0.0005   
     H-3 -> L        75.84% 
9 384 nm  =0.0017 
H -> L+2        80.1% 
407 nm  =0.0082 
H-1 -> L+1        65.0% 
454 nm  =0.0001   
     H-9 -> L+6        29.43% 
     H-7 -> L+6        25.66% 
10 381 nm  =0.0098 
H-1 -> L+1        38.0% 
402 nm  =0.0054 
H-2 -> L+1        70.4% 
448 nm  =0.0036   
     H-4 -> L        70.40%    
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     On the other hand, the transitions originating from Rh2(σ)/Rh2(π*) to Rh2(σ*) in 24 
and 28, occur at λ  ~ 473 nm, which is similar to the lowest energy transitions for 22, 23 
and 26, 27. Other distinct low energy transition are predicted to occur at λ ~ 420-430 nm 
in 22, 430-440 nm in 23, 480-490 nm in 24. They are the transitions from metal-based 
orbitals to the low lying diimine based unoccupied orbitals, thus rendering them MLCT 
character. The bathochromic shifts on going from 22 through 24 are in accord with the 
order of the energy levels for those diimine based unoccupied orbitals being dpq> dppz> 
dppn. Similar bands also occur in compounds 26-28, with all of them also bathochromic-
shifted as compared to 22-24 respectively, attributed to the slight destabilization of the 
Rh2(π*) orbitals by the more electron donating bridging PMP ligands in them (vide 
supra). 
Concluding remarks 
The complexes presented in this chapter comprise two new families of partial 
paddlewheel dirhodium compounds with orthometalated phosphines as bridging ligands 
that exhibit novel structural features, in particular the very long eq Rh-N bond distance. 
This finding is not surprising given the fact that the orthometalated phosphine ligands 
are very good electron donors (vide supra), that exert a strong trans influence on these 
eq Rh-N bonds. Preliminary studies indicate that the lowest energy transitions in the dpq, 
dppz complexes are mainly of metal-centered character whereas the dppn analogs are 
dual dppn ππ* and Rh2(π*) to Rh2(σ*) character. As compared to the results obtained 
from the studies in Chapter III, the use of orthometalated phosphine ligands leads to a 
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drastic change of the electronic structures of the dirhodium complexes, indicating an 
ease of tuning of the ligand field.  
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CHAPTER VI  
CONCLUDING REMARKS AND FUTURE WORK 
As described in the previous chapters, the new dirhodium complexes exhibit potential 
for two very different applications, namely solar energy conversion (specifically water 
splitting to produce hydrogen) and anticancer photodynamic applications. These 
properties are directly related to the nature of the bridging ligands spanning the 
dirhodium metal-metal bond. To further improve their performance in each arena the 
ligand environment was tuned. 
     The ultimate goal for the partial paddlewheel dirhodium complexes in Chapters II and 
IV was to achieve stability of the complexes with respect to lack of substitution of the 
monodentate eq ligands and to induce photolability upon visible light irradiation; in this 
respect, the aim was a medicinal chemistry application. As demonstrated in this 
dissertation, the incorporation of electron rich bridging ligands, e.g. formamidinate or 
orthometalated phosphine ligands, leads to an electron rich dimetal core which renders 
the monodentate eq CH3CN ligands labile even in the absence of light. The use of the 
better electron accepting CH3NC ligand results in the formation of partial paddlewheel 
dirhodium isocyanide complexes, in which the eq CH3NC ligands bind so strongly to the 
dimetal center that they are stable even with light irradiation. By using the less electron-
donating pyridinate ligand with different substituents as described in Chapter IV, one 
can systematically tune the electronic structures of the dirhodium complexes which 
further sheds light on the structure/reactivity relationships for this class of partial 
paddlewheel dirhodium complexes.  
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     Given the above issues, a promising idea is to coordinate CH3NC ligands to cis-
[Rh2(mhp)2(CH3CN)6][BF4]2 for which it is known that the eq CH3CN ligands are less 
labile than those in cis-[Rh2(DTolF)2(CH3CN)6][BF4]2 but more labile than those in the 
case of cis-[Rh2(O2CCH3)2(CH3CN)6][BF4]2. Therefore, the resulting compound, namely 
cis-[Rh2(mhp)2(CNCH3)6][BF4]2, is expected to possess stable eq CH3NC ligands in the 
dark but may achieve the desired photolability upon visible light irradiation. 
     Partial paddlewheel dirhodium complexes with formamidinate bridging ligands 
presented in Chapter III and those with orthometalated phosphine bridging ligands in 
Chapter IV exhibit very different photophysical properties, further underscoring the 
important role of the bridging ligands. Of particular interest, preliminary studies on 
compound 9 from Chapter III, namely cis-[Rh2(DTolF)2(dpq)2(CH3CN)][BF4]2 indicate 
its ability to catalytically reduce H
+ 
to H2 upon visible light irradiation in the absence of 
any external photosensitizer. This result opens up a new strategy for incorporating the 
water reduction catalyst and photosensitizer into a single molecule without the 
complicated synthesis and purification processes. Moreover, compounds based on this 
strategy can also eliminate the undesired electron transfer process from the 
photosensitizer to the water reduction catalyst, thereby increasing the efficiency of the 
H2 production process. We propose that the H2 production ability of compound 9 is 
closely related to the highly reducing 
3
MC excited state, which can facilitate the 
formation of Rh hydride species. Therefore, the development of other dirhodium 
complexes with a similar structural type should also utilize electron rich donating 
ligands to render the excited states of the dirhodium complexes highly reducing. For 
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example, oxopyridinate or acetamide ligands should be utilized to further tune the 
properties of this type of partial paddlewheel dirhodium complexes. In this vein, 
compounds cis-[Rh2(xhp)2(CH3CN)6][BF4]2 and cis-[Rh2(NHCOCH3)2(CH3CN)6][BF4]2 
are readily available as the synthetic precursors for compounds cis-[Rh2(xhp)2(N-
N)2][BF4]2 and cis-[Rh2(NHCOCH3)2(N-N)2][BF4]2 (N-N = dpq, dppz or dppn ligands).  
Improving water solubility 
For the better performance as catalysts or as anticancer agents, one goal of primary 
importance is to develop complexes with higher water compatibility as compared to the 
current ones. For example, the complexes cis-[Rh2(DTolF)2(N-N)2]
2+
 and cis-[Rh2(F-
form)2(N-N)2]
2+
 in chapter III as well as cis-[Rh2[Ph2P(C6H4)]2(N-N)2]
2+
 in chapter V 
(N-N = dpq, dppz, dppn) have very limited water solubility. 
     The introduction of hydrophilic groups (carboxylic acids
231
, sulfonic acids
232-234
 or 
ammonium groups
235
) onto the scaffold of organic ligands is an effective way of 
imparting higher water solubility to coordination complexes. Diarylformamidine ligands 
offer many possibilities for the improvement of water solubility through variation of the 
substituents at different positions on the phenyl groups. The proposed synthetic route for 
formamidine ligands with sulfonate/carboxylate groups is outlined in Figure 6.1. 
     Another commonly applied strategy to enhance water solubility of organic ligands is 
to incorporate hydrophilic peptides as functional groups. One common linker group 
between the organic ligands and the peptides is carboxylate,
236
 which can be readily 
attached to the formamidine ligands according to the synthetic route depicted in Figure 
6.1. The structures of the proposed peptides 
237-238
 are displayed in Figure 6.2 and the  
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Figure 6.1 Synthetic route for formamidine ligands bearing sulfonate or carboxylate 
groups. 
 
 
 
 
 
 
 
Figure 6.2 Structural representations of the proposed peptides to enhance the water 
solubility of the formamidine ligands. 
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Figure 6.3 Synthetic routes for the coupling reaction between peptides and formamidine 
ligands. 
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detailed procedure for the coupling reactions between the carboxylate group and the 
peptides is described in Figure 6.3. 
239
 
     Betaine (Figure 6.4) is a chemically neutral zwitterion with a positively charged 
cationic group and a negatively charged functional group. It is widely used in biology 
and biochemistry to increase the water solubility of various types of drugs and 
proteins.
240 - 241
 The proposed synthetic route for formamidine ligands bearing a 
sulfobetaine group is detailed in Figure 6.4. The sulfobetaine can be easily obtained by 
the reaction of a tertiary amine with 1,3-propanesultone in toluene.
242
 The resulting 
product is then reacted with the p-iodoaniline in DMF catalyzed by [Pd(0)(PPh3)4] 
through a Sonogashira cross-coupling reaction to form the para-substituted aniline.
243
 
Subsequent reaction with triethylorthoformate generates the desired formamidine ligands.  
 
 
 
 
Figure 6.4 Schematic representation of trimethylglycine (betaine). 
 
 
 
Design of dual functionality PDT agents for cancer therapy 
One burgeoning area in the development of effective PDT anticancer drugs is the design 
and synthesis of dual-action phototherapeutic agents. For example, Turro and coworkers 
designed several Ru(II) complexes with 5-CNU (5-CNU = 5-cyanouracil, an anticancer 
active drug) as the monodentate ligands (the structural representation of cationic unit of 
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compound [Ru(tpy)(5-CNU)3]Cl2 is shown in Figure 6.5). Upon light irradiation, the 5-
CNU molecule can be released from the parent compounds. Therefore, the in situ 
generated compounds, 5-CNU and Ru(II) complex have synergic effect and can achieve 
higher cytotoxicity towards cancer cell. 
222,244
  
 
 
 
 
Figure 6.5 Structural representation of [Ru(tpy)(5-CNU)3]
2+
. 
 
 
 
     The same strategy can also be applied to synthesize photoactive Rh2(II,II) compounds. 
For example, it has been shown in chapter V that the complex H-H cis-
[Rh2(fhp)2(CH3CN)6][BF4]2 has two relatively labile eq CH3CN in the dark which 
undergo ligand exchange with the CD3CN molecules. Therefore, it is reasonable to react 
the complex with 1 eq of diimine ligand, e.g. dpq, to replace these two labile CH3CN 
ligands. The resulting product, cis-[Rh2(fhp)2(dpq)(CH3CN)3][BF4]2 should be able to 
subsequently undergo substitution reactions with the 5-CNU ligands to generate cis-
[Rh2(fhp)2(dpq)(5-CNU)3][BF4]2. The detailed synthetic route is described in Figure 6.6 
Presently, compound cis-[Rh2(fhp)2(dpq)(CH3CN)3][BF4]2 has been successfully 
synthesized, the identity of which was confirmed by an X-ray crystallographic study 
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(Figure 6.7); the purity was verified by 
1
H-NMR spectroscopy (Figure 6.8). The four 
resonances at ~ 9.70, 9.29, 9.00 and 8.19 ppm correspond to the dpq ligand, while the  
 
 
 
 
Figure 6.6 Detailed synthetic route to generate cis-[Rh2(fhp)2(5-CNU)3][BF4]2. 
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Figure 6.7 Thermal ellipsoid plot for compound cis-[Rh2(fhp)2(dpq)(CH3CN)3][BF4]2 at 
the 50% probability level. Anions and hydrogen atoms were omitted for the sake of 
clarity. 
 
 
 
 
Figure 6.8 
1
H-NMR spectrum for cis-[Rh2(fhp)2(dpq)(CH3CN)3][BF4]2 in the aromatic 
region measured in CD3CN at room temperature. 
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three resonances at ~ 7.64, 6.66, and 6.27 ppm result from the three different types of 
protons on the bridging fhp ligands. 
     In conclusion, the dirhodium complexes described in this thesis constitute new 
families of compounds that exhibit interesting and intriguing structural and electronic 
properties. Further studies involving the new compounds described in the chapter and 
their respective applications, such as photocatalyzing water reduction to generate H2 and 
PDT agents for cancer, are currently in progress.    
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